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1. General: the marginal zone as an anatomical compartment
The spleen is the largest secondary lymphoid organ of the body that filters the blood, to remo-
ve bacteria, virusses, dead cells, cellular debris, immune complexes etc, and where adaptive 
immune responses towards blood-borne antigens take place (Cesta, 2006; Hofmann et al., 
2010; Steiniger et al., 2006). Anatomically, the spleen is divided into two main compartments, 
the red pulp (RP) and the white pulp (WP) (Figure 1). 
 
Figure 1. Histological structural organization of the rat spleen. The spleen is divided into red pulp (RP) 
and white pulp (WP) regions. The WP are further divided into B and T lymphocyte regions including the 
follicles, marginal zone and periarteriole lymphatic sheath (PALS). Visible in the WP are a secondary fol-
licle i.e. a follicle containing a germinal center. The marginal zone (MZ) forms an interface between the RP 
and the WP. The MZ is further separated from the follicle and PALS by the marginal sinus.
The RP is primarily responsible for filtering of the blood. The RP consists of a sinusoidal 
venous system and RP cords. Blood vessels that carry blood into the spleen deliver their 
contents largely “open” into the spleen. The venous sinuses of the RP collect the blood again. 
The RP cords are characterised by loose lymphatic tissue that harbour mainly macrophages, 
plasma cells and lymphoid cells. Macrophages in the RP not only function in removal of an-
tigens, dead cells and immune complexes from the circulation but also to recycle heme iron 
from senescent red blood cells.
The WP is arranged around blood vessels (arterioles) and is mainly composed of lympho-
cytes, in addition to a variety of non-lymphoid cells. T and B cells are predominantly, but not 
exclusively, located in their own distinct compartments, the pariarteriolar lymphocyte she-








































aths (PALS) and follicles, respectively. The follicles contain recirculating B cells, which are 
in search for their appropriate antigen. Most B cells in these follicles are naive IgM and IgD 
expressing B cells which are called follicular B (FO-B) cells. Upon antigenic stimulation with 
protein antigens, areas of proliferating B cells can be found within these follicles, the so-called 
germinal centers (GC). GC’s are sites where memory B cells are generated, a process that 
is associated with class switch recombination (CSR) and somatic hypermutation (SHM) of 
the immunoglobulin (Ig) genes (Victora and Mesin, 2014). Although the classical mechanism 
of CSR involves direct switching from IgM to any other class (isotype) of Ig molecule, CSR 
can also occur sequentially from IgM via IgG to IgA (van Zelm, 2014) or e.g. from IgG to IgA 
(Takahashi et al., 1986). SHM is the process whereby point mutations are introduced in the 
variable (V) region of Ig genes of B cells. In addition to follicles, a second large, anatomically 
distinct, B cell compartment is found in the spleen: the marginal zone (MZ). The MZ is located 
around the PALS and follicles and forms the interface between the splenic WP and RP (Pillai 
and Cariappa, 2009). The MZ is highly vascularized, similar to the RP, but can be distinguised 
from the RP by the presence of densely arranged lymphocytes. In rats and mice (Figure 2), 
but not in humans, the MZ is separated from the WP by the marginal sinus. This sinus is very 
porous, by gaps in the endothelium that lines the sinusoids, allowing the transit of lymphocy-
tes and dendritic cells (DC) from the circulation to enter the WP. The MZ is largely composed 
of a unique subpopulation of B cells, the so-called MZ-B cells, in addition to non-lymphoid 
cells i.e. MZ macrophages (MZM), marginal metallophilic macrophages (MMM) and DC. 
In mice, MZM can be distinctively recognised by the expression of MARCO (macrophage 
receptor with collagenous structure) and C type lectin SIGN-R1, whereas MMM express 
SIGLEC 1 (Sialic acid-binding lectins 1) (Munday et al., 1999). In humans, marginal sinus and 
MMM are absent (Steiniger et al., 2006). Another structural difference between MZ in human, 
mice and rats is that humans contain a fibroblast-like layer that express mucosal vascular ad-
dressin cell-adhesion molecule 1 (MAdCAM-1), which divides the MZ into an inner and outer 
layer. These fibroblasts are often associated with an accumulation of CD4+ T cells, which are 
also absent in rodent spleens (Steiniger et al. 2001). MAdCAM-1 is also expressed on endo-
thelial cells of the marginal sinus in mice, but not in the spleens of rats (Iizuka et al., 2000).
In rodents, the response of MZ-B cells to infectious agents present in the blood is facilitated 
by the leaky MS endothelial layer that is adjacent to the MZ. Part of the blood that exits the 
circulation enters the spleen through the MS and therefore brings MZ-B cells in close con-
tact with blood borne pathogens. In humans a so-called perifollicular zone (PFZ) is located 
between the MZ and the RP. This zone is not present in rodents. Because of the terminal 
capillaries that directly open in the PFZ, Steiniger et al. proposed that the PFZ serves as exit 
for recirculating CD4+ T cells and B cells from the general circulation into the WP (Steiniger et 








































al., 2001). In addition, the PFZ contains other blood cells such as erythrocytes, macrophages 
and monocytes. Together, the anatomical location of the MZ in close proximity with the RP 
and the rich supply with blood makes it the ideal environment to make initial contact with blood 
borne pathogens. 
 
Figure 2. Diagram of the rat spleen highlighting the anatomical location and cellular composition of the 
MZ. The MZ contains marginal zone B (MZ-B) cells, MZ macrophages, marginal metallophilic macropha-
ges and dendritic cells (DC). Blood that exit the circulation via central arterioles enter the spleen through 
the marginal sinus and therefore bring the MZ-B cells in first contact with blood to remove and detect 
blood borne pathogens (reproduced with permission from (Cyster, 2000)).
2. Marginal zone B cells
2.1. Phenotype
MZ-B cells have been described as a distinct cell type with an unique cell surface phenotype 
and physiological function (Garraud et al., 2012; Martin and Kearney, 2002; Mebius and Kraal, 
2005; Pillai and Cariappa, 2009; Zouali and Richard, 2011). In rats and mice, MZ-B cells are 
IgMhighIgDlowCD21highCD23low cells that distinguish them from the majority population of naïve, 
recirculating, FO-B cells in these animals, which are IgMlowIgDhighCD21intermediateCD23high (Figure 
3). 
In mice MZ-B cells also characteristically express high levels of CD1d, a MHC class-I like 
































































2000). In rats, MZ-B cells can be further discriminated from FO-B cells by their low levels of 
CD45R, recognized by the HIS24 monoclonal antibody (Kroese et al., 1987b) and high levels 
of binding to the monoclonal antibody HIS57, directed to an undefined molecule (Dammers et 
al., 1999). In rats, CD90 (Thy-1) distinguishes immature B cells from mature B cells (Kroese 
et al., 1995); mature MZ-B cells lack therefore CD90.
Also human MZ-B cells are IgMhigh and IgDlow (Weill et al., 2009). Importantly, human MZ-B 
cells also express CD27 (Klein et al., 1998; Tangye et al., 1998; Weller et al., 2004b; Zand-
voort et al., 2001). CD27 is a member of the TNF-receptor family, and is in humans expressed 
by memory B cells (Klein et al., 1998). Klein and colleagues observed that not only class swit-
ched B cells express CD27, but that in human peripheral blood also IgM+IgD+CD27+ B cells 
are present in large numbers (Klein et al., 1998). Studies by Weller et al. (Weller et al, 2004) 
revealed that these IgM+IgD+CD27+ B cells in blood have a similar gene expression profile as 
splenic MZ-B cells, suggesting that peripheral blood IgM+IgD+CD27+ B cells may represent 
circulating MZ-B cells. In humans, these IgM+IgD+CD27+ B cells in the blood are also called 
natural effector cells (Tangye and Good, 2007). In line with the notion that the IgM+IgD+CD27+ 
B cells are circulating MZ-B cells is the observation that numbers of IgM+IgD+CD27+ B cells 
in blood are reduced after splenectomy and are almost completely undetectable in children 
younger than 2 years of age, when also mature MZ-B cells are absent in spleen (Kruetzmann 
et al., 2003). This absence of MZ-B cells in very young children is associated with a reduction 
in antibody responses to encapsulated bacteria (Timens et al., 1989b). In humans MZ-B cells 
(or at least MZ-B like cells) are not only found in spleen and blood but are also present in other 
human lymphoid sites such as the inner wall of the subcapsular sinus in lymph nodes (Spen-
cer et al., 1998), in the crypt epithelium of tonsils (Dono et al., 2000), and under the dome epi-
thelium of Peyer’s patches in gut-associated lymphoid tissues (GALT) (Spencer et al., 1985). 









































Figure 3. Immunohistology structure of the rat spleen stained for IgM and IgD. B cells located in marginal 
zone and follicles of the spleen have a distinct phenotype and express reciprocal levels of cell surface 
molecules recognized by mouse anti-rat IgM and mouse anti-rat IgD mAb’s. MZ-B cells are IgMhighIgDlow 
and FO-B cells are IgDhighIgMlow. Visible is also the PALS which is mainly a T cell zone.
2.2. Activation
The activation status of MZ-B cells also distinguishes these cells from FO-B cells. Even “res-
ting” MZ-B cells seem to be in a kind of “pre-activated” state as e.g. reflected by their larger 
size with nuclei that are more pale and irregular, as well as their higher levels of B7.1/CD80 
and B7.2/CD86 on their cell membrane, compared to FO-B cells (Oliver et al., 1999). Further-
more, in vitro studies have shown that MZ-B cells have less stringent requirements for their 
activation, causing MZ-B cells to react more rapidly in comparison to FO-B cells (Martin et al., 
2001). MZ-B cells require lower levels of lipopolysaccharide (LPS) antigens for their activa-
tion compared to FO-B cells (Martin et al., 2001; Oliver et al., 1999). MZ-B cells also express 
high levels of complement receptor (CR) CD21 (Timens et al., 1989a) and toll like receptors 
(TLR’s) (Gunn and Brewer, 2006). These high levels of CR and TLR’s underline the fact that 
MZ-B cells are equipped for rapid and easy activation in (primary) immune responses (Fer-
guson et al., 2004; Snapper et al., 1993). MZ-B cells can respond to both T-cell independent 
(TI) antigens and T-cell dependent (TD) antigens (Liu et al., 1991). Upon the engagement of 
antigens through their B cell receptor (BCR) and/or in cooperation with either the CR CD21, 
(Molina et al., 1996) or TLR’s (Pone et al., 2012) MZ-B cells can become activated. The acti-
vation of MZ-B cells can be enhanced by macrophages and dendritic cells in the MZ through 
the secretion of cytokines such as BAFF (B cell activating factor) and APRIL (a proliferation 
inducing ligand) (Litinskiy et al., 2002). Human splenic MZ also contain IgG+ cells (Ettinger 
et al., 2007). Uniquely these IgG+ MZ-B cells can be synergistically stimulated by IL-21 and 
BAFF, a member of the TNF family, to induce B-lymphocyte-induced maturation protein-1 








































(BLIMP-1) in the absence of any further co-stimulation (Ettinger et al., 2007). BLIMP-1 is an 
essential transcription factor for the differentiation of B cells to plasma cells. In vitro assays 
have shown that IL-21 and BAFF are secreted respectively by CD4+ T cells (Coquet et al., 
2007; Kobayashi et al., 2009) and DC (Fayette et al., 1998). In view of this, Ettinger et al. 
(Ettinger et al., 2007) speculated that IgG+ MZ-B cells contribute to serological memory in an 
antigen-independent fashion. 
2.3. Function of marginal zone B cells
Although MZ-B cells can respond to both TD-antigens (Gatto et al., 2007) and TI-antigens 
(Martin et al., 2001), they were initially thought to play an indispensable role in the protection 
against polysaccharide antigens (Guinamard et al., 2000). MacLennan and co-workers were 
the first to propose that MZ-B cells in rats are involved in immune responses directed against 
Type 2, T cell independent (TI-2) antigens (MacLennan et al., 1985). These antigens are 
polysaccharide antigens, expressed by the surface of encapsulated bacteria. Much of the 
currently available evidence of this function of MZ-B cells is, however, largely circumstantial, 
i.e. absence of MZ-B cells results in reduced antibody responses towards these kinds of 
antigens. For example, tyrosine kinase (Pyk-2) deficient mice lack MZ-B cells and this result 
in a marked suppression of IgM, IgG3 and IgG2c antibody production when immunized with 
TI-2 antigens (Guinamard et al., 2000). In addition to their involvement of anti-polysaccharide 
responses MZ-B cells also have the ability to launch polyreactive antibody responses (Chen 
et al., 1997). In humans polyreactive antibody responses i.e. the binding of an antibody to 
several different structural antigen elements, are associated with shorter sequence lengths of 
heavy chain complementary determining region 3 (H-CDR3) regions (Schroeder et al., 1995). 
In accordance with this finding our group also showed that, on average, MZ-B cells have a 
shorter H-CDR3 length compared to FO-B cells in rats (Dammers et al., 2000b). 
Available evidence thus suggests that MZ-B cells are polyreactive and directed against TI-2 
antigens. Polysaccharide antigens are present on the surface of bacteria such as Hemophilus 
influenzae, Streptococcus pneumoniae and Neisseria meningitides (Guinamard et al., 2000; 
Martin et al., 2001). The strategic location of MZ-B cells and their “pre-activated” state make it 
possible for MZ-B cells to make a rapid response to foreign particles in the blood, in particular 
caused by encapsulated bacteria. This response was found to occur as rapid as 3 days after 
immunization with TI-2 antigens, producing massive plasmablast in the bridging channels the 
areas where the PALS borders the RP directly, and also in the RP itself (Martin et al., 2001). 
Studies by Balazs et al. (Balazs et al., 2002) have shown that blood-derived neutrophils and 
DC carrying bacterial cargo can interact with splenic MZ-B cells. Puga et al. (Puga et al., 
2012) have implicated the involvement of neutrophils to assist B cells in the clearance of TI-2 
antigens. These authors observed that neutrophils exclusively present in the spleen stimulate 








































IgM production to TI-2 antigens such as LPS and even do so better then MZM, DC and as 
effective as CD4+ helper T cells. Furthermore, they showed that neutrophils stimulate MZ-B 
cells to upregulate the expression of activation induced deaminase (AID), the different class 
(isotype) switched transcripts and also show that in the presence of neutrophils MZ-B cells 
accumulate SHM. In conclusion, neutrophils activate MZ-B cells via BAFF, APRIL and IL-21 
to make antibody responses to LPS (Puga et al., 2012). 
A newly defined subset of innate lymphoid cells (ILC) ILC’s has been identified in the splenic 
MZ by Magri et al. (Magri et al., 2014). Several subsets of ILC can be discriminated based 
on their cytokine secretion profiles (Walker et al., 2013). Magri and co-workers showed that 
these MZ-related ICL’s activate MZ-B cells through BAFF, the ligand of the costimulatory fac-
tor CD40 (CD40L) and notch2 ligand Delta-Like 1 (DLL1) molecule. They further showed that 
these ICL’s amplify the response of MZ-B cells by activating neutrophils through granulocyte 
macrophage-colony stimulating factor (GM-CSF). Importantly, the depletion of ICL’s results 
in the impairment of TI antibody responses and reflect the involvement of ILC’s in MZ-B cell 
responses against TI blood borne particulate antigens. IL-7 is required for the development of 
ILC’s (Satoh-Takayama et al., 2010). Importantly, Willems et al. (Willems et al., 2011) using 
IL-7 deficient mice, have demonstrated that IL-7 signaling is required in the development of 
the intrinsic MZ-B cell function to rapidly induce IgM production against polysaccharide anti-
gens, providing additional evidence that ILC’s are involved in MZ-B cell responses. 
2.4. Exit of activated marginal B cells from the marginal zone 
Activation of MZ-B cells induces their migration from the MZ. Either, they shuttle between the 
MZ and follicular areas (Cinamon et al., 2008) or they proliferate and differentiate to plasma-
blasts leading to the generation of extrafollicular foci (Liu, 1997; MacLennan et al., 2003). It 
is possible that the type of antigens i.e. TI-antigens or TD-antigens might be responsible for 
diverting the development of activated MZ-B cells into either the follicular or the extrafollicular 
pathway (MacLennan et al., 2003). Antigens can stimulate the exit of MZ-B cells from MZ by 
inducing the downregulation of SIP1 and SIP3 (Cinamon et al., 2004) and by the upregulation 
of chemokine receptor CXCR5 (Cinamon et al., 2008; Lu and Cyster, 2002). The expression 
of CXCR5 allows MZ-B cells to be attracted along a gradient induced by chemokine CXCL13 
produced by i.e. follicular dendritic cells (FDC’s) in the follicles. When MZ-B cells bind either 
to TD-antigens (Liu et al., 1988) or TI-antigens (Vinuesa et al., 2001) with their BCR in com-
bination with crosslinking to the complement receptor CD21 (as part of the BCR co-receptor) 
they become permissive to make a cognate interaction with CD4+ T cells at the T-B cells 
border (outer PALS) in the spleen where they can proliferate and produce an antibody res-
ponse (Liu et al., 1988) forming extracellular foci or further proliferate inside the follicles to 
form GC. Possibly, TI-antigens stimulate MZ-B cells to proliferate and differentiate to become 








































plasmablasts at extracellular foci, whereas TD-antigens will most likely cause the migration of 
MZ-B cells into the follicles to generate GC. Although a role of MZ-B cells in the generation of 
plasmablasts/-cells is well known, their capacity to generate GC is less well understood. The 
work of Song and Cerny (Song and Cerny, 2003) have shed some light on this aspect. They 
provide experimental evidence showing that MZ-B cells are capable to form GC albeit with 
a delay in comparison to FO-B cells. However it is still unclear what signals determine the 
divergence into either the GC independent (i.e. extrafollicular foci) or GC dependent pathway.
3. Heterogeneity of marginal zone B cells and their 
developmental origin
3.1. Naive marginal zone B cells
Naive MZ-B cells are antigen-inexperienced cells which express germline (unmutated) en-
coded immunoglobulin variable (IGV) region genes, whereas memory B cells are antigen-
experienced cells that carry somatically mutated IGV region genes which are selected during 
the humoral immune responses by the immunizing antigen. Both naïve and memory B cells 
are present in the MZ, but their relative frequencies appear to be different dependent upon 
the species. In rodents the vast majority (>80%) of the B cells located in the MZ express IgM 
encoded by unmutated IGHV region genes, whereas in humans only a small percentage of B 
cells present in the MZ express unmutated IGHV genes (Dammers et al., 2000b; Makowska et 
al., 1999). These cells thus likely represent naïve, IgM+ MZ-B cells. In rats, MZ-B cells appear 
to be derived from (mature) FO-B cells (Dammers et al., 1999; Kumararatne and MacLennan, 
1981). In the mouse, newly generated immature B cells are called early transitional B cells. 
Three populations, designated as T1, T2 and T3 cells, have been identified in this species 
(Allman et al., 2001), of which T2 cells can subsequently either become FO-B cells or MZ-B 
cells (Srivastava et al., 2005). Not all FO-B cells (rats) or T2 B cells (mice) develop into MZ-B 
cells. Naïve MZ-B cells have a somewhat shorter H-CDR3 region compared to FO-B cells in 
rats (Dammers et al., 2000b) and mice (Carey et al., 2008). Apparently there is some form of 
selection of B cells that may enter the MZ-B cell pool. Dammers and colleagues have specu-
lated that in rats a more tonic signaling of the BCR of MZ-B cell precursor cells would result 
in positive selection of these B cells into the MZ-B cell compartment (Dammers et al., 2000). 
They also reasoned that this enhanced tonic signaling might be the consequence of shorter 
H-CDR3 region, which leads to multireactivity and hence also more (low-affinity) binding of 
autoantigens to the BCR (Dammers and Kroese, 2005). As mentioned above, in mice there 
is a checkpoint for cells to become either FO-B cells or MZ-B cells at the T2 cell stage. Also 
Pillai and colleagues (Cariappa et al., 2001) argue that signaling strength determines to which 
B cell subset the cells develop, but in contrast to rats they reasoned that reduced tonic signa-








































ling results in MZ-B cells. Different signaling proteins such as Btk (Bruton’s tyrosine kinase), 
Aiolos (a zinc finger protein of the Ikaros family), MINT (MSH-homeoboxhomologue 2-interac-
ting nuclear target), neurogenic locus notch homolog protein 2 (Notch2) and protein tyrosine 
kinase (Pyk-2) contribute to BCR signaling in the development of either FO-B cells or naïve 
MZ-B cells in mice (Mebius and Kraal, 2005; Pillai and Cariappa, 2009). Sufficient stimulation 
by (self) antigens will allow BCR signaling via activation of the Btk pathway, to induce FO-B 
cell development, whereas lower stimulation induces MZ-B cell development (Cariappa et al., 
2001). Aiolos is a negative regulator of Btk and absence of Aiolos will therefore enhance BCR 
signaling. As a consequence, precursor B cells preferentially develop into FO-B cells, at the 
expense of MZ-B cells, which are significantly reduced in Aiolos-/- mice (Wang et al., 1998). 
Notch-2 signaling has been shown to be indispensable for development of MZ-B cells. In 
mice with a conditionally targeted deletion of Notch-2 mice their T2 precursor cells and MZ-B 
cells do not develop (Saito et al., 2003). The work of Saito et al. (Saito et al., 2003) have also 
shown that Notch-2 are preferentially expressed on mature B cells whereas Descatoire et al. 
(Descatoire et al., 2014) have shown that Notch-2 ligand Delta-Like1 expression on precursor 
MZ-B cells results in the development of MZ-B cells. MINT acts as a negative regulator of Not-
ch-2. MINT deficient B cells differentiate more effectively into MZ-B cells (Kuroda et al., 2003). 
Studies by Astier et al. (Astier et al., 1997) revealed in both transformed and normal human 
B cells that Pyk-2 phosphorylation is induced by integrins and BCR ligation. Pyk-2 deficient 
mice fail to develop into MZ-B cells and therefore also Pyk-2 is considered to be important 
in the development of MZ-B cells (Guinamard et al., 2000). Together, these data support the 
notion that variable levels of BCR-mediated activation are required for either FO-B or MZ-B 
cell development. Since also MZ-B cells from neonatal and germfree animals already express 
shorter H-CDR3 regions, we speculated that endogenous (auto) antigens are involved as 
ligand in this (positive) selection of naive MZ-B cells (Dammers and Kroese, 2005). 
3.2. Memory B cells
Memory B cells provide the host with long term protection against pathogens. These B cells 
launch a rapid humoral immune response upon secondary stimulation. The Ig’s produced by 
memory B cells have a high affinity for antigens. Memory B cells are generally thought to be 
generated within a GC (see below) (Figure 4). GC’s are specialized areas arising in primary 
lymphoid follicles in response to foreign antigenic stimulation or immunization. At these sites 
memory B cells are generated. These cells are generally characterized by the expression of 
high-affinity, class switched Ig classes (MacLennan, 1994; Thorbecke et al., 1994; Victora and 
Mesin, 2014). In these structures high-affinity antigen-specific B cells are generated by SHM 
of IGV genes followed by positive selection. GC B cells can be distinguished by the expres-
sion of distinctive markers. Peanut agglutinin (PNA) was originally reported to probe for GC 
by the group of Thorbecke et al. (Coico et al., 1983). Additional surface markers have been 








































discovered to distinguish GC cells from other mature B cells e.g. in humans CD77 (Hogerkorp 
and Borrebaeck, 2006), CD38 (Pascual et al., 1994), CD55 and CNA.42 (Kasajima-Akatsuka 
and Maeda, 2006), and in mice GL7 (Balogh et al., 2010). At a molecular level, memory B 
cells are characterized by the presence of somatically mutated IGV genes. Memory B cells 
can either be class switched, or non-class switched B cells. In rats and mice a minor fraction 
(10%-20%) of the MZ-B cells carries SHM IGV genes and are therefore considered to re-
present memory B cells (Dammers et al., 2000b; Makowska et al., 1999). Early experiments 
by Liu et al. (Liu et al., 1988) in rodents have provided evidence that GC derived memory 
antigen-specific B cells can colonize the MZ. This was further supported by the work of Gatto 
et al. (Gatto et al., 2007; Gatto et al., 2004) who observed QB-specific IgG expressing B cells 
after immunization with viral QB capsid that remain associated with the MZ in mice. 
In contrast to rodents, in humans the proportion of mutated B cells in the MZ is much larger: 
more than 90% of the B cells carry mutated Ig’s (Dunn-Walters et al., 1995). Furthermore 
in adults, as mentioned before, nearly all splenic MZ-B cells express CD27 (Tangye et al., 
1998; Zandvoort et al., 2001), which is a marker for mutated (memory) B cells (Klein et al., 
1998). The origin of these CD27+ MZ-B cells in humans is hotly debated in the literature. On 
one hand some authors (Seifert and Kuppers, 2009; Tangye and Good, 2007) consider these 
cells as bona fide GC derived memory B cells, whereas others (Weill et al., 2009; Weller et 
al., 2004a; Weller et al., 2008) proposed that these cells mutate their Ig receptor outside the 
GC during their generation. This last conclusion was largely based upon the observation that 
the IGHV genes of MZ-B cells are also mutated in patients with hyper IgM type I syndrome 
(Weller et al., 2001). Hyper IgM type I patients are characterised by a mutation in the CD40L 
gene and therefore do not express functional CD40L protein. These patients cannot generate 
GC or produce class switched Ig molecules. Because these patients lack GC, but still have 
MZ-B cells, the authors proposed that CD27+ MZ-B cells are apparently not generated inside 
GC and therefore are distinct from the classical GC derived memory B cells. The authors 
postulate that mutations are introduced during their generation, outside the GC’s in a T cell 
and antigen independent fashion, and that the reason for these mutations is to diversify their 
primary Ig repertoire. 
3.3. Germinal centers: A source of memory B cells
Although other pathways are proposed for the development of memory B cells, GC’s are still 
considered as the primary site for memory B cell development (Takemori et al., 2014). In 
brief, upon infection or immunization in a TD immune response a few (1-3) precursor B cells 
(Jacob and Kelsoe, 1992; Kroese et al., 1987c) are recruited to the follicles of secondary 
lymphoid organs, were they rapidly expand. The initiation step for GC formation involves the 
cognate interaction of B cells and follicular helper CD4+ T (Tfh) cells at the border between 








































the T cell zone and the B cell follicle (Garside et al., 1998; Kerfoot et al., 2011; Okada et al., 
2005). B cells receive help of Tfh cells via CD40L expressed on T cells (Kawabe et al., 1994a) 
and Interleukin 21 (IL-21) (Linterman et al., 2010) to proliferate and seed a primary follicle to 
become a GC. A fully developed GC develops into two zones i.e. dark zone (DZ) and a light 
zone (LZ) (Victora et al., 2012). In the DZ B cells proliferate. These proliferative B cells are 
known as centroblasts and express Ki-67 and CD77. Centroblasts upregulate AID (Kolar et 
al., 2007; Muramatsu et al., 2000) to undergo SHM and CSR. AID is an enzyme that belongs 
to the cytosine deaminase family and it has been shown to be indispensable for both SHM 
and CSR (Arakawa et al., 2002; Muramatsu et al., 2000; Petersen-Mahrt et al., 2002; Revy 
et al., 2000). AID expression is induced upon antigen stimulation and is predominantly ex-
pressed in GC B cells (Muramatsu et al., 1999). The ultimate aim of SHM is to generate high 
affinity antibodies, whereas CSR will change the functionality of the secreted antibodies. Cen-
troblasts that exit the DZ become centrocytes and form the so-called LZ, which are CD77-. In 
the LZ these cells are positively selected for their affinity to the antigen that induces the GC 
reaction. FDC and Tfh cells both located in the follicles play a critical role in this process. In the 
LZ centrocytes test their newly develop hypermutated Ig receptors by binding and processing 
antigens presented on FDC. These centrocytes present antigen peptides to Tfh cells and can 
return to the DZ to further increase their affinity against the specific antigen. Positive selection 
occurs when centrocytes with a higher affinity for the antigen present on FDC receive more 
help from Tfh cells compared to B cells with lower affinity (Cerutti et al., 2012; Victora and 
Nussenzweig, 2012). Tfh deliver survival signals to B cells via CD40L, ICOS and cytokines 
(Cerutti et al., 2012). Most GC B cells also undergo CSR. In vitro studies have shown that 
CSR by B cells require both ligation of CD40 by CD40L on T cells and T cell derived cytokines 
(Tangye et al., 2002). Memory B cell development is driven by IL-4 that induces Bcl-6 through 
STAT-6 (STAT: signal transducers and activators of transcription), a transcription factor that is 
essential for IL-4 induction of CSR to IgG1 (Linehan et al., 1998). A unique profile of cytokines 
will induce a particular isotype. In mouse for example CD40 in the presence of IL-4 will induce 
CSR to IgG1 and IgE (Bergstedt-Lindqvist et al., 1988). Conversely, when IL-4 is substituted 
with interferon-gamma (IFN-γ) the CSR is more towards IgG2a in mice. Interestingly Pihlg-
ren et al. (Pihlgren et al., 2013) have provided experimental evidence that in mice lacking 
T cells, CD40L and CD28 B cells can still undergo CSR. This TI IgG class switching was 
strongly driven by ligation of TLR-4 and mediated via TIR-domain-containing adapter inducing 
interferon-β (TRIF). However TI IgG CSR was still associated with GC formation as indicated 
by the expression of PNA, GL-7 and AID on GC B cells. High affinity selected centrocytes 
can either become a plasma cell or a memory B cell, which depends on certain transcription 
factors (Calame et al., 2003; Crotty et al., 2010). Transcription factors, such as paired box 5 
(Pax5), B lymphocyte-induced maturation protein-1 (Blimp-1) and Bcl-6 have been shown to 
play a key role in directing either plasma cell or memory B cell development. Transcription 








































factors Pax-5 and Bcl-6 are required for GC B cells to develop into memory B cells and these 
transcription factors are inhibitory to plasma cell development (Angelin-Duclos et al., 2000; 
Calame et al., 2003). Bcl-6 is a transcriptional repressor that regulates lymphocyte differen-
tiation during immune responses and is particularly highly expressed in GC B cells (Shaffer 
et al., 2000).
Although GC’s are certainly the main site for generation of memory B cells (Shlomchik and 
Weisel, 2012), there is also evidence from studies in mice that memory B cells can develop 
outside GC’s (Good-Jacobson and Shlomchik, 2010; Takemori et al., 2014). Toyama et al. 
(Toyama et al., 2002) have shown that memory B cells can be generated in Bcl-6 deficient 
mice. Although these mice completely lack GC’s, their B cells were able to differentiate into 
IgM and IgG1 memory B cells. Also, CD40 deficient mice that lack GC formation revealed 
normal IgG and IgM responses to TI-antigens (Kawabe et al., 1994b). These have led to 
the proposal that some memory B cells might be formed independent of GC. Also memory 
towards TD antigens can be GC independent as shown by (Kaji et al., 2012). However these 
IgG memory B cells having hallmarks of memory cells, i.e. antigenic experienced B cells that 
express class switched isotype, are unmutated, most likely indicate that mutated memory B 
cells are primarily generated in a GC (Kaji et al., 2012). 
Figure 4. Germinal center: site for SHM, selection and CSR. Illustrated in the above diagram is the GC 
where high affinity antibody-producing B cells are selected. B cells that are activated by an antigen and 
have made contact with a CD4+ Tfh cell initiate the formation of the GC. A fully formed GC contains a 
DZ and LZ. The environment of the DZ and LZ is well suited for the expansion and selection of high af-
finity memory B cells. The DZ contains tightly pack centroblast cells that proliferate and undergo somatic 
hypermutation mutations caused by the AID enzyme either results in antibodies with diminished affinity 
or improved affinity of antibody-antigen binding. These B cells will undergo selection after each round of 
mutations in the LZ. B cells in the LZ that encounter antigen with high affinity from FDCs will internalize 








































the antigen for presentation to antigen activated CD4+ Tfh cells. Activated CD4+ Tfh cells express CD40L 
which binds to CD40 on the B cells, resulting selection of high affinity antibody producing B cells. High 
affinity B cells receive more “help” signals than low affinity B cells. Selected B cells will either differentiate 
into a plasma or memory cell. By cytokine signals CD4+ Tfh cells also instruct B cell to undergo CSR. AID 
is also required for CSR (switching from IgM to IgG, IgA). B cells that binds antigen with low affinity will 
be negatively selected and undergo apoptosis.
4.Introduction to the thesis
In this thesis we aimed at studying the memory compartment of MZ-B cells and compare it to 
recirculating memory B cells present in follicles in the rat. The earliest studies in the rat by the 
group of Liu et al. (Liu et al., 1988) have documented the presence of hapten specific MZ-B 
cells after immunization in the MZ. This work has received later experimental support by the 
group of Kroese et al. (Dammers et al., 2000a) demonstrating that the IGHV-Cµ transcripts 
expressed by phenotypically defined splenic MZ-B cells (defined as CD90negIgMhighIgDlow B 
cells) can carry SHM. However, only a minor fraction (less than 10%-20%) of these MZ-B cells 
is mutated and is considered to represent memory B cells. The presence of mutations in Ig ge-
nes is an important hallmark of memory B cells and determination of nucleotide mismatches 
with their counterpart germline IGHV gene sequence are required to enumerate mutations. In 
order to analyse the presence of these mutations in Ig genes it is therefore necessary to have 
a complete insight into the germline IGHV gene repertoire and understanding of the rat IGHV 
locus. Germline genes refer to the unrearranged DNA (nucleotide) sequences of the different 
IGHV, immunoglobulin heavy diversity (IGHD) and immunoglobulin heavy joining (IGHJ) gene 
segments present at the IGH locus (Figure 5). The chromosomal maps of the IGH locus was 
already published for humans (Matsuda et al., 1998) and the mouse (Johnston et al., 2006), 
but not for the rat. In 2004 the (entire) rat genome was unraveled (Gibbs et al., 2004), alt-
hough a detailed analysis of the IGH loci was lacking. For this analysis genomic sequences of 
the Brown Norway (BN) rat strain were taken. For the analysis of the presence of mutations 
in IGHV genes the availability of genomic sequences of IGHV genes are indispensable. In 
Chapter 2 we therefore aimed at the analysis of these genomic sequences and to give a 
comprehensive description of the organization of the IGH locus in the BN rat. In Chapter 3, 
not only the organization of the IGH locus, but also the organization of the Ig light (IGL) chain 
locus of the rat is reviewed. We used the information of the IGH locus to analyse the presence 
of mutations in rat MZ-B cells. As mentioned before in rats and mice only a minority of the MZ 
B-cells are mutated, in contrast to humans. The reason for this discrepancy is not clear. So 
far the information on SHM in rat and mouse MZ-B cells was limited to only one IGHV family. 
The IGHV locus consist of multiple IGHV genes, which can be subdivided into V gene families 
based on homology of 80% between individual IGHV genes (Brodeur and Riblet, 1984). The 
conclusion by Dammers et al. that in rats only a small fraction of the MZ-B cells are mutated, 








































was based only on the analysis of one IGHV gene family, the IGHV5 (PC7183) gene. This 
study was carried out in the PVG rat strain. As mentioned above, however, the rat IGH locus, 
including germline IGHV gene sequences were from another rat strain, the BN rat (Chapter 
2). For these reasons we analysed in Chapter 4 the presence of mutations in IGHV genes 
expressed by MZ-B cells isolated from BN rats. Furthermore we extended our analysis also 
to other IGHV gene families that contained fewer IGHV gene family members. Analysis was 
done on rearranged IGHV-Cµ (IgM) transcripts derived from FACS defined MZ-B cells (CD90-
IgMhighIgDlow) and these transcripts were compared to such transcripts of FO-B cells (CD90-
IgMlowIgDhigh) to address whether the proportion of 10-20% mutated MZ-B cells are a property 
of the IGHV5 gene family or whether it is uniformly distributed over the other gene families as 
well. Although the GC still prevails as the classical site where memory B cells are generated, 
the origin of mutated IgM expressing MZ-B cells is an issue of much debate. The findings of 
Weller et al. (Weller et al., 2004b) have stirred much attention and discussion on the develop-
ment of IgM memory B cells. These authors proposed that human IgM memory MZ-B cells 
provide the MZ early in life with a diversified and protective preimmune repertoire (formed 
in the absence of antigen) involved in responses against encapsulated bacteria. The lack of 
phenotypically defined MZ-B cells in the blood in infants under 2 years of age and immaturity 
in neonatal rats results in poor immune responses to TI-antigens (Kruetzmann et al., 2003; 
Lane et al., 1986; Timens et al., 1989b). According to Weller et al. (Weller et al., 2004b) IgM 
memory MZ-B cells are distinct from the classical GC-derived memory B cells, as they are 
found in patients that cannot make GC nor class-switched memory cells. These authors pos-
tulated that these cells are generated in a T cell and GC independent fashion, and that these 
mutations are introduced to provide the MZ-B population with a pre-diversified Ig repertoire. 
In Chapter 5 we investigate if a similar pre-diversified (mutated) memory B cell population 
also exists in rats. Since GC are absent in the first few weeks of neonatal rats (Kroese et al., 
1987a; van Rees et al., 1986) analysis of the mutation profiles of IGHV genes from neonatal 
rats might reveal whether mutated IgM MZ-B cells can be generated in an antigen indepen-
dent and GC-independent process in rats as well as proposed by Weller et al. for humans 
(Weller et al., 2004a). In chapter 6 we studied whether in addition to IgM memory MZ-B cells 
also IgG memory MZ-B cells exist in the rat, and if present what the origin is of these isotype 
switched MZ-B cells. They might be derived from GC, as is the case for typical memory B 
cells. In Chapter 6 we analysed the expression of rearranged IGHVDJ-Cγ transcripts in MZ-B 
cells that were defined in an Ig isotype independent fashion. To this end, HIS57highHIS24low 
MZ-B cells were analysed and compared to classical switched isotype IgMnegIgDneg B cells 
and IgG expressing HIS24highHIS57neg FO-B cells. Overall analysis is done on rearranged 
IGHVDJ-Cγ transcripts derived from the respective B cell subsets in terms of the patterns of 
mutations in the IG genes, the usage of the different IGHV genes, H-CDR3 lengths and the 
distribution pattern of IgG subclasses. This analysis may help us to elucidate whether IgG 








































HIS57highHIS24low MZ-B cells are a distinct subset of memory B cells in comparison to other 
classical memory B cells and may give us insights into the origin of these memory MZ-B cells. 
Finally, in Chapter 7 we discuss the findings and implications of this thesis. 
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Chapter 2
Organization of the variable region of the immunoglobulin 
heavy-chain gene locus of the rat.









































We have mapped and annotated the variable region of the immunoglobulin heavy (IGH) 
gene locus of the Brown Norway (BN) rat (assembly V3.4; Rat Genomic Sequence Con-
sortium). In addition to known variable region genes, we found 12 novel previously uni-
dentified functional IGHV genes and 1 novel functional IGHD gene. In total, the variable 
region of the rat IGH locus is composed of at least 353 unique IGHV genes, 21 IGHD 
genes, and 5 IGHJ genes, of which 131, 14, and 4 are potentially functional genes, res-
pectively. Of all species studied so far, the rat seems to have the highest number of functi-
onal IGHV genes in the genome. Rat IGHV genes can be classified into 13 IGHV families 
based on nucleotide sequence identity. The variable region of the BN rat spans a total 
length of approximately 4.9 Mb and is organized in a typical translocon organization. Like 
the mouse, members of the various IGHV gene families are more or less grouped toge-
ther on the genome, albeit some members of IGHV gene families are found intermingled 
with each other. In the rat, the largest IGHV gene families are IGHV1, IGHV2, and IGHV5. 
The overall conclusion is that the genomic organization of the variable region of the rat 
IGH locus is strikingly similar to that of the mouse, illustrating the close evolutionary rela-
tionship between these two species.









































The antigen recognition site of an antibody is the product of a pairing set of immunoglobu-
lin heavy (IGH) and immunoglobulin light (IGL) chain variable domains. Both the IGH-chain 
variable domain and the IGL-chain variable domain are composed of conserved framework 
sequences that alternate with three hypervariable regions, the complementary-determining 
regions (CDRs), which are responsible for actual antigen recognition. The variable domains 
of the IGH chain are encoded by three different genes (or gene segments): variable (IGHV), 
diversity (IGHD), and joining (IGHJ) genes. The IGH gene locus of most mammalian species 
contains a large number of IGHV genes, fewer IGHD genes, and some IGHJ genes (Marcha-
lonis et al., 1998). In many species such as humans, mice, and rats, these gene segments 
recombine by DNA rearrangements during B-cell genesis in the bone marrow. These recom-
binations result in a so-called combinatorial diversity of the variable domain of the heavy chain 
(Yancopoulos and Alt, 1986). Similarly, recombination of IGLV and IGLJ gene segments leads 
to the combinatorial diversity of IGL-chains. Imprecision of the rearrangements by addition 
or removal of nucleotides between the segments during the recombination process results 
in further enlargement of the primary repertoire of the variable domain of both IGH and IGL 
chains (junctional diversity). Another form of combinatorial diversity is created by the com-
bination of IGH and IGL chains that are required to form the actual antigen recognition site. 
All mammals use combinatorial diversity (and junctional diversity) of IGHV, IGHD, and IGHJ 
genes to form a diverse primary preimmune H-chain repertoire (Marchalonis et al., 1998). 
The extent of this combinatorial diversity varies, however, significantly between different spe-
cies (Flajnik, 2002; Marchalonis et al., 1998). Mammalian cross-species comparisons have 
demonstrated considerable divergence in the number and/or expression of IGHV, IGHD, and 
IGHJ genes (Das et al., 2008; Flajnik, 2002; Marchalonis et al., 1998). For example, the 
number of potentially functional germline IGHV genes may vary from only 20 in pigs (Butler 
et al., 2006) to >100 in rats and mice (Das et al., 2008; Johnston et al., 2006). Some mam-
malian species such as rabbit, sheep, and cow use only a very limited number of possible 
IGHV, IGHD, and IGHJ genes (Dufour et al., 1996; Gontier et al., 2005; Mage et al., 2006; 
Saini et al., 1997). In chickens, even only one unique functional IGHV gene is present in the 
heavy-chain locus (Reynaud et al., 1995). Chickens and mammals that use only very few 
IGHV genes must therefore rely on additional mechanisms to compensate for the presence 
of a relatively limited combinatorial preimmune repertoire of their IGH chains. The strategies 
used to form a diverse primary IGH chain repertoire in these species include gene conversion 
in chickens and rabbits (Mage et al., 2006; Reynaud et al., 1995); hypermutation in chickens, 
sheep, and rabbits (Dufour et al., 1996; Gontier et al., 2005; Kothapalli et al., 2008; Mage et 
al., 2006; Reynaud et al., 1995); and extra-long H-CDR3 regions in cows (Saini et al., 1999). 
For a better understanding of the generation of the primary antibody repertoire during B-cell 








































development and the changes (somatic hypermutations) that occur in this repertoire during 
humoral immune responses, detailed knowledge of the germline IGHV, IGHD, and IGHJ ge-
nes and organization of the IGHVDJ locus are of critical importance. This information is also 
essential in giving insight into how various species have evolved different mechanisms to 
create a diverse preimmune specificity repertoire of their antibodies. With the unraveling of 
the mouse and human genomes, a detailed complete physical annotated map of the IGHVDJ 
locus has become available for these species (Johnston et al., 2006; Matsuda et al., 1998). 
One of the remarkable findings of these studies was that the number of functional IGHV 
genes in both species appeared to be much lower than previously estimated, whereas the 
number of nonfunctional IGHV genes [pseudogenes and open reading frame (ORF) genes 
lacking appropriate signal sequences] was relatively high. The genome of the rat has been 
unraveled, and there is a nearly complete sequence of the IGH locus (Gibbs et al., 2004). In 
rats, the exact number and location of IGHV genes are not known. Preliminary data suggest, 
however, that they are among the species with the highest number of (functional) IGHV genes 
in the genome (Das et al., 2008). Our previous studies (Dammers et al., 2000a) have indica-
ted that, similar to the mouse, rat IGHV genes can be subdivided into IGHV gene families, 
on the basis of nucleotide sequence identity. IGHV genes belong to the same family when 
the IGHV genes share more than 80% of their nucleotides (Brodeur and Riblet, 1984). We 
have detected previously the existence of at least 28 functional IGHV (germline) genes that 
belong to the IGHV5 family (PC7183) in the PVG rat strain (Dammers et al., 2001; Stoel et 
al., 2008). Here we present an annotated map of the variable region of the IGH locus of the 
Brown Norway (BN) rat, including not only functional and nonfunctional IGHV genes but also 
IGHD and IGHJ genes.
2. Materials and Methods
2.1. Genomic sequence of the rat IGH locus:
The genomic sequence of the BN/SsNHsdMCW rat (Rattus norvegicus) was generated by 
the Rat Genomic Sequence Consortium (RGSC) (Gibbs et al., 2004; Havlak et al., 2004).
This sequence is available through the National Center for Biotechnology Information (NCBI; 
http://www.ncbi.nlm.nih.gov). Analysis of the variable region of the rat IGH gene locus, located 
on chromosome 6q32–33, was based on the Human Genome Sequencing Center assem-
bly version RGSC V3.4 (November 2004 release; Baylor College of Medicine, Houston, TX, 
USA). Assembly RGSC V3.4 has been established in a hybrid approach combining the clone-
by-clone method and the whole genome shotgun method.








































2.2. Mapping of the variable region of the BN rat:
IGHV and IGHD gene sequences of the BN rat were obtained from the International Immuno-
genetics (IMGT) database (http://imgt.cines.fr) (Lefranc et al., 1999). IGHJ genes were taken 
from (Lang and Mocikat, 1991) (accession number X56791). Additional previously unreported 
IGHV genes were searched for in mapped and unmapped sequences of the rat genome. 
Unmapped sequences were taken from contigs in the “unplaced section” of the NCBI data-
base or from newly established bactigs of the BN rat genome (Baylor College of Medicine; 
http://www.hgsc.bcm.tmc.edu/projects/rat) not yet present in assembly RGSC V3.4. Nucle-
otide alignments were carried out using the NCBI BLASTN program (Altschul et al., 1990). 
New IGHV gene sequences were manually analysed for the presence of an ORF of the 
coding region and for the presence of functional recombination signal sequences (RSS) and 
leader sequences using V-QUEST alignment software (http://www.imgt.cines.fr) (Giudicelli et 
al., 2004). Previously unreported IGHD genes were identified by searching manually in the 
genomic assembly RGSC V3.4 with sets of rat nonamer and heptamer sequences. The rela-
tive positions of the IGHV, IGHD, and IGHJ genes on the chromosomal map were determined 
by aligning the encoding parts of the IGHV, IGHD, and IGHJ genes (functional and nonfunc-
tional) against the BN rat genome using the Genome Browser and BLAT programs (http://
www.genome.ucsc.edu) (Karolchik et al., 2008; Kent, 2002). Because of the relatively small 
size of IGHD genes, we included the IGHD 5′ and 3′ flanking RSS regions in the alignment. 
IGHD genes and flanking RSS were obtained from the IMGT database (accession numbers 
AABR03049813, AABR03051895, and M13798). The location of other predicted genes in 
the IGH locus was taken from NCBI annotation. The complete physical map and annotation 
of the genomic IGHVDJ region were drawn using the software package Genvision (Dnastar, 
Madison, WI, USA).
2.3. Nomenclature of rat IGHV, IGHD, and IGHJ genes:
IGHV, IGHD, and IGHJ gene nomenclature and classification (functional, nonfunctional, ORF 
gene, and pseudogene) were adopted from the IMGT (Lefranc et al., 1999). Briefly, nonfunc-
tional IGHV, IGHD, and IGHJ genes are either genes with an intact ORF but erroneous regu-
latory sequences (“ORF genes”) or genes lacking a correct ORF (pseudogenes).
3. Results and Discussion
3.1. Organization of the variable region of the IGH locus of the BN rat:
Recently, DNA sequencing resulted in elucidation of the vast majority of the genomic nucleo-
tide sequence of the BN rat, including the IGH locus located on chromosome 6q32–33 (Gibbs 
et al., 2004). The current IMGT database (Lefranc et al., 1999) contains 342 IGHV genes (120 








































functional and 222 nonfunctional), 20 IGHD genes (13 functional and 7 nonfunctional), and 5 
IGHJ genes (4 functional and 1 nonfunctional). In order to establish a detailed chromosomal 
map of this part of the IGH locus containing the exact chromosomal location and orientation 
of the individual genes, we aligned the coding sequences of all known IGHV, IGHD, and IGHJ 
genes (functional and nonfunctional) from the IMGT database to the rat genome assembly 
RGSC V3.4. As depicted in Figure 1, the variable region of the IGH locus of the BN rat spans 
a total length of approximately 4.9 Mb and is organized in a typical translocon organization 
(many IGHV genes, a dozen IGHD genes, and a few IGHJ genes) similar to mice and hu-
mans. The locus has a telomeric to centromeric orientation and runs from the distally located 
IGHV7S16 gene towards the proximally located IGHJ4 gene. The upstream boundary of the 
IGHV region is marked by the non-IGH zinc-finger-protein type 386 gene, similar to the situa-
tion in mice (Johnston et al., 2006). 
The IGHV genes of the BN rat can be classified into 13 IGHV gene families based on nu-
cleotide sequence identity (IGHV1, IGHV2, IGHV3, IGHV4, IGHV5, IGHV6, IGHV7, IGHV8, 
IGHV9, IGHV10, IGHV11, IGHV12, and IGHV15) (Table 1). In comparison to rats, the IGHV 
genes in humans and mice can be grouped together into 7 and 16 IGHV gene families, res-
pectively. Most BN rat IGHV gene families are composed of various members, except for 
the IGHV15 gene family, which is composed of only one gene. In rats and mice, the various 
members (both functional and non-functional genes) of these IGHV gene families are more 
or less clustered together on the genome. The order of various IGHV gene families on the 
genome appears to be well preserved between rats and mice. Similar to mice (Johnston et al., 
2006), the IGHV genes that belong to the IGHV1 and IGHV8 gene families are the most telo-
meric IGHV genes, whereas the members of the IGHV2 and IGHV5 gene families are located 
centromeric and closest to the IGHD genes. IGHV gene family members of the rat (and also 
of the mouse) are not completely spatially separated, and members of various IGHV gene 
families are frequently found intermingled with each other (e.g., IGHV2/IGHV5 and IGHV1/
IGHV8 genes). The members of the IGHV1 gene family are more widely distributed over the 
locus and are mixed with members of various other IGHV gene families (such as IGHV7, 
IGHV8, IGHV11, etc.). In comparison to rat and mouse, the human IGHV gene family gene 
members are more extensively interspersed and less clustered on the IGH locus (Matsuda 
et al., 1998). The almost identical distribution pattern of IGHV gene families between mouse 
and rat strongly suggests a close evolutionary relationship shared between these species. 
The vast majority (>90%) of rat IGHV genes are orientated in the direction of the IGHD cluster, 
whereas a small number of IGHV genes have an inverted orientation (in the direction of the 
telomere). These inverted IGHV genes are grouped together on four inverted regions of the 
chromosomal map. Three of these regions are inverted repeats (positions 3.74, 3.79, and 
4.76 Mb on the map of Figure 1) containing eight pairs of 100% identical IGHV genes. The 
majority of the inverted IGHV genes are, however, located on a large inverted region of the
















































































Figure 1. Chromosomal map of the variable region of the IGH locus of the BN rat. Shown is the IGHV 
region from chromosome 6 ranging from gene Znf386 to IGHJ4 (RGSC V3.4: 138,451,833–143,326,393 
bp).The map was established on the basis of the IMGT database (http://imgt.cines.fr), as indicated in 
“Materials and Methods,” and does not contain the 12 newly identified IGHV genes. Genes and their 
orientation are indicated by an arrow point. The IGHV, IGHD, and IGHJ genes are numbered according to 
the IMGT nomenclature (Lefranc et al., 1999). Members of the same IGHV family share identical colors 
(non-IGHV genes are shown in gray). Nonfunctional genes are indicated with a “p” for pseudogene or 
with an “r” for ORF gene after the family number. The last number in the gene name is the rank number 
of the gene in the locus, starting at the centromeric end. Black dotted lines indicate near-perfect inverted 
repeats. Gaps in assembly V3.4 are marked by solid gray bars. This map is also available as an MS Excel 
file (Online Resource 1) and as a “bed”-type file (Online Resource 2) that can be projected on the current 
rat genome version V3.4 at the UCSC genome website (www.genome.ucsc.edu). 
IGHV locus (between the genes IGHV2S28p, 39 and IGHV2S12, 16) close to the centromeric 
end of the IGHV region of the locus. This area of the locus also contains a gene, IGHV5S47, 
which is identical to the non-inverted gene IGHV5S8. These two genes are approximately 
1.1 Mb separated from each other. We further noted the presence of another pair of identical 
IGHV genes (IGHV5S51p) located only 1,183 bp apart (Figure 1; 3.41 Mb). In contrast to the 
other repeated pairs of genes, the latter pair of IGHV genes has the same (normal) orientation 
on the chromosome. If the rat VDJ locus indeed contains inverted regions, then this would 
imply that the VDJ recombination mechanism for these genes would use inversion instead of 
deletion. The presence of inverted repeats and completely 100% identical IGHV genes has 
not been identified in humans (Matsuda et al., 1998) and mice (Johnston et al., 2006). It might 
well be that the presence of inverted repeats in rats in the IGH locus may reflect inconsisten-
cies in the current genome assembly (Worley et al., 2008). Our map must therefore be taken 
as tentative, and it will be interesting to see whether an “upgraded” version of the rat genome 
sequences confirms the current assembly in regions with inverted repeats. In addition to 
IGHV genes, there are also six non-IGHV genes mapped on the IGHV gene locus (Figure 1). 
A metallopeptidase domain 6 gene (Adam6) is found at the proximal end of this locus. Of the 
remaining five non-IGHV genes, two have reported annotations: nuclear-case independent 
kinase substrate 1 (Nucks1) and the olfactory receptor pseudogene 874. These genes are 
located between IGHV1 and IGHV8 gene family members at the distal end of the IGHV gene 
locus. The other three genes are NCBI predicted genes: homolog of the Brix domain gene 
BXDC1 (RGD1560842) and two prematurely terminated fragments of potential rat homologs 
(RGD1559843 and LOC691867). It is unknown whether these non-IGHV genes are functio-
nally expressed. If these genes are functional, their expression might well be influenced by 
immunoglobulin enhancers as a consequence of the VDJ recombination process, or they may 
even be lost during this process. For these reasons, we assume that these non-IGHV genes 
in this locus are nonfunctional genes.








































3.2. Identification of novel IGHV genes:
The current assembly (RGSC V3.4) has a number of gaps in the IGHV region of the IGH locus 
(~300 kb) of which the nucleotide sequence still has to be determined (Twigger et al., 2008). 
Approximately 7% of the variable region of the IGH locus has not been mapped yet. These re-
gions are indicated in Figure 1 as gap regions. The largest gap is found in the IGHV2–IGHV5 
region (Figure 1; between 3.6 and 3.7 Mb). These gaps may potentially contain novel IGHV 
genes. There are available genomic sequences of the BN rat that have not yet been incorpo-
rated into the current assembly (RGSC V3.4). These sequences are present as contigs and 
are grouped together as “unplaced sequences” in the NCBI database. To explore the pres-
ence of unidentified IGHV genes, we used BLASTN to align all IMGT-listed rat IGHV genes 
to the unplaced contigs NW_047922.1 and NW_047772.1. Contig NW_047922.1 contains 
genomic sequences that are not yet assigned to any specific chromosome, whereas contig 
NW_047772.1 contains genomic sequences that are specific for chromosome 6. This search 
resulted in the identification of 18 IGHV genes (17 genes in contig NW_ 047922.1 and 1 gene 
in contig NW_047772.1). All these 18 IGHV genes share 100% identity to an IGHV gene 
already present in the IMGT database. All other potential IGHV homologs (i.e. sequences 
with ≥80% identity with a known IGHV sequence in the IMGT database) found in unplaced 
sequences did not comply with the IMGT criteria for functional IGHV genes (Lefranc et al., 
1999). Thus, the unplaced genomic sequences did not reveal any new previously unidentified 
rat IGHV genes. 
In addition to the unplaced sequences mentioned in the previous paragraph, there are also 
available bactig sequences (Baylor College of Medicine) that are not included in assembly 
RGSC V3.4. These bactigs are composed of overlapping bacterial artificial chromosome (BAC) 
sequences that may contain sequences that could map on the gap regions of this assembly. 
We analysed two nonoverlapping bactigs that span the entire variable region of the IGH locus, 
including the gap regions in assembly V3.4 (Figure 1), for the presence of additional unrepor-
ted IGHV genes. One of these bactigs (gpwy_grzy) (7.5 Mb) includes 71 BACs and extends 
into the major gap region. The other bactig (kdyb_kdzq; 1.65 Mb) is located centromeric to 
the largest gap region and consists of 18 overlapping BACs and probably also extends into 
the major gap region. Bactig gpwy_grzy did not reveal any previously unknown IGHV genes, 
although this bactig partially overlaps the major gap region. Because the nucleotide sequen-
ces of these BACs are currently not complete and also lack sufficient accuracy, this does not, 
however, imply that the major gap region does not contain any IGHV gene. On the other hand, 
11 novel IGHV sequences that meet the IMGT criteria for functional germline IGHV genes 
(preliminary third-party annotation accession numbers BN001223–BN001233) were found in 
bactig kdyb_kdzq. These criteria include the appropriate sequence length, at least one ORF, 
a proper leader sequence, and a functional RSS (Lefranc et al., 1999). Furthermore, the 








































flanking intron regions of these genes were not identical to the flanking regions of previously 
established IGHV genes already listed in the IMGT database. Based on sequence identity, 
five of these novel IGHV genes belong to the IGHV5 gene family (designated IGHV5-1 to 
IGHV5-5), and six belong to the IGHV2 gene family (designated IGHV2-1 to IGHV2-6). The 
finding that these novel IGHV genes all belong to either the IGHV2 gene family or the IGHV5 
gene family is consistent with the notion that most gap regions are found in the area of the 
IGHV locus where members of these two IGHV gene families are located. To reveal whether 
these 11 newly identified IGHV genes are also functionally expressed in rearranged IGHVDJ 
transcripts, we aligned the newly identified IGHV sequences to the R. norvegicus nucleotide 
collection database of the NCBI. Two of these IGHV genes (IGHV2-3 and IGHV5-1) share a 
100% identity with rearranged IGHVDJ BN rat complementary DNA sequences (accession 
numbers L07402 and X78897, respectively). In a recent study, we looked at the expression 
of IGHV5 genes in rat B cell subsets (Hendricks et al., manuscript in preparation). We found 
the expression of 100% identical IGHV5-1 and IGHV5-2 genes in mature B cells. In addition, 
we detected another previously unidentified IGHV5 gene (named IGHV5-6). This IGHV gene 
is also 100% identical to the IGHV gene expressed in BN hybridoma Hg16 (Dammers et al., 
2001) (accession number Z75899). These findings indicate that at least some of these novel 
germline genes are also functionally used. 
3.3. Identification of an additional IGHD gene:
So far, 20 (13 functional and 7 nonfunctional) IGHD genes have been described by the 
IMGT. We manually searched genomic assembly RGSC V3.4 for the presence of additional 
IGHD genes by using available RSS from functional rat IGHD genes. With this approach, we 
found a previously unidentified member of the IGHD1 subgroup (Figure 1). Remarkably, this 
gene, named IGHD1-9 (third-party annotation accession number pending), is located among 
IGHV2/IGHV5 genes ~200 kb upstream of the IGHD gene cluster (Figure 1). This IGHD gene 
contains an ORF and has functional RSS (12-bp spacer) flanking the gene on both sides 
(chromosomal coordinates can be found in supplementary files). Most probably, IGHD1-9 is 
also functionally expressed, since it is used in a rearranged IGHVDJ sequence (accession 
number AJ286179), albeit this IGHVDJ sequence is derived from another rat strain (PVG). 
The total number of functional IGHD genes in the BN rat is therefore most likely 14. 
4. Concluding remarks 
Together, our data imply that the total number of unique IGHV genes in the BN rat is at least 
353 (see Table 1), including the 12 newly identified IGHV genes. In this estimate, the pairs 
of identical genes (ten pairs in total) are counted as one. Of these 353 IGHV genes, 131 








































(37%) meet all criteria for functional germline IGHV genes and can therefore be potentially 
expressed. The remaining genes are nonfunctional because they either do not have at least 
one ORF (pseudogenes) or lack an appropriate RSS (ORF genes). Nearly all nonfunctional 
IGHV genes are pseudogenes. It should be noted here that there may be more nonfunctional 
IGHV genes because the bactigs (see the previous discussion) were only analysed for the 
presence of functional IGHV genes. Also in humans, the number of nonfunctional IGHV ge-
nes exceeds the number of functional IGHV genes (approximately one third) (Matsuda et al., 
1998); however, in the mouse, there seems to be a higher number of functional (55%) IGHV 
genes than non-functional IGHV genes (Johnston et al., 2006). In general, however, there is 
a positive correlation between the number of functional IGHV genes and the number of non-
functional IGHV genes (Das et al., 2008). The presence of large numbers of nonfunctional 
genes reflects the diversification of IGHV genes in evolution, as proposed before (Ota and 
Nei, 1994). This process involves gene duplications and functional elimination after deleteri-
ous mutations (pseudogenes and ORF genes). 
The rat genome harbors the highest number of functional IGHV genes (at least 131) of all 
mammalian species studied so far (Table 1). The (antigen-independent) recombination of this 
large number of IGHV genes with one of the 14 IGHD genes and with one of the 4 IGHJ genes 
accounts for a more diverse combinatorial IGH repertoire in rats compared to other species. 
In addition, this repertoire is enlarged by junctional diversity, as illustrated by the presence of 
TdT in rat B cell precursor cells (Opstelten et al., 1986) and variable numbers of N insertions 
in sequenced rat IGHV genes (Dammers et al., 2000b). 
Our main conclusion is that the overall organization of the variable region of the IGH locus and 
the distribution of IGHV gene family members in the rat are strikingly similar to the correspon-
ding region in the mouse (Johnston et al., 2006), despite the fact that these two species diver-
ged from each other 41 million years ago (Kumar and Hedges, 1998). Also in the mouse, the 
IGHV1 (J558), IGHV2 (Q52), and IGHV5 (PC7183) gene families have the highest number 
of IGHV members. Both in rat and in mice, members of these IGHV gene families represent 
approximately two thirds of all functional IGHV genes. These genes therefore contribute the 
most to the available germline repertoire. In the mouse, the IGHV1 family (J588) is, by far, 
the largest IGHV gene family (almost half of all functional IGHV genes), whereas in the rat, 
the largest IGHV gene family is the IGHV2 (Q52) family, with 40 unique members (31% of all 
functional IGHV genes).








































Table 1. numbers of IGHV gene family members in the IGHV locus of the BN rat














IGHV1 J558 25 42 67
IGHV2 Q52 39 (+4d) 60 (+ 2) 99 (+6)
IGHV3 36–60 4 4 8
IGHV4 X-24 2 2 4
IGHV5 7183 26 (+ 1) 53 (+ 3) 79 (+4)
IGHV6 J606 8 11 19
IGHV7 S107(T15) 6 9 15
IGHV8 3609 9 10  19
IGHV9 VGAM3-8 4 4 8
IGHV10 VH10 2 17 19
IGHV11 CP3 5 7 12
IGHV12 CH27 1 2 3
IGHV15 VH15A 0 1 1
Total 131 (+ 5) 222 (+ 5)
The table also contains the 12 newly identified IGHV genes (see the text for further explanation).
aIGHV nomenclature according to IMGT.
bIGHV family nomenclature according to (Brodeur and Riblet, 1984).
cFunctional and nonfunctional (pseudogenes or ORF genes), according to IMGT standards.
dThe number of 100% identical genes is presented in parentheses.
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Rats of the genus Rattus norvegicus are undoubtedly one of the most popular animals 
used for experimental biomedical research. Despite the fact that the initial publications 
on immunoglobulin (IG) genes and their organization in the rat were shortly behind those 
of mouse and human, our knowledge on the complexity and organization of the IG loci 
in this rodent species has been hampered for years, due to lack of (genomic) nucleotide 
sequence information. The tide turned as of the establishment of most of the genomic 
nucleotide sequence from the Brown Norway (BN) rat strain. This genomic sequence 
information allows researchers to more accurately map the IG genes in this so commonly 
used species. To date, the organization of the rat immunoglobulin heavy (IGH) locus has 
been described in detail, whereas effort is undertaken to resolve the organization of the 
IG light (IGL) chain loci including IG kappa (IGK) and IG lambda (IGL) loci. This chapter 
summarizes the current knowledge on the complexity and organization of the IGH, IGK, 
and IGL loci in the rat and reveals that the IG loci in this animal bear much resemblance 
to mouse and human.
 









































Rats belong to the largest order of mammals, named Rodentia (rodents; family Muridae). This 
order comprises more than 2,000 species, including mice (family Muridae), guinea pigs (fa-
mily Caviidae), squirrels (family Sciuridae), beavers (family Castoridae) and hamsters (family 
Cricetidae) (Carleton and Musser, 2005). The most well-known rat species belong to the ge-
nus Rattus (“true rats” or “Old World” rats) of which the roof rat (Rattus rattus) and the brown 
rat (Rattus norvegicus) are the most common members. The evolutionary history of genus 
Rattus goes back to Asia, where the oldest fossil specimens of Rattus sp. were excavated 
from sediments that extend to the late Pliocene (2.5 MYA) (Carleton and Musser, 2005). No-
wadays, both Rattus rattus and Rattus norvegicus are established worldwide in the temperate 
climate areas and parts of tropical and subantarctic zones. Most laboratory rats used today 
trace their heritage to Wistar ancestors (R. norvegicus), originally held at the Wistar Institute 
of Anatomy and Biology, Philadelphia PA, in the beginning of the twentieth century (Clause, 
1993). At present, a large number of genetically well-defined inbred rat strains are established 
that serve as models for important human disease traits, including susceptibility to cancer, hy-
pertension, ischemia, obesity, diabetes, and autoimmune diseases. So, the rat became “from 
evil harbinger of pestilence to hero of modern medicine”, as described by Clause (Clause, 
1993), and has undoubtedly become one of the most frequently used animals in experimental 
biology and medical research. 
As in other mammalian species, diversity in the immunoglobulin (IG) antigen-recognition site 
in the rat is established during early B cell development by rearrangement of variable region 
genes (or gene segments) located at the IG heavy (H)-chain and light (L)-chain loci. The Va-
riable domain of the IGH chain is encoded by three different genes: Variable (IGHV), diversity 
(IGHD), and joining (IGHJ), whereas the IGK and IGL chain Variable domains are encoded 
by a combination of IGKV–IGKJ and IGLV–IGLJ, respectively (Roth, 1996). Recombination 
at the IGH, IGK and IGL loci is mediated (among other enzymes) by two “recombinase acti-
vation genes”―RAG-1 and RAG-2―that recognize a recombination signal sequence (RSS), 
flanking each of the IG Variable region genes (Fugmann et al., 2000; Roth, 1996). During 
recombination, RAG-1 and RAG-2 produce double-strand breaks between the IG Variable re-
gion genes to be joined and the flanking RSS. The joining-ends are subsequently subjected to 
hairpin opening nicks (generating small palindrome sequences called P-nucleotides), exonu-
clease activity, and nucleotide additions (N-nucleotides) by terminal deoxy-nucleotidyl trans-
ferase (TdT) (Gilfillan et al., 1993; Komori et al., 1993). The end result is the generation of 
highly variable nucleotide sequences at the junctions of the rearranged gene segments. Rats 
are able to produce the following eight Ab isotypes: IgM, IgD, IgG1, IgG2a, IgG2b, IgG2c, IgA, 
and IgE (Bazin et al., 1974). The constant region exons (IGHC) necessary to encode these 
different isotypes are located at the 3′-end of the IGH locus.








































2. Genomic organization of the rat immunoglobulin heavy chain locus 
2.1. Immunoglobulin heavy variable chain locus
The Vast majority of the genomic nucleotide sequence of the Brown Norway (BN) rat has 
been elucidated and this confirmed the location of the IGH locus on chromosome 6q32–33 
(Gibbs et al., 2004), as determined before by Pear et al. (Pear et al., 1986). The IGH locus in 
rats bears much resemblance to that of mice, both with respect to its genomic organization as 
well as the nucleotide sequence of the coding regions (Bruggemann et al., 1986; Dammers 
and Kroese, 2001; Dammers et al., 2000; Hendricks et al., 2010; Lang and Mocikat, 1991). 
The rat IGH locus consists of a typical translocon organization (Marchalonis et al., 1998), 
comprised of 353 individual IGHV genes (of which 131 are functional), 21 IGHD genes (14 
functional), and five IGHJ genes (four functional) (Hendricks et al., 2010). A detailed map 
of the organization of the rat IGH variable region locus has been published by Hendricks et 
al. (Hendricks et al., 2010). The IGH locus in rat is orientated from telomere (distal) towards 
centromere (proximal). Similar to mouse and human, the Vast majority of rat IGHV genes are 
orientated towards the IGHD and IGHJ genes, and deletional joining, instead of inversional 
joining, is therefore most preferably used as major recombination mechanism at the IGH 
locus. The size of the rat IGHV locus spans about 4.8 Mb and is therefore two times larger 
than the IGHV region in mouse (2.5 Mb) (Johnston et al., 2006) and five times larger than in 
human (0.9 Mb) (Matsuda et al., 1998; Pallares et al., 1999). The rat IGHV region comprises 
two and three times as many IGHV genes in comparison to mouse (195 IGHV genes) and 
human (123–129 IGHV genes), respectively. This indicates that the overall density of IGHV 
genes in the IGHV region is very similar between rat and mouse (74 en 78 genes per Mb, 
respectively), but lower in comparison to humans (137–143 genes per Mb). The intergenic 
distance between the IGHV genes is rather large in comparison to the size of the IGHV genes 
(~500 bp). For mouse and rat, the density of IGHV genes is somewhat higher at 3′ end of 
the IGHV region than at the 5′ end. The total number of functional IGHV genes (i.e., germline 
IGHV genes with an open reading frame in the coding regions and no defects in splice sites, 
recombination signals and/or regulatory elements) is more or less the same between mouse 
and rat (110 Vs. 131), and significantly more in comparison to human (39–46). Furthermore, 
the mouse IGHV locus contains relatively more functional IGHV genes (56%), compared to 
rat and human (37% and 36%, respectively). In Table 1, the total numbers of IGHV genes in 
the IGH locus of rat, mouse, and human are depicted, according to current IGH chromosomal 
maps (Hendricks et al., 2010; Johnston et al., 2006; Matsuda et al., 1998). For this table, 
numbers of human IGHV genes were obtained from the study of Matsuda et al. (Matsuda et 
al., 1998). However, due to allelic variation and structural Variants (i.e., deletions, insertions, 
and duplications that result in changes in gene copy number), the numbers of IGHV genes in 
the human IGH locus differs among individuals (Lefranc, 2001; Pallares et al., 1999; Watson 








































et al., 2013). The human IGH locus is estimated to contain between 123–129 IGHV genes 
of which 39–46 are considered functional (Pallares et al., 1999). The data of Matsuda et al. 
(Matsuda et al., 1998) are therefore not applicable for every individual. Nearly all nonfunctio-
nal IGVH genes in rat are pseudogenes that lack an open reading frame (ORF). Some non-
functional genes, however, have an ORF. In ORF genes, alterations in the splice, regulatory, 
and/or RSS signal sequence(s), and/or amino acid constitution, and/or chromosomal position 
(i.e., orphan) renders the gene or product nonfunctional (Lefranc, 2001). Das et al. (Das et 
al., 2008) showed that there is a positive correlation between the number of nonfunctional 
and functional IGVH genes (in general, the more IGHV genes, the higher the number of non-
functional genes in the IGH locus). This observation is assumed to result from the evolution 
of the IGVH genes. As proposed by Ota and Nei (Ota and Nei, 1994), the evolution of IGVH 
genes is the consequence of two evolutionary processes: the birth-and-death process and 
diversifying selection. Whereas some duplicated IGVH genes diversify and acquire new func-
tions by mutations and evolutionary selection (“birth”; diversifying selection), others become 
functionally eliminated after obtaining deleterious mutations (“death”; pseudogenes) (Nei et 
al., 1997; Ota and Nei, 1994; Tanaka and Nei, 1989). As a result of this evolutionary process, 
IGHV genes can be grouped into genes with highly homologous sequences, the IGHV gene 
families or subgroups. As in mice (Brodeur and Riblet, 1984), IGHV subgroup members in rat 
share at least 80% identity over the coding exon nucleotide sequence, whereas the sequence 
identity between members of different IGVH subgroups is generally less than 70% (Dammers 
et al., 2000). Rat, mouse and human IGHV genes can be grouped into 13, 16, and 7 IGHV 
gene families, respectively. The IGHV genes in the BN rat can be subdivided into 13 IGHV 
subgroups based on nucleotide sequence identity: IGHV1, IGHV2, IGHV3, IGHV4, IGHV5, 
IGHV6, IGHV7, IGHV8, IGHV9, IGHV10, IGHV11, IGHV12, and IGHV15 (Hendricks et al., 
2010). In rat, most IGHV gene families are composed of various members, ranging from 3 to 
99 (total genes, i.e., functional and nonfunctional), except for the IGHV15 gene family, which 
consists of only one (nonfunctional) member.
The largest IGHV gene families in rat are represented by IGHV1, IGHV2, and IGHV5, which 
contain a total of 67, 99, and 79 IGHV genes, respectively. In the IGHV locus of mouse and 
rat, the various IGHV gene family members are often found clustered together (Hendricks et 
al., 2010; Johnston et al., 2006). However, the IGHV gene families are not completely spati-
ally separated from each other and members of different IGHV gene families are frequently 
found intermingled with one another. Similar to mouse, the IGVH1 and IGHV8 gene family 
members in rat are located at the 5′end of the IGHV locus, whereas members of the IGHV2 
and IGHV5 gene families are located at the 3′ end of the IGHV locus, closely to the IGHD 
region (Hendricks et al., 2010; Johnston et al., 2006). In comparison to mouse and rat, the 
IGHV gene family members in human are more extensively intermingled with each other and 








































therefore clustering of IGHV gene family members is hardly observed (Matsuda et al., 1998). 
The almost identical IGHV locus organization between mouse and rat strongly implies a close 
evolutionary relationship between the two species.
Table 1. Numbers of IGHV genes in the IGH locus of rat, mouse, and human grouped by IMGT subgroup
Total number of IGHV genesa
IMGT Subgroup Previous mouse 
nomenclature
BN Rat C57BL/6 Mouse Humanb
IGHV1 J558 67 (25) 89 (52) 14 (9)
IGHV2 Q52 105 (43) 13 (9) 4 (3)
IGHV3 36–60 8 (4) 8 (6) 65 (19)
IGHV4 X24 4 (2) 2 (1) 32 (6)
IGHV5 PC7183 83 (27) 21 (10) 2 (1)
IGHV6 J606 19 (8) 5 (5) 1 (1)
IGHV7 S107(T15) 15 (6) 4 (3) 5 (0)
IGHV8 3609 19 (9) 16 (8) —
IGHV9 VGAM3.8 8 (4) 4 (4) —
IGHV10 VH10 19 (2) 3 (2) —
IGHV11 VH11(CP3) 12 (5) 2 (2) —
IGHV12 VH12(CH27) 3 (1) 1 (1) —
IGHV13 3609N — 2 (1) —
IGHV14 SM7 — 4 (4) —
IGHV15 VH15 1 (0) 1 (1) —
IGHV16 VH16 — 1 (1) —
Unclassified — — 19 (0) —
Total 363 (136) 195 (110) 123 (39)
a Total numbers of IGHV genes grouped by IMGT subgroup (functional + ORF + pseudogenes) (Lefranc, 
 2001; Lefranc et al., 2009). Numbers of functional IGHV genes are shown in parentheses. A germline 
 IGHV gene is regarded functional if the coding region has an open reading frame without stop codon 
 and if there are no defects in splice sites, RSS and/or regulatory elements (Lefranc, 2001). Numbers of 
 IGHV genes for the different species were obtained from (Hendricks et al., 2010; Johnston et al., 2006; 
 Matsuda et al., 1998). Please note that the human IGHV subgroup nomenclature is not fully compatible 
 between with rat and mouse, for instance human IGHV3 subgroup members share the highest identity 
 with members of the rat/mouse IGHV5 subgroup and human IGHV4 with rat/mouse IGHV3.
b Number of IGHV genes in the human IGH locus can Vary among individuals due to copy-number Varia- 
 tion (Pallares et al., 1999; Sudmant et al., 2010; Watson et al., 2013).








































2.2. Immunoglobulin heavy diversity chain locus 
The rat IGHD gene-cluster spans about 70 kB and is similar in size in comparison to mouse 
(Hendricks et al., 2010; Kurosawa and Tonegawa, 1982; Lang and Mocikat, 1991; Sakano et 
al., 1980; Ye, 2004). In addition to the size of the loci, rat IGHD genes (both coding as well 
as RSS regions) also show high sequence identity to those of the mouse (Figure 1). The 
IGHD locus in BN rat is comprised of 14 functional IGHD genes (Table 2), which include nine 
IGHD1 (DFL16), four IGHD4 (DST4) genes, and one IGHD5 (DQ52) gene (previous mouse 
nomenclature is shown in parentheses). The number of functional IGHD genes in rat is very 
comparable to the situation in mouse, where the IGH locus contains about 10–13 functional 
IGHD genes, depending on the mouse strain (Chang et al., 1992; Feeney, 1990; Feeney and 
Riblet, 1993; Gerondakis et al., 1988; Kurosawa and Tonegawa, 1982; Lawler et al., 1987; Ye, 
2004). As indicated in Figure 1, rat IGHD genes are flanked on both sides by a typical RSS, 
characterized by a 12-bp spacer and the rather conserved heptamer and nonamer sequen-
ces (Ramsden et al., 1994). This allows the proper rearrangement of IGHD genes with an 
IGHV and an IGHJ gene at the 5′ and 3′ side, respectively. In addition to the functional IGHD 
genes, there are seven nonfunctional ORF genes containing non-canonical/aberrant RSS 
sequences, which probably render them nonfunctional. All these nonfunctional IGHD genes 
either belong to the subgroups IGHD2 (3 genes) or IGHD3 (4 genes). Rat IGHD2 genes show 
high nucleotide identity to mouse IGHD5 genes (Figure 1), which are also considered to be 
nonfunctional (Ye, 2004).
R|IGHD1-7 GCT T T T T GT GA A GGGA T T T A T T A CT GT GT T T AT - - - T ACT AT GAT GGT AGT T AT T ACT AC- - - CA CA GT GGT A CGT CCA A CA GCA A A A A CC
R|IGHD1-1 . . . . . . . . . . . . . . . . . A C. C. . . . . . . . . . . . GT A . . . . . C. G- A T . - A . . . C. . . - - - - - - . . . . . . . . . . T A . . . . G. . . . . . . . . . .
R|IGHD1-9 . . . . . . . . . . . . . . . . . . . . C. . . . . . . . . . . . - - - . . . . . . - - - A . C- A - - GC. . T A T . T A C. . . . . . . A . . T A . . . . G. . . . . . . . . . .
R|IGHD1-8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - - - . . . . . . . . . . . . T A . . . . C. . - - - - - - . . . . . . . . . . . . . . . . . . . . . . . . . . . .
R|IGHD1-6 . . . . . . . . . . . . . . . . . C. . C. . . . . . . - . . . - - - - - . . . . C. GA . . GT A . A G. G. G- - - - - - . . . . . . . T . . T A . . . . GT . . . . . . . . . .
M|IGHD1-1 . . . . . . . . . . . . . . . . . C. . C. . . . . . . . . . . . - - - . . . . . C. G. A . . - A - - GC. . . - - - - - - . . . . . . . C. . T A . . . . T . . . . . . . . . . .
R|IGHD1-4 . A . . . . . . . . . . . . C. . A C. C. . . . . . . . A C. . - - - - . . . . . . - - . . . - A . A . C. . . - - - - - - . . . . . . . . A . T A . . . . G. . . . . . . . . . .
R|IGHD1-2 . A . . . . . . . . . . . . C. . A C. C. . . . . . . . . C. . - - - - . . . . . . - - . . . - A . G. C. . . - - - - - - . . . . . . . . A . T A . . . . G. . A . . . . . C. .
R|IGHD1-3 A T . . . . . . . . . . . . . . . C. . C. . . . . . . . . . T . - - - A . . . . C- - - A . . - A - - GC. . . - - - - - - . . . . . . . . A . T A . T . . G. . A . . . . . . . .
R|IGHD1-5 . . . . . . . . . . . . . . A . . A . . C. . . . . . . . . . . . - - - A . . - - - - - - - - - - A - - . C. . . - - - - - - . . . . . C. A . . T A . A . T G. . . . . . . . . . .
R|IGHD4-1 GGA T T T T GA A CT A GT T A GT GT CA CA GT GGGT AT AAT T CGGGGT ACCA CT GT A GGA A A A GCT GCA A CGA A A ACT
R|IGHD4-2 A . . . . . . . . . . . . . . . . C. . . . . . . . . . . . . G. . . . . . . . . . . T A . T A . . . . A . . . . . . . . . . . . . C. . . . . A
R|IGHD4-3 . . . . . . . . . . . A . . . . . C. . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . CT C. . . CT G
M|IGHD3-1 . . . . . . . . . . . A . . . . . C. . . . . . . . . . . . C. C. GC. . . . . C. . . . . . . . . . A . . . . . . . . CA . . . C. . . . . .
R|IGHD4-4 . . . . . . . . . . . . . . G. . C. . . . . T G. . . . . . . . . - . . T . . . C. T . . . T . . . . . . . . . . T . . . . T . . T . . . . . .
R|IGHD5-1 GGT T T T GA CT A A GCA A A GCA T CA CA GT GCT AACT GGGAGCA CA GT GA CT T GT GGCT CA A CA A A A A CC
M|IGHD4-1  . . . . . . . . . . . . . . GG. . . . C. . . . . . . . . . . . . . . . . C. . . G. . . . . A C. . . . . . . . . . . . . . . . .
IGHD ORF+pseudogenes
R|IGHD2-1 GGA T T T T GT A T GGGCCT CT CT CA CT GT GGGAT ACT T AC CA T A GT A GT A T A GT T CA GT CCCA A A A GC
R|IGHD2-3 . . . . . CC. . . . . . . T . C. . . . . . . . . . . . . . . . . C. . . . . A . . . GA . . . . . A . . . . . . . . . . . T T .
M|IGHD5-3 . . . . . C. . . . . . T . . . . . . . . . . . C. . . . A . . . . C. . . . . C. T . G. . . C. . A G. . . . . T . . . . T T .
R|IGHD2-2 . . . . . C. . A . . . . . . . . T . . . . . . . . . . . . . . . . C. . T . . C. . . GT . . . . . A . T . A . . . T . . . GCA
R|IGHD3-1 A CA A CCCA T GGT GGCT T CA GGCA GCA GGCCT CT GCAGT GCCCCCAACCCAACA T GCCA T CT GCT CT GGGA CCA GA A A GT
R|IGHD3-4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T .
R|IGHD3-2 . GT . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . - . T . . . . . . . . . . . . . T . . . . . . . . T . . . . . . . .
R|IGHD3-3 . GT . . . . . . . . . . . . . . . . . A . . T . . . . . . . . . . . . . . A T . . . . . . T . . . . . . . . A . . . . . T . . . . . . . . . T . . . . GT .
M|UNDEF . GT . . . . . . . . . . A A . . . . . . . . . . T A . . . . . . . . . . . . . - . A . . . . . . . CA . . . A . T . G. . A C. . - - T . . A . . . . . . G
Figure 1. Alignment of the IGHD sequences of the BN rat. Sequences are described in Ref. (Hendricks 
et al., 2010) and obtained from the UCSC (http://genome.ucsc.edu) (Meyer et al., 2013) using Baylor 3.4/








































rn4 rat genome assembly (Nov. 2004) (Gibbs et al., 2004). All rat IGHD genes have the same orientation 
in the locus (5′ to 3′ on the minus strand). In each IGHD subgroup, a mouse IGHD gene from the most 
homologous subgroup is included for comparison (R: rat, M: mouse). Dots and dashes denote nucleotide 
identities and gaps, respectively. The RSS heptamer and nonamer sequences are underlined. The IGHD 
region is marked in bold. The coordinates of the IGHD genes in Baylor 3.4/rn4 assembly are as follows:
IGHD1–1 chr6:138,521,262–138,521,344;  IGHD1–2 chr6:138,511,394–138,511,471
IGHD1–3 chr6:138,505,008–138,505,083;  IGHD1–4 chr6:138,503,455–138,503,532;
IGHD1–5 chr6:138,496,518–138,496,587;  IGHD1–6 chr6:138,490,407–138,490,485;
IGHD1–7 chr6:138,483,608–138,483,692;  IGHD1–8 chr6:138,471,761–138,471,842;
IGHD1–9 chr6:138,743,870–138,743,951;  IGHD4–1 chr6:138,509,072–138,509,144;
IGHD4–2 chr6:138,501,150–138,501,222;  IGHD4–3 chr6:138,494,453–138,494,525;
IGHD4–4 chr6:138,486,905–138,486,976;  IGHD5–1 chr6:138,453,776–138,453,842;
IGHD2–1 chr6:138,518,929–138,518,994;  IGHD2–2 chr6:138,510,119–138,510,184;
IGHD2–3 chr6:138,495,637–138,495,702;  IGHD3–1 chr6:138,518,691–138,518,769;
IGHD3–2 chr6:138,509,882–138,509,959;  IGHD3–3 chr6:138,488,933–138,489,011;
IGHD3–4 chr6:138,495,398–138,495,476.
The rat IGHD3–1 sequence matches with a previous undefined (UNDEF) region in the mouse IGH locus 
at chromosomal position chr12:113,469,160–113,469,235 of Genome Reference Consortium assembly 
Dec. 2011 (GRCm38/mm10) (Church et al., 2009).
 
Table 2. Numbers of IGHD genes in the IGH locus of rat, mouse, and human grouped by IMGT subgroup.
IMGT subgroupa Number of genesb
Rat Mouse Human BN Rat C57BL/6 Mouse Human
IGHD1 IGHD1 (DFL16) IGHD4 9 (9) 1 (1) 4 (2)
— IGHD2 (DSP2) — — 6 (6) —
— — IGHD5 — — 4 (3)
IGHD2 IGHD5 — 3 (0) 8 (0) —
IGHD3 UNDEFc — 4 (0) 6 (0) —
IGHD4 IGHD3 (DST4) IGHD1 4 (4) 2 (2) 5 (4)
IGHD5 IGHD4 (DQ52) IGHD7 1 (1) 1 (1) 1 (1)
— IGHD6 IGHD2 — 2 (0) 4 (4)
— — IGHD3 — — 5 (5)
— — IGHD6 — — 4 (4)
Total 21 (14) 26 (10) 27 (23)
a IGHD genes are grouped by IMGT nomenclature and arranged in corresponding subgroups. Grouping 
 of the mouse IGHD6 subgroup with human IGHD2 is tentative.
b Numbers of IGHD genes for the different species were obtained from (Hendricks et al., 2010; Lefranc, 
 2001; Watson et al., 2013; Ye, 2004) and IMGT (mouse IGHD5 genes) (Lefranc et al., 2009). Numbers 
 of functional IGHD genes are shown in parentheses.
c Previously undefined murine IGHD subgroup, provisionally consisting of six nonfunctional IGHD genes 
 (pseudo/ORF).








































Rat IGHD3 homologous, however, have not been described for mouse, but alignment of the 
rat IGHD3–1 sequence to the mouse genome using the BLAT genome search program (Kent, 
2002), revealed the presence of a previously undefined IGHD gene in the mouse IGH locus 
equivalent to the rat IGHD3 subgroup (Figure 1; M|UNDEF). This murine IGHD gene is most 
probably also nonfunctional, since it contains a 2-bp deletion in the 3′ RSS spacer and has 
heptamer and nonamer sequences that carry aberrant (non-canonical) bases. A preliminary 
BLAT search (assembly Dec. 2011, GRCm38/mm10) (Church et al., 2009; Kent, 2002), indi-
cates that this new IGHD gene most likely belongs to a new murine IGHD subgroup consisting 
of six (presumably nonfunctional) members. The distribution of IGHD genes in the IGH locus 
is not completely similar between rat and mouse (Figure 2). Except for the single functional 
DQ52 gene (rat IGHD5–1 and mouse IGHD4–1), which is located in close proximity (approx. 
0.6 kB) to the IGHJ locus, the relative position and numbers of IGHD subgroup members are 
less well preserved between these species. For instance, the IGH locus of C57BL/6 mice 
harbors one DFL16 (IGHD1) gene, six DSP2 (IGHD2) genes, two DST4 (IGHD3) genes, and
 
Figure 2. Comparison of the IGHD locus organization of BN rat Vs. C57BL/6 mouse. Rat and mouse 
IGHD sequences are described by Hendricks et al. (Hendricks et al., 2010) and Ye (Ye, 2004), respecti-
vely, and retrieved from the IMGT (http://www.imgt.org) (Lefranc et al., 2009). Relative positions were in-
ferred using the BLAT genome search program (http://genome.ucsc.edu) (Kent, 2002; Meyer et al., 2013) 
on the basis of genome assemblies Baylor 3.4/rn4 (Nov. 2004) and GRCm38/mm10 (Dec. 2011) (Church 
et al., 2009; Gibbs et al., 2004). IGHD genes are designated in abbreviated IMGT nomenclature. Solid 
and open triangles represent functional and pseudo(p)/ORF(r) genes, respectively. The IGHJ locus is 
marked by an open box and is approx. 0.6 kB downstream from gene DQ52 (rat D5–1and mouse D4–1). 
For rat, the IGHD gene-clusters (see text) are indicated by bidirectional arrows. Rat IGHD1–9 is located 
200 kB upstream of the IGHD gene-cluster and is not included in the figure.
one DQ52 (IGHD4) gene, revealing that the IGHD locus of the BN rat contains relatively 
more DFL16 (IGHD1) genes, whereas genes belonging to the DSP2 subgroup, which is the 
largest in mouse, seem to be absent from the rat IGH locus. Typically, five clusters of tan-
dem IGHD genes can be found in the rat IGH locus, generally consisting of a functional 








































IGHD1 and IGHD4 gene separated from each other by an approx. 6 kB region harboring 
most frequently two pseudo(p)/ORF(r) genes of the IGHD2 and IGHD3 subgroup, respecti-
vely ([IGHD1–IGHD2r–IGHD3p–IGHD4] gene-cluster). A similar phenomenon is observed in 
mouse, where five out of six IGHD2 genes are flanked at the 3′ side by a pseudogene of the 
IGHD5 subgroup. Most likely, such clusters of tandem IGHD genes evolved by duplication of 
a common ancestral IGHD gene-cluster and may well result in a rapid expansion of certain 
IGHD subgroups during species evolution. The human IGHD gene locus, on the other hand, 
is about 40 kB and contains 27 IGHD genes (23 functional) subdivided into seven subgroups 
(Lefranc, 2001; Matsuda et al., 1998). The number of functional IGHD genes in the human 
IGH locus is therefore about twice the number of functional IGHD genes in rat and mouse. Fi-
gure 3 shows the evolutionary relationship between the functional IGHD genes of rat, mouse, 
and human, as inferred from the nucleotide sequences of the IGHD genes. This phylogenetic 
analysis shows that rat IGHD1 genes are closely related to mouse IGHD1 (DFL16), mouse 
IGHD2 (DSP2), and human IGHD4 genes. Also the rat IGHD5–1, mouse IGHD4–1 (DQ52), 
and human IGHD7–27 genes, seem to be relatively preserved among the three species. On 
the other hand, the human IGHD2, IGHD3, IGHD5, and IGHD6, form more isolated phyloge-
netic clusters. It seems likely that the human IGHD5 genes evolved from an ancestor shared 
with the human IGHD4 (rat/mouse IGHD1) subgroup, but the IGHD5 genes have substantially 
diverged from this group.
2.3. Immunoglobulin heavy joining chain locus 
The rat IGHJ locus was initially partly described by Brüggemann et al. (Bruggemann et al., 
1986) and further completed by Lang and Mocikat (Lang and Mocikat, 1991). The IGHJ locus 
of rat is comprised of four functional IGHJ genes (IGHJ1 to IGHJ4), with intact 5′ RSS and 3′ 
splice signal sequences, and one IGHJ pseudogene (Jψ0; coding region is interrupted by a 
stop codon). The order of the IGHJ genes in the locus is Jψ0–IGHJ1–IGHJ2–IGHJ3–IGHJ4. 
Both IGHJ2 and IGHJ3 have a 23–bp RSS, whereas IGHJ1 and IGHJ4 (and the pseudogene 
Jψ0) carry a 22–bp RSS. Considering the preference of 23–bp over 22–bp RSS during re-
combination (Suzuki and Shiku, 1992), this may result in a higher frequency of IGHJ2 and 
IGHJ3 gene usage in IGH transcripts. The rat IGHJ locus is about 2 kB in size and bears 
much resemblance to that of mouse and human, both in respect to organization as well as 
nucleotide and amino acid (coding region) sequence. In general, rat IGHJ coding regions 
share around 80% or more identity at both nucleotide and amino acid sequence level with the 
IGHJ genes of mouse (Lang and Mocikat, 1991). A similar degree of identity is also observed 
upon comparison with human IGHJ genes (Lang and Mocikat, 1991), although in human the 
IGHJ locus is comprised of six functional IGHJ genes and three IGHJ pseudogenes (Ravetch 
et al., 1981).
 








































Figure 3. Evolutionary relationships of functional IGHD genes from rat, mouse and human. The evolu-
tionary relationship was inferred using the Neighbor-Joining method (Nei and Kumar, 2000). The tree is 
drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer 
the phylogenetic tree. Evolutionary distances were computed from IGHD 5′ to 3′ RSS nonamer sequen-
ces using the Kimura 2-parameter method (number of base substitutions per site), and modeled with a 
gamma distribution (shape parameter = 1). Bootstrap confidence Values of interior branches (500 repli-
cates) are depicted near the branches. Values of 95% or higher are considered to represent the correct 
topology (Nei and Kumar, 2000). All ambiguous positions were removed for each sequence pair (partial 
deletion). There were a total of 95 positions in the final dataset. Evolutionary analyses were conducted 
with MEGA5 software (Tamura et al., 2011). Sequence identifiers show GenBank accession number, 
IGHD gene number, and whether the sequence is derived from rat (R), mouse (M), or human (H), respec-
tively. Mouse and human IGHD sequences were retrieved from the IMGT (http://www.imgt.org) (Lefranc 
et al., 2009). Rat IGHD sequences (rn4) were obtained from the UCSC (http://genome.ucsc.edu) (Meyer 












































































































































The close evolutionary relationship among rat, mouse, and human IGHJ genes is illustrated 
by the phylogenetic tree depicted in Figure 4. This phylogenetic analysis, based on the nu-
cleotide sequences of the functional IGHJ genes, reveals that rat, mouse and, human IGHJ 
genes are related in the following way: rat/mouse IGHJ1 to human IGHJ2, rat/mouse IGHJ2 
to human IGHJ1 and IGHJ4, rat/mouse IGHJ3 to human IGHJ5, and rat/mouse IGHJ4 to 
human IGHJ6.
2.4. Immunoglobulin heavy constant chain locus
The eight serological-defined IGH isotypes in the rat (IgM, IgD, IgG1, IgG2a, IgG2b, IgG2c, 
IgE, and IgA) (Bazin et al., 1974) are encoded by the IGHC genes: Cμ (IGHM), Cδ (IGHD), 
Cγ1 (IGHG1), Cγ2a (IGHG2A), Cγ2b (IGHG2B), Cγ2c (IGHG2C), Cε (IGHE), and Cα (IGHA), 
respectively. The coding and surrounding intron nucleotide sequences are described for many 
of the rat IGHC genes (Alcaraz et al., 1980; Bruggemann, 1988; Bruggemann et al., 1988; 
Bruggemann et al., 1986; Bruggemann et al., 1989; Dammers et al., 2001; Hellman et al., 
1982; Hellman et al., 1988; Parker et al., 1994; Sire et al., 1982; Steen et al., 1984). The 
chromosomal order of the IGHC genes in the rat was originally resolved by Brüggemann et 
al. (Bruggemann et al., 1986) and is: Cμ–Cδ– Cγ2c–Cγ2a–Cγ1–Cγ2b–Cε–Cα. To our know-
ledge, however, an exact chromosomal map of the rat IGHC locus has never been published. 
On the basis of the rat IGHC exon nucleotide sequences that were retrieved for the IMGT/GE-
NE-DB (Giudicelli et al., 2005; Lefranc et al., 2009), we were able to establish a genomic map 
of the rat IGHC region using the Baylor 3.4/rn4 genome assembly (Nov. 2004) at the UCSC 
(http://genome.ucsc.edu) (Gibbs et al., 2004; Meyer et al., 2013). As shown in Figure 5, the 
size of rat IGHC locus is about 220 kB and the IGHC genes are arranged in the following 
order: JH–7.5 kB–Cμ–2 kB–Cδ–35 kB–Cγ2c–42 kB–Cγ2a–32 kB–Cγ1–19 kB–Cγ2b–21 kB–
Cε–8 kB–Cα. The number of IGHC genes in the rat and the distance between them is rather 
similar to the IGHC gene organization in mouse [JH–6.5 kB–Cμ–4.5 kB–Cδ–55 kB–Cγ3–34 
kB–Cγ1–21 kB–Cγ2b–15 kB–Cγ2a–14 kB–Cε–12 kB–Cα] (Shimizu et al., 1982), but is dif-
ferent from that observed in human, in which a tandem gene-cluster [Cγ–Cγ–Cε–Cα] is found 
[JH–8 kB–Cμ–8 kB–Cδ–±60 kB–Cγ3–26 kB–Cγ1–19 kB–Cψε2–13 kB–Cα1–±55 kB (incl. 
Cψγ)–Cγ2–18 kB–Cγ4–23 kB–Cε1–10 kB–Cα2] (Lefranc, 2001; Lefranc and Lefranc, 1987; 
Ravetch et al., 1981). In contrast to human, the rat and mouse (Shimizu et al., 1982) IGHC 
locus does not seem to contain any conserved IGHC pseudogenes. Except for Cα, the IGHC 
genes in the rat are comprised of four exons encoding the IGH chain constant domains and 
two exons coding for the membrane anchor (M1 and M2). The relative position of the most 
5′ (Cμ and Cδ) and 3′ (Cε and Cα) IGHC genes in the IGHC locus is similar between mouse 
and rat.The Cμ, Cδ, and Cα loci are, however, not extensively described for the rat. Genomic 
sequences of the exons Cμ2 and Cα3 were established by Brüggemann et al. (Bruggemann 
et al., 1986), whereas the nucleotide sequence of the Cμ1 region was recovered from cDNA 








































(Dammers et al., 2001). The rat Cμ and Cα sequences bear high similarity to their counterpart 
in the mouse and generally ≥90% sequence identity is revealed upon comparison (both at 
nucleotide and amino acid level).  
Figure 4. Phylogenetic tree of the functional IGHJ genes from rat, mouse and human (Neighbor-Joining 
method; (Nei and Kumar, 2000)). IGHJ sequences are described by (Bruggemann et al., 1986; Gough 
and Bernard, 1981; Lang and Mocikat, 1991; Sakano et al., 1980) and retrieved from the IMGT (http://
www.imgt.org) (Lefranc et al., 2009). Evolutionary distances were computed from the IGHJ 5′ RSS nona-
mer sequence up to the IGHJ 3′ splice donor site (based on a total of 105 positions). See Figure 3 legend 
for further details.
A large proportion of the cDNA sequence of the rat Cδ gene was determined by Sire et al. 
(Sire et al., 1982). The rat Cδ locus spans nearly 20 kB and is therefore twice the size of the 
other IGHC genes (Figure 5). Comparison to the mouse reveals that the rat Cδ1 exon differs 
substantially from mouse Cδ1 (50–55% identity), whereas much more identity is observed 
in the more C-terminal parts of the Cδ gene encoded by the Cδ3 and CHS exons (85–90% 
identity) (Sire et al., 1982). The genomic organization of the rat Cε gene was described by 
Steen et al. (Steen et al., 1984) and is about 5 kB in size. Overall, the rat ε-chain yields ≥60% 
and ≥80% nucleotide identity with the ε-chain in man and mouse, respectively. Of all rat IGHC 
genes, Cγ genes have been described most extensively (Bruggemann, 1988; Bruggemann et 
al., 1988; Bruggemann et al., 1986; Bruggemann et al., 1989). The rat Cγ1 and Cγ2a genes 
share 94% nucleotide identity with each other and best resemble the single mouse Cγ1 gene 
(87% and 86%, respectively). The rat Cγ2b gene, on the other hand, bears high nucleotide 
sequence identity to the mouse Cγ2a and Cγ2b genes (82% and 81%, respectively). Further-
more, the rat Cγ2c gene seems to be the equivalent of mouse Cγ3 gene (87% identity), as 


































































Similar to other IGH genes, the IGHC genes in mammals most probably evolved from series 
of gene duplication(s) followed by mutation and selection of new genes. Some of these dupli-
cations occurred before species divergence, whereas others occurred in recent species evo-
lution. In this regard, rat and mouse Cγ genes are most likely derived from a common set of 
three ancestral genes that evolved to Cγ2c, [Cγ2a–Cγ1], and Cγ2b in rat, and Cγ3, Cγ1, and 
[Cγ2b–Cγ2a] in mouse (Bruggemann, 1988). The pairs of closely related Cγ2a/Cγ1 genes in 
rat and Cγ2b/Cγ2a genes in mouse are expected to result from a duplication event in recent 
evolution of either species. Also the presence of two Cγ gene-clusters [Cγ–Cγ–Cε–Cα] in the 
human IGHC locus can be explained by a segmental-duplication in recent human evolution.
Figure 5. Genomic organization of the entire IGHC region of the BN rat. The 220 kB map was construc-
ted on the basis of rat Baylor 3.4/rn4 genome assembly (Nov. 2004) at UCSC (http://genome.ucsc.edu) 
(Gibbs et al., 2004; Meyer et al., 2013) and Genvision software (DNASTAR, Madison, WI; http://www.
dnastar.com). Direction is from telomere to centromere on chromosome 6q32 (minus strand in UCSC 
genome browser). The region corresponds to the assembly coordinates chr6:138450912–138230912. 
Nucleotide sequences of the IGHC exons were obtained using IMGT/GENE-DB (http://www.imgt.org) 
(Giudicelli et al., 2005; Lefranc et al., 2009). The JGHJ locus is shown for map orientation. Red tick marks 
indicate positions of (small) assembly gaps in the Baylor 3.4/rn4 assembly (first 6 gaps approx. 10 bp; 








































last gap approx. 130 bp). Long arrows represent the loci of individual IGHC genes, including the introns, 
but excluding the 5′ and 3′ untranslated regions (UTR). IGHC exons are indicated by short arrows and 
annotated with standard IMGT labels (Lefranc et al., 2009).
3. Genomic organization of the rat immunoglobulin 
kappa and lambda loci 
The IGK and IGL chains in rats are transcribed from two loci of which only one copy of either 
locus is present in the rat haploid genome (Frank et al., 1987; Sheppard and Gutman, 1981a; 
Steen et al., 1987). The IGK and IGL loci are located on chromosome 4 and 11, respectively 
(Perlmann et al., 1985; Wahlstrom et al., 1988). In rodents, the IGK and IGL chains are not 
equally expressed among peripheral B cells and most (>90%) express IGK chains. In contrast 
to the rat IGH locus, limited information is available on the genomic organization of the rat IGK 
and IGL loci. Initial Southern blotting experiments by Breiner et al. (Breiner et al., 1982) using 
Vκ probes revealed the presence of dozens of Vκ genes in the rat genome and that they pre-
sumably could be subdivided into subgroups similar to mouse. The current IMGT/GENE-DB 
(Giudicelli et al., 2005) lists 163 (135 functional) IGKV genes for the IGK locus of the BN rat 
that are subdivided over 21 IGKV subgroups. The largest IGVK subgroups in rat are IGKV1 
(of which 22 are functional), IGKV4 (19 functional), and IGKV12 (21 functional). Together, 
members of these subgroups comprise almost half (46%) of the functional IGKV gene reper-
toire. In comparison, the mouse IGK locus on chromosome 6 consists of 169 IGKV genes (98 
functional; current IMGT/GENE-DB) (Giudicelli et al., 2005), which belong to 20 subgroups. 
The total number of IGKV genes is therefore very similar between rat and mouse, but the rat 
IGK locus contains relatively more functional IGKV genes (83% Vs. 68%).
In addition to the IGKV genes, the IGK locus harbors seven IGKJ genes (IGKJ1, IGKJ2–1, 
IGKJ2–2, IGKJ2–3, IGKJ3, IGKJ4, and IGKJ5) and only one IGKC (Cκ) gene (Breiner et al., 
1982; Burstein et al., 1982; Frank et al., 1987; Sheppard and Gutman, 1981b). As in mouse, 
IGKJ3 is probably not functional, because of a mutation in the splice-donor site, leaving six 
functional IGKJ genes available (Burstein et al., 1982; Sheppard and Gutman, 1982). The 
rat IGKJ genes bear much resemblance to their murine homologs (>90% nucleotide identity 
for the coding regions). The same degree of nucleotide sequence identity is observed for the 
IGKC genes of rat and mouse (88.5%) (Sheppard and Gutman, 1981a). An interesting ob-
servation was made by Sheppard and Gutman (Sheppard and Gutman, 1981a) and Frank et 
al. (Frank et al., 1987), who demonstrated that on short-term evolutionary scale the mutation 
rate in the IGKC coding region is higher in comparison to the surrounding noncoding regions. 
This results in a rapid divergence of the IGKC region in the rat lineage and the creation of 
many allelic Variants. A phenomenon which is also observed for the IGLC gene (Frank and 
Gutman, 1988).The rat IGL and related loci (15 and VpreB) have not been as extensively 








































studied as those of mouse and an exact physical map of these loci has still to be established. 
In mouse, the IGL locus spans a region of about 180 kB on chromosome 16 and is arranged 
from a limited number of IGL genes. The IGL genes in this species are organized in two 
[VnJCJC] gene-clusters, about 94 kB separated from each other, which have the following 
order: IGLV2–18.5 kB–IGLV3–40.4 kB–IGLJ2–1.3 kB–IGLC2–2.0 kB–IGLJ4–1.2 kB–IGLC4 
and IGLV1–14.4 kB–IGLJ3–1.3 kB–IGLC3–2.1 kB–IGLJ1–1.1 kB–IGLC1 (Gerdes and Wabl, 
2002). The IGLJ4 and IGLC4 combination is considered nonfunctional due to a defective 
splice donor-site (Blomberg and Tonegawa, 1982). Only three IGLV genes are described for 
the mouse IGL locus. The number of combinations that can be generated during IGLV–IGLJ 
rearrangement is therefore Very restricted. In case of the rat, only three IGLC genes and one 
IGLV gene are described (Frank and Gutman, 1988; Steen et al., 1987). Two of these IGLC 
genes (originally named Cλ2 and Cλ1) are located at approximately 3 kB from each other. 
Each of these IGLC genes seems to be preceded by two IGLJ genes, instead of one in case 
of the mouse. One of these IGLC genes (Cλ1) does not seem to be functionally expressed, 
as both Jλ1 genes upstream of Cλ1 have aberrant RSS and splice donor-sites. Also one of 
the Jλ2 genes is not functional, leaving only the Jλ2–Cλ2 combination apparently able to be 
functionally expressed. A third IGL gene (Cλ1.2) was also described by Frank and Gutman 
(Frank and Gutman 1988) and initially thought to represent another IGLC pseudogene. Cλ1.2, 
however, may well represent the rat homologue of the mouse λ5 gene (unpublished obser-
vations; accession number Z68145). Rat Cλ2 bears the highest resemblance to the murine 
IGLC3 gene (>90% sequence identity in coding and surrounding noncoding region), whereas 
the rat Cλ1 gene is most closely related to both IGLC1 and IGLC4 (Frank and Gutman, 1988; 
Steen et al., 1987). The rat Cλ2–Cλ1 cluster described before (Frank and Gutman, 1988; 
Steen et al., 1987) may therefore well be the homologue of the mouse IGLC3–IGLC1 cluster. 
In addition to the IGLJ and IGLC genes, Aquilar and Gutman (Aguilar and Gutman, 1992) 
showed that the IGL locus in rats also comprises about 10–15 IGLV genes (including some 
pseudogenes), representing at least four distantly related IGLV subgroups. 
At present, the rat IGL locus seems to have a rather low complexity, apparently consisting 
of only one [VnJJCJJC] cluster. According to the current IMGT/GENE-DB (Giudicelli et al., 
2005), the rat IGL locus on chromosome 11 consists of seven functional IGLV (representing 
three subgroups: IGLV1, IGLV2, and IGLV3), four IGLJ (two functional), and four functional 
IGLC genes. Whether the two additional IGLC genes listed in the IMGT database represent 
the members of a second IGL cluster in the rat, as observed in mouse, is currently not known.









































The rapid evolution of IG loci suggests that these loci are subjected to high diversifying-selec-
tion pressure, to establish a large repertoire of antigen-receptors on B cells. This evolutionary 
process results in variation of complexity and organization of IG loci among different mam-
malian species and provides optimal protection against threatening pathogens. Knowledge 
on the IG complexity and organization is prerequisite for the appropriate evaluation of the 
functional repertoire expressed by B cells. With the background information on the IG loci in 
the rat that is presented in this chapter, it will be feasible to maximize the usefulness of the rat 
as an experimental model for many important human disorders.
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The proportion of mutated IgM positive marginal zone B cells varies 


















































The splenic marginal zone is a unique anatomical B cell compartment populated with B 
lymphocytes with distinctive phenotypical and functional capabilities. Previous studies 
have shown that in rodents the vast majority of B cells are naïve cells with unmutated 
immunoglobulin genes, which is in marked contrast to humans, where nearly all splenic 
marginal zone B (MZ-B) cells are memory type B cells with mutated immunoglobulin 
genes. Here, we show that the proportion of mutated IgM+ MZ-B cells varies significantly 
between the various IGHV genes analysed, ranging from 27% mutated IGHV5 trans-
cripts to 66% mutated IGHV4 transcripts. Also mutated IgM+ follicular B (FO-B) cells can 
be observed, but their proportion is much lower compared to MZ-B cells, Excitingly we 
observed mutated sequences from clonally related B cells with a MZ-B cell and FO-B 
cell phenotype indicating that mutated IgM+ MZ-B and FO-B cells have a common origin. 
Together we conclude that the splenic MZ of rats harbors a significant number of memory 
type IgM+ MZ-B cells with mutated immunoglobulin genes and that these memory MZ-B 
cells are probably generated as a result of an antigen driven immune response in germi-
nal centers.
 









































The marginal zone is a distinct anatomical white pulp compartment of the spleen, at the bor-
der with the red pulp (Steiniger et al., 2006). This unique compartment is characterized by a 
high blood flow and is separated, in rodents, from follicles and T cell zones by a layer contai-
ning a small blood sinus, the so-called marginal sinus. The splenic marginal zone harbors B 
cells, macrophages and dendritic cells, and in humans also CD4+ T cells. In rodents, B cells 
in the marginal zone (MZ-B cells) are pre-activated, non-recirculating cells, expressing high 
levels of IgM and low levels of IgD (Oliver et al., 1999). This phenotype distinguishes them 
from the majority population of naïve B cells, which express low levels of IgM and high levels 
of IgD. This latter population of B cells is recirculating B cells that home to lymphoid follicles 
of secondary lymphoid organs, and hence are called follicular B (FO-B) cells. The location 
of MZ-B cells, together with their functional properties make these cells perfectly suited for 
mounting rapid antibody responses to blood-borne antigens. In particular, these cells ap-
pear to be effectively involved in T cell independent humoral immune responses directed 
towards carbohydrate (Type 2) antigens (Guinamard et al., 2000). Another important role of 
MZ-B cells comprises the facilitation of antigen transport towards the follicles (Cinamon et al., 
2008). MZ-B cells constitute a heterogeneous population of cells. In rats and mice, the vast 
majority (80-90%) of the MZ-B cells is naïve cells, with unmutated immunoglobulin heavy 
variable (IGHV) region genes (Dammers et al., 2000; Makowska et al., 1999). Their IGHV 
genes differs from FO-B cells and show more negatively charges amino acids (Carey et al., 
2008; Schelonka et al., 2007). On average the heavy chain complementarity regions 3 (H-
CDR3) are 2-3 amino acids smaller, compared to their FO-B cell counterparts (Dammers et 
al., 2000). Autoantigens, rather than exogenous antigens might likely play a role in the ligand 
selection of these naïve MZ-B cells (Dammers and Kroese, 2005; Martin and Kearney, 2000). 
In addition to naïve B cells a small fraction of the MZ-B cells might be either unswitched or 
class switched memory B cells as shown by their appearance after immunization (Gatto et 
al., 2007; Gatto et al., 2004; Obukhanych and Nussenzweig, 2006; Pape et al., 2003; Phan 
et al., 2005; White and Meng, 2012). A hallmark of memory B cells is the presence of somatic 
mutations in the IGV genes (Tangye and Tarlinton, 2009). Indeed, approximately 10-20% of 
rodent sIgM+ MZ-B cells carry mutated IgM-encoding IGHV genes (Dammers et al., 2000; Ma-
kowska et al., 1999). Recently, we revealed in rats the presence of class switched B cells with 
a MZ-B cell phenotype, as defined by non-Ig markers expressing somatically mutated IGHV 
genes encoding for IgG (Hendricks et al., 2011). Interestingly, these class switched memory 
MZ-B cells exhibit significantly fewer mutations, compared to memory B cells with a FO-B 
cell phenotype (Hendricks et al., 2011). There is some evidence that these class switched 
memory MZ-B cells and FO-B cells have a common, germinal center (GC) origin. In marked 
contrast with rodents, the vast majority MZ-B cells in adult human spleens are unswitched 








































(IgM+) memory B cells as revealed by their expression of CD27 (Tangye et al., 1998; Zand-
voort et al., 2001) and the notion that virtually all MZ-B cells expressed mutated IGHV genes 
(Dunn-Walters et al., 1995; Spencer et al., 1998). The discrepancy between the frequency of 
mutated MZ-B cells in rodents and humans is not clear. There might be developmental dif-
ferences between the species. Weller and co-workers (Weill et al., 2009; Weller et al., 2004; 
Weller et al., 2008) speculated that presence of mutations in human MZ-B cells is an intrinsic 
property of these cells. According to their view human MZ-B cells are not generated during 
antigen-induced immune responses in GC and thus do not represent memory B cells. Rather, 
mutations are introduced in the IGHV genes of MZ-B cells in an antigen independent fashion, 
in order to diversify their naïve Ig repertoire, during the generation of these MZ-B cells (Weller 
et al., 2008). Another factor that might contribute to this discrepancy between (adult) human 
and rodent MZ-B cells is the analysis of IGHV genes themselves. Both in humans (Dunn-
Walters et al., 1995; Tierens et al., 1999) and rodents (Dammers et al., 2000; Makowska et al., 
1999) mutational analysis on IGHV genes derived from splenic MZ-B cells was carried out on 
only a very restricted set of IGHV genes of certain IGHV gene families. Whether these IGHV 
genes are representative for the mutation frequencies of the IGHV genes of the entire MZ-B 
cell pool is not known. MZ-B cells are ligand selected and for this reason, there might well be 
significant differences in the frequencies of mutated IGHV genes between the individual IGHV 
genes or IGHV gene families in rodents and humans. This issue was addressed in the work 
described here by looking at the mutation frequencies of individual IGHV genes that belong 
to several IGHV gene families that varied in size (viz. IGHV3, IGHV4, IGHV5) expressed in 
rat MZ-B or FO-B cells. 
2. Materials and Methods
2.1. Animals 
Adult male BN/SsNOlaHsd rats were obtained from Harlan (Horst, The Netherlands) at 4.5 
months of age. Animals were housed until the age of 9 months under clean conventional 
conditions at the Central Animal Facility of the University Medical Center Groningen. All expe-
riments were approved by the Animal Ethics Committee of the University of Groningen.
2.2. Isolation and purification of B cell subsets by flow-cytometry
Rat B-lymphocytes were isolated and purified from splenic tissue as described previously 
(Dammers et al., 1999). Briefly, spleen cell suspensions from 2 animals were labeled for 
flow-cytometry with the following mouse monoclonal antibodies: FITC conjugated anti-rat IgM 
(HIS40; eBioscience, San Diego, CA, USA), biotinylated anti-rat IgD (MaRD3; AbD Serotec, 
Oxford, UK), APC conjugated anti-rat CD90/Thy1.1 (HIS51; eBioscience) and PE conjugated 
anti-rat TCRαβ (R73; eBioscience); TCRγδ (V65; eBioscience), CD161a/NKRP1a (10/78; BD 








































Pharmingen). Biotinylated mAb were revealed with streptavidin conjugated to the tandem 
fluorochrome PE-Cy5.5 (Ebioscience). The PE channel was used as a “dump” channel: only 
PE negative (i.e. Dump- and CD90- cells) were sorted. Herewith, we were able to exclude im-
mature B cells (i.e. CD90+ B-cells: (Dammers et al., 1999), T cells and NK cells from our sorts. 
Cell analysis and cell sortings were performed with a MoFlo flow cytometer (Cytomation, 
Ft Collins, CO). Dead cell, plasma cell, monocyte/macrophage, and erythrocyte contamina-
tion was excluded from sorting by using forward and side scatter profiles. Sorted FO-B cells 
(CD90-IgDhighIgMlow) and MZ-B cells (CD90-IgMhighIgDlow) cells were collected in sterile FACS 
tubes (Greiner Bio-One, Alphen a/d Rijn, The Netherlands) containing 500 μl of newborn calf 
serum (PAA laboratories GmbH, Pasching, Austria). At least one million cells per B cell subset 
were sorted. B cell subsets were obtained with >95% purity. FlowJo software (Tree Star, San 
Carlos, CA) was used for flow cytometry data analysis.
2.3. Molecular cloning of IGHV-Cμ transcripts
Total RNA was extracted from sorted cells using the Absolutely RNA Miniprep kit (Stratage-
ne, La Jolla, CA, USA) according to instructions of the manufacturer. Briefly, sorted cells 
were pelleted by 300xg centrifugation for 10 min at 4oC and then resuspended in a total 
volume of 350 μl lysis buffer containing β-mercaptoethanol (Stratagene). First strand cDNA 
was synthesized using an oligo-(dT) 12-18 primer (Invitrogen, Breda, The Netherlands) and 
SuperScriptTMII reverse transcriptase (200U/μl; Invitrogen) as described in the manufactu-
rer’s protocol. Rearranged IGHV3-Cµ, IGHV4-Cµ IGHV5-Cµ transcripts were amplified in a 
50 μl reaction mixture, containing 2 μl cDNA of either IGHV3-Cµ, IGHV4-Cµ and IGHV5-
Cµ family specific primer ,plus 0.6 pmol/µl universal Cµ constant region primer and 2.5U 
Taq DNA Polymerase (Invitrogen). The IGHV gene family specific primers were: IGHV3:5’-
TGAAACCCTCACAGTCACTC-3’, IGHV4:5’-GGTGCARCCTGGAAGATCCT-3’ and IGHV5’-
CTTAGTGCAGCCTGGAAGGT-3’ (Dammers et al., 2000). Individual IGHV gene family spe-
cific primers were used in separate RT-PCR reactions in combination with the constant region 
Cµ primer 5’-CAACACTGAAGTCATCCAGGG-3’. To assess the amount and quality of the 
cDNA, PCR was also performed for β-actin, using β-actin specific primers as described by 
Stoel et al. (Stoel et al., 2005). The PCR program for amplification of IGHV-Cμ transcripts and 
β-actin consisted of 35 cycles of 30 sec at 94°C (2 min in first cycle), 1 min at 58°C and 1 min 
at 72°C, respectively. This program was followed by an additional incubation period of 25 min 
at 72°C to allow extension of all IGHV-Cμ products. The quality and size of the PCR products 
was evaluated by agarose gel electrophoresis.
2.4. Cloning and sequencing
PCR products were cloned into the pJET1/blunt vectors using the GeneJETTM PCR Cloning 
Kit (Fermentas Life Sciences). TOP10F E. coli competent cells (Invitrogen) were transformed 








































with plasmids containing the PCR product. Plasmid DNA was isolated from randomly picked 
colonies with the Nucleospin Plasmid QuickPure kit (Bioke, Leiden, The Netherlands). Size 
of the inserts was determined by digestion of a DNA sample of the plasmids with the appro-
priate restriction enzymes followed by agarose gel electrophoresis. Plasmids containing an 
insert of approximately 500 bp were sequenced in both directions by ServiceXS (Leiden, The 
Netherlands). Sequence processing was performed using EMBL/Genbank Data Libraries and 
Chromas software (Digital River GmbH, Cologne, Germany). IGHV-Cµ sequences displaying 
100% identity and obtained from the same PCR amplification, might be derived from a single 
B cell and were therefore counted only once in our subsequent analysis. Mutational analysis 
was performed using IMGT/V QUEST database (www.imgt.org/IMGT_vquest/share/textes/).
2.5. Statistical analysis of IGHV gene analysis
Statistical analysis of the data was performed using SPSS 16 software (SPSS Inc. Chica-
go, Ill. USA). Since Taq DNA polymerase errors might be responsible for 1–2 mutations per 
sequence, only sequences with more than 2 mutations were considered as truly mutated 
sequences (Dammers et al., 2000). The number of mutations was determined by counting 
the number of nucleotide mismatches in comparison with each IGHV gene sequence to its 
closest germline counterpart (Hendricks et al., 2010). Statistical analysis was performed by 
Fisher’s exact test to determine possible differences between groups with regard to frequency 
of mutated sequences. Nonparametric tests (Kruskal-Wallis and Mann-Whitney tests) were 
used to compare groups with respect to the number of mutations in mutated sequences. In all 
statistical tests a P-value < 0.05 was considered to be statistically significant different.
3. Results
3.1. Analysis of the IGHV genes in FO-B cells and MZ-B cells.
Recently, we have constructed and annotated the complete genomic repertoire of the IGH 
locus of the BN rat (Hendricks et al., 2010). The completion of the IGH locus has allowed us to 
analyse individual IGHV genes among different IGHV gene families by FO-B and MZ-B cells. 
In Figure 1 the strategy for sorting of FO-B and MZ-B cells is illustrated. Viable lymphocytes 
were gated on the basis of forward-sideward scatter profiles, and non-T, non-NK cells (Dump- 
cells) were further analysed. FO-B cells and MZ-B cells were subsequently defined as CD90-
IgMlowIgDhigh and CD90-IgMhighIgDlow. The post sort purity for FO-B cells and MZ-B cells was 
>95%. Expressed IGHV3, IGHV4 and IGHV5 genes were amplified, cloned and sequenced. 
These IGHV gene families were chosen, because of their difference in size, with respectively 
4, 2 and 26 potentially functional IGHV genes in the BN rat.








































Figure 1. Four colour cytometry of FO-B cells and MZ-B cells. Single cell suspensions of spleen from rats 
were stained with FITC conjugated anti-rat IgM, biotinylated anti-rat IgD, APC conjugated anti-rat CD90/
Thy1.1 and PE conjugated anti-rat TCRαβ, TCRγδ, CD161a/NKRa. Biotinylated monoclonal antibodies 
were revealed with streptavidin conjugated to the tandem fluorochrome PE-Cy5.5. Viable lympocytes 
were gated by forward scatter and side scatter profiles. Acquisition gates were set to exclude PE positive 
cells (T cells and NK cells) and CD90 positive (immature) B cells. Mature FO-B cells, defined as CD90-
IgDhighIgMlow and MZ-B defined as CD90-IgMhighIgDlow were sorted. Post sort reanalysis showed that the 
purity of FO-B cells and MZ-B cells was >95%.
We obtained 19 and 16 complete IGHV3-Cµ transcripts from FO-B cells and MZ-B cells, 
respectively. Three of the four IGHV3 germline genes were expressed as productive genes in 
both B cell subsets i.e. IGHV3S1, IGHV3S3 and IGHV3S5 (Table 1). From the IGHV4 gene 
family we were able to successfully amplify only one of the two potentially functional genes 
(viz. IGHV4S2). In total we obtained 12 IGHV4-Cµ transcripts from FO-B cells and 59 IGHV4-
Cµ transcripts from MZ-B cells (Table 1). From the second largest IGHV gene family in the BN 
rat, the IGHV5 gene family (also called the PC7183 family), 16 different, out of 26 potentially 
functional IGHV5 genes were found among 40 and 61 IGHV5-Cµ transcripts (see Table 1) 
that were amplified from FO-B cells and MZ-B cells, respectively.
3.2. MZ-B cells express more mutated IGHV-Cµ transcripts then FO-B cells 
We subsequently analysed the obtained IGHV-Cµ transcripts that were amplified from both 
B cell subpopulations. The number of mutations within each rearranged IGHV gene was as-
sessed on the bases of the nucleotide identity to the closest corresponding germline of the 
IGHV gene counterparts. Sequences with only 1 or 2 mutations were considered to be germ-
line because we cannot exclude the possibility that these differences compared to germline 
IGHV genes were due to PCR artifacts (Dammers et al., 2000). We first analysed the propor-
tion of mutated among the combined IGHV3, IGHV4 and IGHV5 sequences. As we show in 
Figure 2 18% of FO-B cells and 45% of MZ-B cells expressed mutated IGHV-Cµ transcripts. 
This percentage of mutated sequences is significantly higher within the MZ-B cell subset com-
pared to the percentage of mutated sequences present within the FO-B cell subset (Fisher’s 
exact test: P < 0,001). 








































3.3. The difference in frequency of mutated sequences between MZ-B cells and FO-B 
cells is largely due to the IGHV3 gene family.
We subsequently analysed whether this difference in percentage of mutated sequences 
between FO-B cells and MZ-B cells was present in all three IGHV gene families tested. There 
was no statistical difference in percentage mutated sequences between the two B cell sub-
sets among sequences of the IGHV4 and IGHV5 gene families, albeit that there was a strong 
trend that a higher percentage of MZ-B cells expressing mutated IGHV4 genes were present 
compared to the percentage of mutated IGHV4 genes of FO-B cells (Fisher’s exact test: P = 
0,051) (Figure 2). In contrast, within the IGHV3 gene family, 31% of the sequences derived 
from MZ-B cells were mutated, whereas none of IGHV3 sequences derived from FO-B cells 
were mutated (Fisher’s exact test: P = 0,016) (Figure 2). Thus, the higher frequency of MZ-B 
cells expressing mutated IGHV sequences is largely due to the contribution of the IGHV3 
gene family.
3.4. The IGHV4 gene family contains the highest percentage of mutated IGHV-Cµ trans-
cripts, both among MZ-B cells and among FO-B cells
We analysed whether there was a difference in the percentage of mutated IGHV-Cµ trans-
cripts between the three IGHV gene families (IGHV3, IGHV4, and IGHV5) in the two B cell 
subsets. As we show in Figure 2 within both MZ-B cells and FO-B cells, the IGHV4 gene 
family contains a significantly higher proportion of mutated IGHV-Cµ transcripts, compared to 
the two other IGHV gene families (IGHV3 and IGHV5) (Fisher’s exact test: P = 0,023 and P < 
0,001, respectively). Of the IGHV4 sequences two-third of the MZ-B cell derived sequences 
and one-third of the FO-B cell sequences were mutated. Thus, based upon these findings 
we conclude that there is a significant difference in the percentage of mutated sequences 
between the various IGHV gene families, for both MZ-B cells and FO-B cells.








































Figure 2. Percentage of mutated IgM+ FO-B cells and MZ-B cells within different IGHV gene families. 
Analysis of the proportion of mutated (>2 mutations compared to the closest germline gene) shows that 
MZ-B cells express more mutated sequences than FO-B cells, when all sequences from the three IGHV 
gene families are combined (i.e. “total”) (Fisher’s exact test: P < 0.001). This difference between MZ-B 
cells and FO-B cells was largely due to a significant difference in percentage mutated sequences within 
the IGHV3 family (Fisher’s exact test: P = 0.016). There are relatively more mutated sequence found in 
the IGHV4 gene family compared to IGHV3 and IGHV5 both for the MZ-B cells (Fisher’s exact test: P < 
0.001) and FO-B cells (Fisher’s exact test: P = 0.023).






































































Table 1. Sequence analysis of IGHV3, 4 and 5-Cµ transcripts expressed by FO-B cells and MZ-B cells 
from adult BN rat spleen
Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
Sequences of IGHV3 gene family from FO-Bd cells
A2RFV3-A4 IGHV3S1 IGHD1-7 IGHJ1 0 12 ARTTRVYWYFDF
A2RFV3-B2 IGHV3S1 IGHD4-4 IGHJ2 0 9 ARFVGYFDY
A2RFV3-B3 IGHV3S1 IGHD4-1 IGHJ2 1 11 AYSPGGYRFDY
A2RFV3-C2 IGHV3S1 IGHD1-6 IGHJ2 0 12 ARYGATEGIVDY
A2RFV3-C4 IGHV3S1 IGHD4-1 IGHJ3 0 14 VNMSNNSGYDWFAY
A2RFV3-D1 IGHV3S1 IGHD1-7 IGHJ1 0 16 ARFYDGSYYYDWYFDF
A2RFV3-D3 IGHV3S1 IGHD1-7 IGHJ3 0 17 ARYYGIYYYSSYDWFAY
A2RFV3-E1 IGHV3S1 IGHD1-8 IGHJ3 0 17 ARAGGRDSYAHVGWFAY
A2RFV3-E2 IGHV3S1 IGHD1-3 IGHJ2 1 11 ARLYSIAAPYY
A2RFV3-E3 IGHV3S1 IGHD4-1 IGHJ3 0 8 ARNPGFAY
A2RFV3-G3 IGHV3S1 IGHD3-3 IGHJ2 2 11 ARSGQKSLFDY
A2RFV3-H1 IGHV3S1 IGHD1-7 IGHJ2 0 16 ARYGDYYDGSYYAFDY
A2RFV3-H3 IGHV3S1 IGHD3-1 IGHJ2 0 10 ASPYPGQRWY
A2RFV3-A3 IGHV3S3 IGHD1-3 IGHJ2 1 12 ARSELQWYYFDY
A2RFV3-B4 IGHV3S3 IGHD5-1 IGHJ2 0 16 ARRPITGSGGGYYFDY
A2RFV3-F2 IGHV3S3 IGHD5-1 IGHJ4 0 12 ASGNWDSYVMDA
A2RFV3-G1 IGHV3S3 IGHD1-7 IGHJ2 0 15 ARSSYYYDGSYSLDY
A2RFV3-A1 IGHV3S5 IGHD1-5 IGHJ3 0 10 AGNNLDWFAY
A2RFV3-F3 IGHV3S5 IGHD1-8 IGHJ4 1 16 ASPLDGYYPYYYVMDA
Sequences of IGHV3 gene family from MZ-Be cells
A2MZV3-A5 IGHV3S1 IGHD1-1 IGHJ2 0 9 ARRTVSFDY
A2MZV3-A6 IGHV3S1 IGHD1-4 IGHJ2 8 12 ARRDPGITLFDY
A2MZV3-B7g IGHV3S1 IGHD1-3 IGHJ2 0 13 ARGQQLSEYYFDYC#1
A2MZV3-F5g IGHV3S1 IGHD1-3 IGHJ2 1 13 ARGQQLSEYYFDYC#1
A2MZV3-C5 IGHV3S1 IGHD1-7 IGHJ1 0 14 ARYDGSYYYWYFDF
A2MZV3-C7h IGHV3S1 IGHD1-4 IGHJ2 1 12 ARSGGYNYYFDYC#2
A2MZV3-E7h IGHV3S1 IGHD1-4 IGHJ2 0 12 ARSGGYNYYFDYC#2
A2MZV3-D4 IGHV3S1 IGHD1-6 IGHJ3 5 10 ARYSERGFAY
A2MZV3-E4 IGHV3S1 IGHD1-5 IGHJ2 0 12 ARGGIYNTYFDY
A2MZV3-E5 IGHV3S1 IGHD4-1 IGHJ2 7 13 ARKGDSNSGLFDY
A2MZV3-F6 IGHV3S1 IGHD1-1 IGHJ2 0 15 ARGGVYYGLLSSFDY
A2MZV3-G6 IGHV3S1 IGHD1-7 IGHJ2 0 13 ARSTTVVHYYFDY
A2MZV3-G7 IGHV3S1 IGHD1-1 IGHJ2 4 12 ARSGYTTDYPDY
A2MZV3-H4 IGHV3S1 IGHD3-2 IGHJ2 0 9 ARSTDYFDY








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
A2MZV3-E6 IGHV3S3 IGHD3-1 IGHJ2 0 10 ARSGSGDFDY
A2MZV3-B5 IGHV3S5 IGHD1-5 IGHJ4 4 12 ARRTTSDYVMDA
Sequences of IGHV4 gene family from FO-Bd cells
A2RFV4-10 IGHV4S2 IGHD4-1 IGHJ2 6 10 IRERNSGAEY
A2RFV4-2i IGHV4S2 IGHD4-1 IGHJ2 9 9 VREAFGVREC#3
A2RFV4-2.25 IGHV4S2 IGHD1-7 IGHJ4 0 14 ARVYDGSYYYVMDA
A2RFV4-2.27 IGHV4S2 IGHD1-2 IGHJ1 0 10 GGSLYWYFDF
A2RFV4-5 IGHV4S2 No IGHD IGHJ3 0 5 ASRAY
A2RFV4-6 IGHV4S2 IGHD1-6 IGHJ4 4 11 TRAGTVLQMDA
A3RFV4-12 IGHV4S2 IGHD1-8 IGHJ2 0 12 ARASYYDGYGDY
A3RFV4-3j IGHV4S2 IGHD4-1 IGHJ2 11 9 VREAFGVDYC#4
A3RFV4-3.2 IGHV4S2 IGHD1-4 IGHJ3 0 13 ARADGYNFNWFAY
A3RFV4-3.4 IGHV4S2 IGHD3-3 IGHJ1 0 12 ARLWRRYWYFDF
A3RFV4-43 IGHV4S2 IGHD1-5 IGHJ2 1 12 ARWNNYDYYFDY
A3RFV4-9 IGHV4S2 IGHD1-5 IGHJ2 0 11 AREDYNNIGDH
Sequences of IGHV4 gene family from MZ-Be cells
A2MZV4-1i IGHV4S2 IGHD4-1 IGHJ2 9 9 VREAFGVREC#3
A2MZV4-10 IGHV4S2 IGHD1-6 IGHJ2 1 9 AREVGYFDY
A2MZV4-11 IGHV4S2 IGHD3-4 IGHJ2 1 9 TRARKSVDY
A2MZV4-12 IGHV4S2 IGHD1-1 IGHJ3 2 6 EGGIIG
A2MZV4-13 IGHV4S2 IGHD1-6 IGHJ4 11 11 ARASGQRVLDA
A2MZV4-14k IGHV4S2 IGHD4-1 IGHJ4 5 14 TRREFGPHYYVMDAC#5
A2MZV4-3k IGHV4S2 IGHD4-1 IGHJ4 7 14 TRREFGPHYYVMDAC#5
A2MZV4-2.1 IGHV4S2 IGHD1-1 IGHJ3 9 12 ARGLYYGFGFAY
A2MZV4-2.10 IGHV4S2 IGHD4-1 IGHJ4 0 13 ARARNSDYYVMDA
A2MZV4-2.11 IGHV4S2 IGHD4-1 IGHJ2 0 10 ASHERYTSDY
A2MZV4-2.13l IGHV4S2 IGHD4-2 IGHJ2 11 9 VREHFGVDFC#6
A2MZV4-2.17l IGHV4S2 IGHD4-2 IGHJ2 13 9 VREHFGVDFC#6
A2MZV4-2.14 IGHV4S2 IGHD4-1 IGHJ2 8 9 AREAFGVRE
A2MZV4-2.18 IGHV4S2 IGHD1-6 IGHJ2 10 9 AREEAGIDY
A2MZV4-2.20 IGHV4S2 IGHD1-6 IGHJ4 5 9 VREALGVNA
A2MZV4-2.21 IGHV4S2 IGHD2-2 IGHJ2 9 9 VREAYGVDY
A2MZV4-2.3 IGHV4S2 IGHD1-1 IGHJ2 1 25 AREGVYYYSSYRDVYY-
GLLPGYFDY
A2MZV4-2.4 IGHV4S2 IGHD1-7 IGHJ2 8 15 ARGYYYDGSYYHFDY
A2MZV4-2.7 IGHV4S2 IGHD1-5 IGHJ1 2 16 AREALITTTSYWYFDF
A2MZV4-2.8 IGHV4S2 IGHD1-6 IGHJ4 16 9 VREALGVDA








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
A2MZV4-2.9m IGHV4S2 IGHD1-1 IGHJ2 5 13 ARARGMSTTDYLYC#7
A2MZV4-7m IGHV4S2 IGHD1-1 IGHJ2 4 13 ARARGMSTTDYLYC#7
A2MZV4-5 IGHV4S2 IGHD4-2 IGHJ2 6 9 VREELGVDY
A2MZV4-8 IGHV4S2 IGHD5-1 IGHJ1 10 13 GRLSWELYWYFDF
A2MZV4-9 IGHV4S2 IGHD3-2 IGHJ2 3 9 VRAHSSAGD
A3MZV4-1 IGHV4S2 IGHD1-4 IGHJ2 2 15 ARGTSYGSSSDYFDY
A3MZV4-10 IGHV4S2 IGHD1-3 IGHJ2 0 15 ARALDYYSSYIYLDY
A3MZV4-35 IGHV4S2 IGHD1-6 IGHJ2 13 12 ARGDYYRGDFDY
A3MZV4-11n IGHV4S2 IGHD1-6 IGHJ2 11 9 VREHLGVDYC#8
A3MZV4-3.1n IGHV4S2 IGHD1-6 IGHJ2 11 9 VREHLGVDYC#8
A3MZV4-9n IGHV4S2 IGHD1-6 IGHJ2 10 9 VREHLGVDYC#8
A3MZV4-12 IGHV4S2 IGHD1-6 IGHJ2 0 10 ARVVTEGIDY
A3MZV4-36 IGHV4S2 IGHD1-3 IGHJ2 0 11 AREDYSGDFDY
A3MZV4-13 IGHV4S2 IGHD1-6 IGHJ4 0 12 FNGGIAAGVMDA
A3MZV4-14 IGHV4S2 IGHD1-8 IGHJ2 5 10 SGGLGWIFDY
A3MZV4-15 IGHV4S2 IGHD1-1 IGHJ4 0 17 ARVLFMYTTDYQGVMDA
A3MZV4-16 IGHV4S2 IGHD4-1 IGHJ2 19 9 VREDFGVDY
A3MZV4-17 IGHV4S2 IGHD5-1 IGHJ2 0 11 ARARETGNFDY
A3MZV4-18 IGHV4S2 IGHD1-2 IGHJ2 9 15 TRGPSYGSDSDFFDY
A3MZV4-19 IGHV4S2 IGHD1-4 IGHJ2 8 15 ARGTSYGSNSDYFDY
A3MZV4-20 IGHV4S2 IGHD4-1 IGHJ2 8 9 AREAFGVDY
A3MZV4-20Bo IGHV4S2 IGHD1-4 IGHJ2 14 10 AKSGPGIIEYC#9
A3MZV4-7o IGHV4S2 IGHD1-4 IGHJ2 13 10 AKSGPGIIEYC#9
A3MZV4-22 IGHV4S2 IGHD4-1 IGHJ2 9 9 IREAFGVDY
A3MZV4-37 IGHV4S2 IGHD3-2 IGHJ1 15 14 AGLRSGAPYWYLDF
A3MZV4-23 IGHV4S2 IGHD1-6 IGHJ3 9 12 ARELSTGEWFAY
A3MZV4-24 IGHV4S2 IGHD1-3 IGHJ2 1 9 GREIPPVDY
A3MZV4-29 IGHV4S2 IGHD1-7 IGHJ2 2 14 ARSLMVVISHYFDY
A3MZV4-3 IGHV4S2 IGHD1-6 IGHJ4 0 10 ARRRSDVMDA
A3MZV4-3.12 IGHV4S2 IGHD1-6 IGHJ4 0 14 ARVGDSSYYYVMDA
A3MZV4-3.14 IGHV4S2 IGHD1-6 IGHJ3 1 11 VRERSTEGFAY
A3MZV4-3.2j IGHV4S2 IGHD4-1 IGHJ2 14 9 VREAFGVDYC#4
A3MZV4-3.5 IGHV4S2 IGHD4-1 IGHJ2 12 9 VREDLGVDY
A3MZV4-30 IGHV4S2 IGHD2-2 IGHJ2 14 9 AREIPPVDY
A3MZV4-31 IGHV4S2 IGHD1-4 IGHJ4 11 11 ARAVISRVLDA
A3MZV4-32 IGHV4S2 IGHD4-1 IGHJ2 6 9 VREEFGVDY








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
A3MZV4-5N IGHV4S2 IGHD1-6 IGHJ2 11 9 VREQRGVDYC15
A3MZV4-5A IGHV4S2 IGHD1-2 IGHJ2 8 15 TRGPSYGSDSDYFDY
A3MZV4-9 IGHV4S2 IGHD1-5 IGHJ2 0 11 ARADNNSGFDY
Sequences of IGHV5 genes from FO-Bd cells
A2RFV5-39 IGHV5S16 IGHD1-1 IGHJ3 0 12 ARPNYYSGPLAY
A3RFV5-11 IGHV5S13 IGHD1-2 IGHJ2 0 9 ARRAMGFDY
A2RFV5-42p IGHV5-1 IGHD1-6 IGHJ2 17 9 TKGVGGPDYC#10
A2RFV5-46 IGHV5S10 IGHD5-1 IGHJ2 0 9 ATHLGYFDY
A2RFV5-38 IGHV5S14 IGHD1-1 IGHJ2 1 12 VRLCGERDYFDY
A2RFV5-45 IGHV5S14 IGHD1-6 IGHJ1 1 16 ARHVPLHYGGHGYFDF
A3RFV5-14N IGHV5S14 IGHD1-2 IGHJ2 0 8 ARRDDFDY
A3RFV5-48 IGHV5S14 IGHD1-6 IGHJ1 0 17 ARLPAYYGGYSELPFAY
A3RFV5-5 IGHV5S14 IGHD1-1 IGHJ2 0 18 ARHLMYTTDYYYPGAFDY
A2RFV5-17 IGHV5S23 IGHD1-4 IGHJ3 4 14 ARGDYPGITGWFAY
A2RFV5-19 IGHV5S23 IGHD1-4 IGHJ2 0 6 ARPYSV
A3RFV5-12 IGHV5S23 IGHD1-8 IGHJ1 1 20 ARPPRWDYDGYYHVG-
WYFDF
A3RFV5-15 IGHV5S23 IGHD1-1 IGHJ4 6 17 ARSLMYTTDYYYGVMDA
A3RFV5-8 IGHV5S23 IGHD1-7 IGHJ2 4 12 ARGDDGSYYFDY
A3RFV5-3 IGHV5S27 IGHD1-4 IGHJ2 4 12 ARRPPGYNPFDY
A3RFV5-41 IGHV5S27 IGHD1-8 IGHJ2 0 7 ARHYPDY
A3RFV5-45 IGHV5S27 IGHD1-7 IGHJ3 0 20 ARHGADGAMMVVITNGW-
FAY
A3RFV5-47 IGHV5S29 IGHD2-3 IGHJ2 2 10 TTDRLSTFDY
A2RFV5-20 IGHV5S30 IGHD1-1 IGHJ3 1 16 ATEVYTTDYYEGWFAY
A2RFV5-21 IGHV5S30 IGHD1-5 IGHJ2 1 11 ARPHYNNYFDY
A2RFV5-22 IGHV5S30 IGHD1-1 IGHJ3 4 17 ARHMYTTDYYHGDWFAY
A2RFV5-23 IGHV5S30 IGHD1-4 IGHJ3 2 14 ATRPLPGYNYGFAY
A2RFV5-35 IGHV5S30 IGHD1-8 IGHJ3 11 9 ARQDQEFAY
A2RFV5-37 IGHV5S30 IGHD1-7 IGHJ2 4 13 ARLDYYDGSYYDY
A2RFV5-42 IGHV5S30 IGHD4-1 IGHJ2 0 9 ATVAGYFDY
A2RFV5-8 IGHV5S30 IGHD1-3 IGHJ2 0 8 ATLLYSGH
A3RFV5-13N IGHV5S30 IGHD1-1 IGHJ3 0 16 ATDSPTTDYYSNWFAY
A3RFV5-2 IGHV5S30 IGHD1-6 IGHJ3 0 17 ATDTDYGGYSELGGFAY
A3RFV5-4 IGHV5S43 IGHD4-2 IGHJ3 1 13 TRDRGYSSHWFAY
A3RFV5-46 IGHV5S43 IGHD1-3 IGHJ4 0 14 TREPGDYSSYVMDA
A3RFV5-13 IGHV5S43 IGHD1-7 IGHJ2 2 13 TRVGHYYSSYFDY








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
A2RFV5-18 IGHV5S45 IGHD1-1 IGHJ2 2 12 ARRYTTDYWFDY
A2RFV5-88 IGHV5S45 IGHD1-7 IGHJ1 0 21 A R G L G L I T M M V V I T T -
DWYFDF
A2RFV5-41 IGHV5S45 IGHD1-2 IGHJ2 0 10 ARPPYGAFDY
A3RFV5-43 IGHV5S45 IGHD1-1 IGHJ3 4 24 T T G A Y S S Y A V M Y T T -
DYYYAGWFAY
A3RFV5-42 IGHV5S45 IGHD2-2 IGHJ1 2 12 ARRDTLYWYFDF
A2RFV5-47 IGHV5S57 IGHD3-3 IGHJ1 1 15 TRASSSYVSDWYFDF
A3RFV5-44 IGHV5S57 IGHD1-2 IGHJ2 0 11 TRTRVSYYFDY
A2RFV5-43 IGHV5S65 IGHD1-5 IGHJ2 1 13 AKDQGNNYGYFDY
A3RFV5-2 IGHV5S74 IGHD5-1 IGHJ2 2 11 ARGHGDYYFDY
Sequences of IGHV5 genes from MZ-Be cells
A2MZV5-37p IGHV5-1 IGHD1-6 IGHJ2 13 9 TKGVGGPDYC#10
A2MZV5-39 IGHV5S10 IGHD4-1 IGHJ2 0 11 ATHPGEYYFDY
A3MZV5-4 IGHV5-1 IGHD1-6 IGHJ2 16 9 AKGVGGPDY
A2MZV5-2.5 IGHV5S13 IGHD1-1 IGHJ2 0 14 ARFGLITVAVHFDY
A2MZV5-20 IGHV5S13 IGHD1-6 IGHJ1 1 18 ARTTGLTTEGIGYWYFDF
A2MZV5-38 IGHV5S13 IGHD1-1 IGHJ3 4 7 GYYGFAY
A3MZV5-16 IGHV5S13 IGHD1-6 IGHJ3 2 14 ARHETTVVTGWFAY
A3MZV5-38 IGHV5S13 IGHD1-1 IGHJ2 1 11 ASIITTGYFDY
A3MZV5-66 IGHV5S13 IGHD1-3 IGHJ1 1 12 ASQSSYNWYFDF
A2MZV5-11 IGHV5S14 IGHD1-1 IGHJ2 0 9 ARRLLQWDY
A2MZV5-33 IGHV5S14 IGHD1-4 IGHJ2 1 17 ARGGINNIGTTRGVMDA
A3MZV5-3.8 IGHV5S14 IGHD1-7 IGHJ2 0 12 ARYYYDGPWGDY
A3MZV5-5 IGHV5S14 IGHD1-7 IGHJ2 2 15 ARTGFYYYSGDYFDY
A3MZV5-8 IGHV5S14 IGHD1-7 IGHJ2 1 13 ARHYYDGSYYFDY
A2MZV5-14 IGHV5S16 IGHD5-1 IGHJ2 4 7 TTDLNNY
A2MZV5-19 IGHV5S16 IGHD1-8 IGHJ1 0 11 ATCSPYWYFDF
A2MZV5-22 IGHV5S16 IGHD1-7 IGHJ4 4 11 ATDEGGGVMDA
A3MZV5-13 IGHV5S16 IGHD1-6 IGHJ3 4 12 TTLYGGPPWFAY
A3MZV5-8 IGHV5S16 IGHD4-1 IGHJ4 0 7 ARRGMDA
A2MZV5-21 IGHV5S23 IGHD1-2 IGHJ1 5 15 ARQSTYYEDGWYFDF
A3MZV5-3.3 IGHV5S23 IGHD1-2 IGHJ3 4 14 ATEGTMGMSDWFAY
A2MZV5-23 IGHV5S27 IGHD1-4 IGHJ3 0 13 ARPYGYNYRWFAY
A2MZV5-24 IGHV5S27 IGHD1-1 IGHJ3 1 19 ARHPYSSYIYGYTTDWFAY
A3MZV5-61 IGHV5S29 IGHD1-6 IGHJ3 0 12 TTDRGNYGWFAY
A3MZV5-65 IGHV5S29 IGHD1-7 IGHJ2 1 13 TSPLTTVVPYFDY








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acids 
A2MZV5-16 IGHV5S30 IGHD1-3 IGHJ2 6 10 ATDQLYLRAF
A2MZV5-18 IGHV5S30 IGHD1-5 IGHJ2 1 13 ARHDNNYVAYFDY
A2MZV5-2.2 IGHV5S30 IGHD1-3 IGHJ2 2 17 ATDQYYSSYTLAGYFDY
A3MZV5.57 IGHV5S30 IGHD1-3 IGHJ3 1 15 ATDRAYRSYIPTFAY
A3MZV5-10 IGHV5S30 IGHD1-6 IGHJ1 0 12 ATEIDSDWYFDF
A3MZV5-14 IGHV5S30 IGHD1-8 IGHJ2 0 6 ATLSYY
A3MZV5-17 IGHV5S30 IGHD1-7 IGHJ2 5 15 AKMWGGSYYYVPFDY
A3MZV5-2N IGHV5S30 IGHD4-1 IGHJ2 0 6 ATDSSG
A3MZV5-24 IGHV5S30 IGHD5-1 IGHJ3 0 11 ATDDQLDWFAY
A3MZV5-25 IGHV5S30 IGHD4-1 IGHJ3 11 11 AHNAGDVWFPY
A3MZV5-26 IGHV5S30 IGHD1-3 IGHJ2 0 13 ATGVHYSSYIFDY
A3MZV5-3.11 IGHV5S30 IGHD1-2 IGHJ2 2 10 ATQLGGSFDY
A3MZV5-3.13 IGHV5S30 IGHD1-6 IGHJ4 0 12 ATDQTEGPPMDA
A3MZV5-3.4 IGHV5S30 IGHD1-8 IGHJ2 1 12 ATGDYYDGYPDY
A3MZV5-3.6 IGHV5S30 IGHD1-7 IGHJ2 0 13 ATDRSDDGGFFDY
A3MZV5-3.7 IGHV5S30 IGHD1-1 IGHJ2 0 12 ATDHVYYGLLGA
A3MZV5-33 IGHV5S30 IGHD1-1 IGHJ3 0 14 ATAGDTTDYSRFAY
A3MZV5-39 IGHV5S30 IGHD1-6 IGHJ2 0 11 ARGINYGGYAH
A3MZV5-6 IGHV5S30 IGHD1-1 IGHJ3 2 14 ATEVYYGLSDWFAY
A3MZV5-63 IGHV5S30 IGHD1-4 IGHJ2 1 11 ATDEAGDTGDY
A3MZV5-8 IGHV5S30 IGHD1-5 IGHJ2 0 12 ATAFITTTGFDY
A2MZV5-4 IGHV5S30 IGHD1-7 IGHJ3 0 13 ATDGGYAPRWFAY
A2MZV5-25 IGHV5S45 IGHD1-4 IGHJ2 2 10 TTGDMGITPY
A2MZV5-35 IGHV5S45 IGHD1-2 IGHJ4 2 11 ARQGDYGPMDA
A2MZV5-9 IGHV5S45 IGHD4-2 IGHJ1 1 13 ARRGGSAYWYFDF
A3MZV5-11 IGHV5S32 IGHD1-1 IGHJ4 4 17 ATDGAFTTNYFYDVMAA
A3MZV5-12 IGHV5S32 IGHD1-6 IGHJ2 1 12 ARQGYGGYPFDY
A2MZV5-36 IGHV5S36 IGHD1-6 IGHJ2 7 11 TTEVLQWVFDY
A2MZV5-40 IGHV5S36 IGHD1-3 IGHJ3 1 12 TTGTIAANWFAY
A3MZV5-21 IGHV5S36 IGHD1-2 IGHJ2 6 7 ATGLGDY
A2MZV5-12 IGHV5S43 IGHD1-4 IGHJ2 0 13 TREGPYGYNYFDY
A3MZV5-3.15 IGHV5S43 IGHD1-1 IGHJ4 14 10 TIYSNYVMDA
A3MZV5-6 IGHV5S43 IGHD1-6 IGHJ3 0 9 TRGTTEAAY
A3MZV5-10 IGHV5S65 IGHD1-2 IGHJ2 0 9 AKESTMGMG
A3MZV5-36 IGHV5S65 IGHD1-1 IGHJ2 19 7 AINKYNY
A3MZV5-7 IGHV5S65 IGHD1-2 IGHJ2 6 13 AKDSYGGYRYFDY








































a  Cµ (IgM) transcripts from FO-B cells and MZ-B cells   
b  Mutations, nucleotide differences between IMGT germline gene and rearranged Cµ transcript
c  H-CDR3, heavy chain complementarity determining region 3
d  FO-B cells, recirculating follicular B cells    
e  MZ-B cells, marginal zone B cells      
f  Lenght of H-CDR3 in amino acids
g The sequence A2MZV3-B7 and A2MZV3-F5 are from clonally related B cells and designated as clone
 set C#1
h  The sequence A2MZV3-C7 and A2MZV3-E7 are from clonally related B cells and designated as clone 
 set C#2
i  The sequences A2RFV4-2 and A2MZV4-1 are from clonally related B cells and designated as clone 
 set C#3
j  The sequences A3RFV4-3 and A3MZV4-3.2 are from clonally related B cells and designated as clone 
 set C#4
k  The sequences A2MZV4-14 and A2MZV4-3 are from clonally related B cells and designated as clone 
 set C#5
l  The sequences A2MZV4-2.13 and A2MZV4-2.17 are from clonally related B cells and designated as 
 clone set C#6
m The sequences A2MZV4-2.9 and A2MZV4-7 are from clonally related B cells and designated as clone 
 set C#7
n The sequences A3MZV4-11, A3MZV4-3.1 and A3MZV4-9 are from clonally related B cells and
  designated as 
 clone set C#8
o  The sequences A3MZV4-20B and A3MZV4-7 are from clonally related B cells and designated as clone 
 set C#9
p The sequences A2RFV5-42 and A2MZV5-37 are from clonally related B cells and designated as clone 
 set C#10
3.5. Mutation frequency of MZ-B cells with mutated IGHV-Cµ transcripts is higher com-
pared to FO-B cells. 
We next compared the number of mutations among the mutated IGHV-Cµ transcripts (i.e. > 2 
mutations per transcript) IGHV genes in FO-B cells and MZ-B cells. When taking all mutated 
sequences from the three families together, MZ-B cells have a significantly (Mann-Whitney, 
P = 0.046) higher number of mutations then FO-B cells (Figure 3). In MZ-B cells the number 
of mutations is 8.8±4.0 (median 8) and in FO-B cells 6.8±3.9 (median 4). Further analysis 
reveals that the mutation frequency of mutated IGHV-Cµ sequences from MZ-B cells is signi-
ficantly higher among IGHV4 sequences than among IGHV3 or IGHV5 sequences (Kruskal-
Wallis, P = 0.011). These results indicate that the number of mutations in mutated MZ-B cells 
is higher in comparison to FO-B cells, which appears largely to be due to the higher number 
of mutations among IGHV4 sequences (Figure 3).
3.5. Clones of B cells are found within the MZ-B cell subset and some of these clones 
have members that are also present within the FO-B cell subset. 
H-CDR3 regions can be used to assess for clonal relationships between B cells because 
the H-CDR3 region is virtually unique for each different IGHV rearrangement. A total of 10 
independent clone sets (designated as C#1-C#10) were found among the two B cell subsets. 








































Seven clone sets (2-3 members per clone) have members exclusively found within the MZ-B 
cell subset and the remaining three clone sets have shared members between the MZ-B 
cell subset and the FO-B cell subset (see Table 1). The sequences that belong to clonally 
related cells with 2 or 3 members only found in the MZ-B cell subset include clone sets using 
IGHV3: clone set C#1 (A2MZV3-B7, A2MZV3-F5), clone set C#2 (A2MZV3-C6, A2MZV3-C7, 
A2MZV3-E7), clone set C#8 (A3MZV4-11, A3MZV4-3.1, A3MZV4-9) and clone set C#9 (A3M-
ZV4-20B, A3MZV4-7) or clone sets using IGHV4: clone set C#5 (IGA2MZV4-14, A2MZV4-3), 
clone set C#6 (A2MZV4-2.13, A2MZV4-2.17) and clone set C#7 (A2MZV4-2.9, A2MZV4-7). 
IGHV genes used by members of clone sets C#1 and C#2 had none or only one mutation in 
their IGHV genes. Members from other clone sets (C#5, 6, 8 and 9) exhibit more mutations 
(more than 6 mutations per IGHV sequence); most of these mutations were shared between 
the members of a clone. Sequences from three clone sets C#3 (A2RFV4-2, A2MZV4-1), 
C#10 (A2RFV5-42, A2MZV5-37) and C#4 (A3RFV4-3, A3MZV4) have members found in both 
B cell subsets. Clone sets C#3 and C#10 exhibits an identical mutation pattern, while clone 
set C#4 show many shared mutations. Overall, most of these clonally related sequences thus 
display both shared mutations in combination with unique mutations, indicating that members 
from one clone set were probably derived from the same naive precursor cell.








































Figure 3. Mutation frequency of IGHV-Cµ trancripts of different IGHV gene families within MZ-B cells 
and FO-B cells. Analysis of the distribution of the number of mutations of all (“total”) IGH-Cµ transcripts 
shows that MZ-B cells have significantly more mutations per transcript then FO-B cells (Mann-Whitney P 
= 0.046). Within the MZ-B cell subset, IGHV4 sequences contain more mutations than in IGHV3 or IGHV5 



















































































































































In this study we demonstrate that both FO-B cells and MZ-B cell populations contain mutated 
IgM sequences, albeit that among MZ-B cells the frequency of mutated sequences is gener-
ally higher compared to that in FO-B cells. Previous studies revealed that human FO-B cells 
(naïve mature cells) contain largely unmutated IgM encoding transcripts for various IGHV 
genes and families (Berkowska et al., 2011; Dunn-Walters et al., 1995; Klein et al., 1998; Kup-
pers et al., 1993; Pascual et al., 1994; Tangye et al., 1998). In mice, IGHV1 (J558) sequences 
derived from splenic FO-B cells are also unmutated (Gu et al., 1991). On the other hand 
Carey et al. (Carey et al., 2008) observed in mice that 10% of the IgM transcripts encoding 
for IGHV5 (PC7183) genes in splenic FO-B cells were mutated (i.e. contained more than 2 
mutations). As we show here, there is a significant difference in frequency of IGHV3, IGHV4, 
and IGHV5). For example we did not observe FO-B cells with mutated IGHV3 sequences 
mutated sequences between the three studied IGHV gene families in rats (whereas up to 
20-30% of FO-B cells express mutated IGHV4 or IGHV5 transcripts. Apparently, rodent B 
cells with a FO-B cell phenotype can be mutated, but the frequency varies with the expressed 
IGHV gene family. The finding that in human FO-B cells (mature naïve B cells) are virtually 
unmutated can be explained by species differences or that in most studies usually only a 
limited set of IGHV genes or gene families was used for analysis. Another, more likely expla-
nation might be how naïve (unmutated) and memory (mutated) B cells are defined in humans. 
In humans unmutated B cells lack CD27 whereas mutated B cells express CD27 (Klein et al., 
1998). CD27 is therefore widely used in human studies to discriminate naïve (unmutated) B 
cells from memory (mutated) B cells. However, some IgG+ or IgA+ B cells express mutated 
IgG or IgA genes but lack CD27 expression. (Berkowska et al., 2011; Fecteau et al., 2006) 
IgM and IgD expressing human B cells, lacking CD27 are all unmutated and are truly naïve B 
cells. In contrast, IgM and IgD expressing B cells that express CD27 are all mutated and are 
considered to represent memory B cells (Berkowska et al., 2011; Klein et al., 1998; Weill et 
al., 2009). In contrast to humans, in rodents CD27 expression cannot be used to distinguish 
memory B cells from naïve B cells (Xiao et al., 2004). In rats and mice, B cells expressing IgM 
and IgD (including FO-B cells), might therefore represent a heterogeneous population of cells 
composed of both naïve and memory B cells. 
As we show here, in comparison to FO-B cells, a much higher proportion of splenic MZ-B cells 
in (BN) rats express mutated IgM encoding transcripts. This proportion of mutated IgM+ MZ-B 
cells varied significantly between the different IGHV gene families and ranged from 28% to 
66%. Previous studies in another rat strain (PVG) or in mice revealed a much smaller fraction 
(up to ~10%) of mutated MZ-B cell derived sequences (Carey et al., 2008; Dammers et al., 
2000; Makowska et al., 1999). Differences in rat strain or species differences may explain 








































(part of) the observed discrepancy in percentage of mutated MZ-B cells. We show here, there 
is a significant variation in frequency of mutated IgM transcripts encoded by the various IGHV 
gene families. The highest frequency of mutated sequences (66%) was observed among 
MZ-B cells expressing IgM transcripts using IGHV4 gene family genes. This IGHV gene family 
consists of only two potentially functional members (Hendricks et al., 2010), of which only one 
appeared to be expressed. Based upon our findings, conclusions about frequency of mutated 
sequences among MZ-B cells should be drawn with care and analysis of a single IGHV gene, 
or a small IGHV gene family cannot be extrapolated for the entire MZ-B cell population. In 
contrast to MZ-B cells in rodents, nearly all human splenic MZ-B cells appear to be mutated 
(Dunn-Walters et al., 1995; Tangye et al., 1998; Tierens et al., 1999; Weller et al., 2004). Hu-
man splenic MZ-B cells express CD27 (Tangye et al., 1998), which is, as mentioned before, 
expressed by B cells with mutated IGHV genes. In these studies, however, only a limited set 
of IGHV genes expressed by human splenic MZ-B was analysed. However, given the notion 
that human splenic MZ-B cells express CD27 (Tangye et al., 1998), which is, as mentioned 
before, expressed by B cells with mutated IGHV genes, it is very likely that nearly all adult 
human splenic MZ-B cells are mutated. However, definite conclusions about frequencies of 
mutated versus unmutated MZ-B cells in various species awaits high throughput sequencing 
of large numbers of cells. Taken together, apparently both FO-B cells and MZ-B cells can 
express either unmutated or mutated IgM molecules on their cell membrane. 
The origin of mutated IgM expressing FO-B and MZ-B cells is not clear. Among the mutated 
sequences we observed groups of mutated sequences that were derived from clonally rela-
ted B cells, i.e. these sequences had identical H-CDR3 regions, used the same IGHV gene, 
expressed shared mutations and were from the same rat. Most (70%) of clonally related 
groups of cells had members that were confined to the MZ-B cell compartment. However, 
importantly, some clonally related groups of cells had members that were found among MZ-B 
cells and FO-B cells. This clonal relationship strongly suggests that there is a common origin 
between mutated IgM+ MZ-B cells and mutated IgM+ FO-B cells. Remarkably, we have previ-
ously shown the existence of clonally related class switched, mutated B cells with members 
in both the MZ-B and FO-B cell compartment (Hendricks et al., 2011). Possibly both unswit-
ched and class switched B cells are generated in the same fashion. Somatic hypermutations 
(SHM) are usually introduced in B cells proliferating in the GC environment. Mutated B cells 
are subsequently subjected to some form of positive selection for B cells expressing im-
munoglobulins that bind with high affinity to antigen, presented by follicular dendritic cells. 
Genetically engineered mice that cannot form GC (such as Bcl6 deficient or CD40 deficient 
mice) indeed lack B cells with mutated IGHV genes, including mutated IgM genes (Bergqvist 
et al., 2010; Toyama et al., 2002). Thus, at least in mice GC appear to be critically involved in 
SHM of IGHV genes during regular immune responses. This indicates that both mutated IgM+ 








































FO-B cells and MZ-B cells are probably GC derived. In contrast to mice, mutated IgM+ B cells 
can still be found in humans with CD40 or CD40L deficiency (hyper IgM syndrome patients, 
HIGM), that lack classical CD40L mediated T cell help and lack GC formation (Agematsu et 
al., 1998; Berkowska et al., 2011; Weller et al., 2004; Weller et al., 2001). These mutated B 
cells are IgM+IgD+CD27+ cells, also called natural effector cells, and correspond to splenic 
MZ-B cells (Weller et al., 2004). Other CD27+ B cell populations could not be formed in CD40/
CD40L deficient HIGM patients. Berkowska et al. observed that IgM+IgD+CD27+ cells have a 
relatively low replicative history (Berkowska et al., 2011). Furthermore they are already pre-
sent in very young (<2 years) children and in human fetus (Scheeren et al., 2008; Weller et al., 
2004; Weller et al., 2008). These findings suggest that at least a significant proportion of these 
mutated IgM+IgD+CD27+ MZ-B (-like) cells are not derived from GC and are generated in the 
absence of T cell help. Weill and colleagues (Weill et al., 2004; Weill et al., 2009; Weller et 
al., 2004) speculate that these MZ-B (-like) cells use SHM in order to diversify their repertoire 
early during ontogeny outside T-dependent or T-independent humoral immune responses. 
This hypothesis is, however, challenged in the literature (Seifert and Kuppers, 2009; Tangye 
and Good, 2007). Our observation that there are clonally related FO-B cells and MZ-B cells, 
expressing mutated IgM molecules indicates that these cells have a common origin and ar-
gues against the notion that such a postulated diversification process would then be unique 
for MZ-B cells. Furthermore, the variation in percentage of mutated sequences between the 
various IGHV gene families also argues against the notion, that SHM is used for diversifica-
tion. In that case is would be more likely that mutations occur more or less at a similar rate 
in all IGHV gene families. This variation in mutation frequency between different IGHV gene 
families is more in favor of a diversification as a result of antigenic stimulation. 
Thus, a high percentage of IgM+ MZ-B cells in rat spleen have mutated IgM transcripts. This 
percentage is much higher than observed previously in this species (Dammers et al., 2000). 
These mutated IgM+ FO-B cells and MZ-B cells are likely generated in GC during antigen-
driven immune responses. We do not know which cells give rise to the GC that generate (si-
multaneously) IgM+ mutated FO-B cells and MZ-B cells. However, it is known that both naïve 
FO-B cells and naïve MZ-B cells can give rise to GC, although MZ-B cells appear to be far 
less effective (Phan et al., 2005; Song and Cerny, 2003). In any case, given our observation 
that some mutated IgM+ FO-B cells and MZ-B cells are clonally related, the phenotype of 
at least a proportion of the mutated cells has to change. Where and how they acquire their 
phenotype is also not known. Interestingly, the average number of mutations in mutated IgM 
transcripts is slightly higher among MZ-B cells than in FO-B cells. The reason for this is not 
clear. It could suggest that mutated IgM+ MZ-B cells have a longer history in successive GC 
reactions, or that they expand more within the GC environment. 
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Marginal zone B cells in neonatal rats express 



















































The majority of marginal zone (MZ)-B cells (80%) in the rat are naive (antigen inexperi-
enced) B cells that express unmutated immunoglobulin variable region (IGHV) genes. In 
this species only a minor fraction of the IGHV-Cµ transcripts carry somatic mutations, and 
are considered to be memory B cells. This is in marked contrast to humans where nearly 
all MZ-B cells are mutated. Although memory (mutated) B cells are generally believed to 
be derived from germinal centers (GC’s) the origin of mutated IgM MZ-B cells remains 
unclear. In this study, we analysed whether rearranged IGHV-Cµ transcripts using IGHV4 
and IGHV5 genes from neonatal MZ-B cells and follicular B (FO-B) cells carry mutations. 
We were not able to detect mutations in any of the IGHV4 and IGHV5 genes expressed 
by MZ-B cells or FO-B cells from neonatal rat spleen. Since GC’s are absent from neo-
natal rat spleen, these data argue against the notion that MZ-B cells mutate their IGHV 
genes as part of their developmental program, but are consistent with the notion that 
mutated rat MZ-B cells require GCs for their generation. 
 









































The splenic marginal zone (MZ) is a distinct anatomical compartment dominated by a unique 
population of B lymphocytes, in addition to macrophages, dendritic cells and other cell types 
(Martin and Kearney, 2002; Mebius and Kraal, 2005; Pillai et al., 2005). This compartment 
forms an interface between the splenic red pulp and white pulp. This unique localization in 
combination with the blood flow through this compartment, allows intimate contact between 
antigens in the blood and cells present. The B cells in the MZ (MZ-B) cells have a distinctive 
phenotype, generally characterized by their high levels of IgM and low levels of IgD (IgM-
highIgDlow). This contrasts to the majority population of mature (naïve) B cells located in follicles 
of peripheral lymphoid organs which express low levels of IgM and high levels of IgD (IgMlo-
wIgDhigh), the follicular B (FO-B) cells. MZ-B cells appear to be in a “pre-activated” state, which 
is illustrated for example by their high expression levels of CD80/CD86 and complement 
receptor 2 (CD21) on their membrane surface in comparison with FO-B cells (Oliver et al., 
1999). MZ-B cells have important physiological functions and are primarily held responsible 
for T cell-independent (TI) responses to polysaccharides antigens, present on the surface of 
encapsulated bacteria (Guinamard et al., 2000; Martin et al., 2001).  
The majority of MZ-B cells in rats and mice express unmutated transcripts for IgM heavy 
chain molecules and are considered to represent naïve B cells. A small proportion of the 
cells, however, express mutated IgM transcripts and is therefore classified as IgM memory 
B cells (Dammers et al., 2000; Makowska et al., 1999). We have recently observed that the 
percentage of these mutated IgM memory MZ-B cells varies significantly between the various 
immunoglobulin heavy variable (IGHV) gene families analysed and ranges from 28% to 66%. 
Furthermore we also observed a clonal relationship between IgM memory (mutated) MZ-B 
cells and IgM memory (mutated) FO-B cells, suggesting that these two B cell subsets have 
a common origin. In addition to IgM memory B cells, a small (but unknown) fraction of the 
splenic MZ-B cells are classically class switched (IgG expressing) memory B cells (Hendricks 
et al., 2011). 
In contrast to rodents, nearly all MZ-B cells in human spleens express mutated IGVH ge-
nes (Dunn-Walters et al., 1995; Tierens et al., 1999). Phenotypically, these B cells express 
CD27, which is an important, but not conclusive, characteristic property of human memory 
B cells (Klein et al., 1998). In humans MZ-B cells are therefore defined as IgM+IgD+CD27+ B 
cells (Weller et al., 2004). Whether the (mutated) MZ-B cells in humans represent bona fide 
memory B cells is a matter of debate. On one hand these B cells are considered to be true 
memory cells, generated in germinal centers (GC) during antigen-driven humoral immune 
responses (Seifert and Kuppers, 2009; Tangye and Good, 2007). On the other hand these 








































cells were proposed to be generated during TI immune responses (Kruetzmann et al., 2003). 
Weller and co-workers argued that the presence of mutations reflects an intrinsic property of 
MZ-B cells that is exploited by these cells to diversify their primary antibody repertoire (Wel-
ler et al., 2004; Weller et al., 2001; Weller et al., 2008). According to Weller and colleagues 
the IgM+IgD+CD27+ MZ-B cells are not memory cells, but cells that develop in the absence 
of antigen, in a TI fashion, outside GC, along a pathway that differs from classical memory B 
cells. This conclusion was initially based on the finding that also patients with CD40L or CD40 
deficiency harbour mutated IgM+IgD+CD27+ MZ-B cells in blood (Weller et al., 2004; Wel-
ler et al., 2001). These patients lack classical cognate T-B cell collaboration leading to GC. 
Furthermore, also in very young children under the age of 2 years, the majority of blood and 
splenic MZ-B cells appear to be mutated, with no signs of antigen-driven clonal expansion, in 
contrast to classical class switched memory B cells (Weller et al., 2004; Weller et al., 2008). 
Furthermore Scheeren et al. (Scheeren et al., 2008) observed that a low fraction (~20%) of 
human fetal splenic IgM+IgD+CD27+ B cells are mutated, and these authors hypothesized that 
somatic hypermutation (SHM) in this population occurs mainly during fetal development and 
in very young children. 
MZ-B cells are already found early during ontogeny in rat spleen (Dammers and Kroese, 
2005; Dammers et al., 2002). At that time GCs are absent from spleen (Kroese et al., 1987; 
van Rees et al., 1986). Whether early in neonatal life IGHV genes expressed by MZ-B cells 
in rodents are mutated or not is not known and was studied here. We show that in contrast 
to humans, neonatal MZ-B cells in rats are all unmutated, supporting the view that, at least in 
rodents, mutated MZ-B cells are memory B cells, generated in GC. 
2. Materials and Methods
2.1. Animals 
Pregnant BN/SsNOlaHsd rats were obtained from (Harlan Horst, The Netherlands). Rats 
were housed under clean, conventional conditions at the Central Animal Facility of the Uni-
versity Medical Center Groningen. Two day old neonatal rats of both sexes were killed by 
decapitation. The experiment was approved by the Animal Experimental Committee of the 
University of Groningen.
2.2. Isolation and purification of B cell subsets by Flow-cytometry
Single cell suspensions were prepared from 5 pooled spleens from two day old neonatal 
rats and labelled with monoclonal antibodies for cell sorting as described previously (Dam-
mers et al., 2000). Briefly, cells were incubated with FITC conjugated anti-rat IgM (HIS40; 








































eBioscience, San Diego, CA, USA), biotinylated anti-rat IgD (MaRD3; AbDSerotec, Oxford, 
UK), APC conjugated anti-rat CD90/Thy1.1 (HIS51; eBioscience) and PE conjugated anti-rat 
TCRαβ (R73; eBioscience), anti-TCRγδ (V65; eBioscience) and anti-CD161a/NKRa (10/78; 
BD Pharmingen). BiotinylatedmAb were revealed with streptavidin conjugated to the tandem 
fluorochrome PE-Cy5.5 (Ebioscience). The PE channel was used as a “Dump” channel; only 
PE negative (Dumpneg) cells were sorted. Herewith, we were able to exclude immature B cells 
(i.e. CD90+ B cells), T cells and NK cells from our sorts. Analysis and sorting of B cells was 
carried out on a MoFlo flow cytometer (Cytomation, Ft Collins, CO). Dead cells, plasma cells, 
monocytes/macrophages, and erythrocytes were excluded from cell sorting by using forward 
and side scatter profiles. Sorted FO-B cells (CD90-IgDhighIgMlow) and MZ-B cells (CD90-IgM-
highIgDlow) were collected in sterile FACS tubes (Greiner Bio-One,Alphen a/d Rijn, The Nether-
lands) containing 500 μl of newborn calf serum (PAA laboratories GmbH, Pasching, Austria). 
FlowJo software (Tree Star, San Carlos, CA) was used for flow cytometry data analysis.
2.3. Molecular cloning of IGHVDJ-Cμ transcripts
Total RNA was extracted from sorted cells using the Absolutely RNA Miniprep kit (Stratagene, 
La Jolla, CA, USA) according to instructions of the manufacturer. Briefly, sorted cells were 
pelleted by 300xg centrifugation for 10 min at 4oC and then resuspended in a total volume 
of 350µl lysis buffer containing β-mercaptoethanol (Stratagene). First strand cDNA was syn-
thesized using an oligo-(dT)12-18 primer (Invitrogen, Breda, The Netherlands) and Super-
ScriptTMII reverse transcriptase (200U/μl; Invitrogen) as described in the manufacturer’s 
protocol. Rearranged IGHV4-Cµ and IGHV5-Cµ gene transcripts were amplified in a 50 μl 
reaction mixture, containing 2 μl cDNA of either IGHV4 or IGHV5 family specific primer, plus 
0.6 pmol/µl universal Cµ constant region primer and 2.5U Taq DNA Polymerase (Invitrogen). 
The following primers were used: IGHV4 (5’-GGTGCA(A/G)CCTGGAAGATCCT-3’), IGHV5 
(5’-CTTAGTGCAGCCTGGAAGGT) (Dammers et al., 2000) and the constant region Cµ pri-
mer (5’-CAACACTGAAGTCATCCAGGG-3’). To assess the amount and quality of the cDNA, 
PCR was also performed for β-actin, using β-actin specific primers as described by (Stoel et 
al., 2005). The PCR program for amplification of IGHVDJ-Cμ transcripts and β-actin consisted 
of 35 cycles of 30 sec at 94°C (2 min in first cycle), 1 min at 58°C and 1 min at 72°C, res-
pectively. This program was followed by an additional incubation period of 25 min at 72°C to 
allow extension of all IGHVDJ-Cμ transcripts. The quality and size of the PCR products was 
evaluated by agarose gel electrophoresis.
2.4. Cloning and sequencing
PCR products were subsequently cloned into the pJET1/blunt vectors using the GeneJETTM 
PCR Cloning Kit, respectively (Fermentas Life Sciences). TOP10F E. coli competent cells 
(Invitrogen) were transformed with plasmids containing the PCR product. Plasmid DNA was 








































isolated from randomly picked colonies with the Nucleospin Plasmid QuickPure kit (Bioke, 
Leiden, The Netherlands). Size of the inserts was determined by digestion of a DNA sample of 
the plasmids with the appropriate restriction enzymes followed by agarose gel electrophore-
sis. Plasmids containing an insert of approximately 500 bp were sequenced in both directions 
by Service XS (Leiden, The Netherlands). Sequence processing was performed using EMBL/
Genbank Data Libraries and Chromas software (Digital River GmbH, Cologne, Germany).
2.5. Statistical analysis of IGHVDJ –Cµ transcripts
Statistical analysis of the sequence data was performed using SPSS 16 software (SPSS Inc. 
Chicago, Ill. USA). IGHV-Cµ sequences displaying 100% identity were considered to be de-
rived from a single B cell and counted only once for statistical analysis. Since Taq DNA poly-
merase errors might be responsible for 1–2 mutations per sequence, we considered only se-
quences with more than 2 mutations as truly mutated (Dammers et al., 2000). The number of 
mutations was determined by counting the number of nucleotide mismatches in comparison 
with each IGHV gene sequence to its closest germline counterpart. We used Fisher’s exact 
test to determine possible differences between groups with regard to the binary response 
variable indicating mutation or not. Non parametric tests, Kruskal-Wallis and Mann-Whitney, 
were used to compare groups with respect to the number of mutations. In all statistical tests 
a p-value < 0.05 was considered to be significant.
3. Results and Discussion 
Adult MZ-B cells in rodents and humans are a heterogeneous population of B cells, compri-
sing both unmutated IgM expressing B cells (naïve MZ-B cells) and either class switched or 
unswitched B cells with mutated IGHV genes. Both subsets of mutated MZ-B cells are gene-
rally believed to represent memory type B cells. Weller et al and others, however, postulate 
that mutations present in MZ-B cells are not the consequence of an antigen driven response, 
but are an intrinsic property of these B cells, introduced during their development (Weller et 
al., 2004; Weller et al., 2008). In this study we addressed this issue, by analysing the oc-
currence of SHM in IGHV genes, expressed by MZ-B cells present in neonatal rats, i.e. at a 
time point that antigen-driven humoral immune responses have not been taken place yet, as 
witnessed by the absence of GC in lymphoid organs during the first few weeks of life (Kroese 
et al., 1987; van Rees et al., 1986). MZ-B cells and FO-B cells were sorted from (pooled) 
neonatal rat spleen, as is illustrated in Figure 1. A large proportion of MZ-B cells in neonatal 
rats express CD90 and are therefore considered to represent immature MZ-B cells (Dammers 
et al., 2000); mature MZ-B cells and FO-B cells are defined as CD90-IgMhighIgDlow cells and 
CD90-IgMlowIgDhigh respectively. By including CD90 in our staining combination, we excluded 








































immature MZ-B and FO-B cells from our analysis. IGHV-Cµ mRNA transcripts from both neo-
natal FO-B cells and MZ-B cells were amplified by RT-PCR, cloned, sequenced and analysed 
for the presence of SHM. 
Figure 1. Three colour cytometry was used to analyse FO-B cells and MZ-B cells. Single splenic cell sus-
pension of neonatal rats was stain with FITC conjugated anti-rat IgM (HIS40; eBioscience, San Diego, CA, 
USA), biotinylated anti-rat IgD (MaRD3; AbD Serotec, Oxford, UK), APC anti-rat CD90/Thy1.1 (HIS51; 
eBioscience). Biotinylated mAb were revealed with streptavidin conjugated to the tandem fluorochrome 
PE-Cy5.5 (Ebioscience). Lymphocytes were sequentially gated by forward scatter and side scatter. Ac-
quisition gates were set to exclude the unwanted immature B cells (CD90+-APC). Gate settings were set 
appropriately for FO-B cells (CD90negIgDhighIgMlow) and MZ-B (CD90negIgMhighIgDlow) cells.
Table 1. Neonatal IGHV Cµ mRNA transcripts from FO-B cells and MZ-B cells
Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acid 
Sequences of IGHV4 gene family from FO-Bd cells
NRFVH4-60 IGHV4S2 IGHD5-1 IGHJ2 0 7 ATGSFDY
NRFVH4-71g IGHV4S2 IGHD1-6 IGHJ2 1 9 ARAPGGYDY C#1
NRFVH4-16 IGHV4S2 IGHD1-1 IGHJ2 0 14 ARESYYYYSGDFDY
NRFVH4-37g IGHV4S2 IGHD1-6 IGHJ2 1 9 ARAPGGYDYC#1
NRFVH4-2.1 IGHV4S2 IGHD1-6 IGHJ2 0 11 ARAGGYYYFDY
NRFVH4-2.4 IGHV4S2 IGHD1-2 IGHJ2 0 10 ARVLWVYFDY
NRFVH4-2.5 IGHV4S2 IGHD1-4 IGHJ2 0 12 ARAYYGYNYFDY
NRFVH4-2.6 IGHV4S2 IGHD1-4 IGHJ2 0 11 ARYYGYNYFDY
NRFVH4-2.7 IGHV4S2 IGHD1-4 IGHJ2 0 12 ATYYGYNYYFDY
Sequences of IGHV4 gene family from MZ-Be cells
NMZVH4-1 IGHV4S2 IGHD1-1 IGHJ1 0 15 AIMYTTDYXYWYFDF


















































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acid 
NMZVH4-4 IGHV4S2 IGHD1-1 IGHJ4 0 16 ARAHMYTTDYYYVMDA
NMZVH4-5 IGHV4S2 IGHD1-5 IGHJ1 0 10 AIYNNWYFDF
NMZVH4-6 IGHV4S2 IGHD1-4 IGHJ2 0 10 ARLPGYNFDY
NMZVH4-9 IGHV4S2 IGHD2-2 IGHJ2 0 9 ARDTYYFDY
NMZVH4-13 IGHV4S2 IGHD1-3 IGHJ1 0 12 ARARSSYWYFDF
NMZVH4-17 IGHV4S2 IGHD1-7 IGHJ2 0 12 ARNYPGMYYFDY
NMZVH4-20 IGHV4S2 IGHD1-6 IGHJ2 0 8 ARTEGIDY
NMZVH4-3.1 IGHV4S2 IGHD3-2 IGHJ2 0 10 ARARYNYFDY
NMZVH4-3.2h IGHV4S2 IGHD1-7 IGHJ1 1 16 ARFYYDGSYYYWYFDFC#2
NMZVH4-3.3 IGHV4S2 IGHD1-3 IGHJ2 0 10 ARYSSYYFDY
NMZVH4-3.4 IGHV4S2 IGHD5-1 IGHJ2 0 8 ATGSYFDY
NMZVH4-3.6h IGHV4S2 IGHD1-7 IGHJ1 0 16 ARDYYDGSYYYWYFDFC#2
NMZVH4-3.7 IGHV4S2 IGHD1-3 IGHJ2 0 6 ARGSYY
NMZVH4-3.8 IGHV4S2 IGHD4-1 IGHJ2 0 9 ARAQFGVDY
NMZVH4-3.9 IGHV4S2 IGHD1-5 IGHJ2 0 9 ARIYNNFDY
NMZVH4-3.10 IGHV4S2 IGHD5-1 IGHJ2 1 11 ARTGYYWSFDF
NMZVH4-3.11 IGHV4S2 IGHD5-1 IGHJ2 1 10 ARDWELYFDY
NMZVH4-3.12 IGHV4S2 IGHD5-1 IGHJ1 0 12 ARTGSYYWYFDF
NMZVH4-3.13 IGHV4S2 IGHD1-4 IGHJ2 0 13 ARRYYGYNYYFDY
Sequences of IGHV5 gene family from FO-Bd cells
NRFVH5-50 IGHV5S30 IGHD4-1 IGHJ1 1 13 ATDNSGYYWYFDF
NRFVH5-72 IGHV5S30 IGHD1-4 IGHJ2 0 13 ATIAAISTYYFDY
NRFVH5-8 IGHV5S30 IGHD5-1 IGHJ2 0 8 ATGSYFDY
NRFVH5-18 IGHV5S30 IGHD1-2 IGHJ3 1 9 ATGYNWFAY
NRFVH5-1 IGHV5S27 IGHD1-7 IGHJ2 0 12 ARHYYSGDYFDY
NRFVH5-3 IGHV5S13 IGHD1-8 IGHJ2 0 14 ARHYYDGYYHYFDY
NRFVH5-4 IGHV5S11 IGHD4-1 IGHJ3 1 12 ARHNSGYNWFAY
NRFVH5-6 IGHV5-6 IGHD1-2 IGHJ2 0 8 TTDHYGDY
NRFVH5-7 IGHV5S74 IGHD1-2 IGHJ3 1 12 ARTYYGYNWFAY
NRFVH5-8 IGHV5S27 IGHD1-7 IGHJ2 0 14 ARHYYDGSYYYFDY
NRFVH5-9 IGHV5S10 IGHD1-5 IGHJ1 2 12 ATHNNYYWYFDF
NRFVH5-10  IGHV5-1 IGHD1-3 IGHJ2 0 11 ANYYYSSYIDY
NRFVH5-11 IGHV5S74 IGHD1-1 IGHJ3 1 12 ARMYTTDNWFAY
NRFVH5-12 IGHV5S10 IGHD1-8 IGHJ2 0 10 ATHYYDGYYY
NRFVH5-13 IGHV5-6 IGHD4-1 IGHJ2 0 10 TTNSGYYFDY
NRFVH5-14 IGHV5S57 IGHD1-8 IGHJ2 1 12 TNYRDSYAYFDY
NRFVH5-15 IGHV5S45 IGHD1-6 IGHJ2 1 10 ARQLRRVFDY








































Clonea IGHV IGHD IGHJ Mutationsb H-CDR3c 
 member member member  Nf Amino acid 
NRFVH5-16 IGHV5S10 IGHD1-6 IGHJ3 0 10 ATYGGYWFAY
NRFVH5-17 IGHV5S57 no 
results
IGHJ3 0 8 TRGYWFAY
NRFVH5-18 IGHV5S29 IGHD1-7 IGHJ2 0 15 TTETYYYDGSYYFDY
NRFVH5-19 IGHV5S16 IGHD5-1 IGHJ1 0 9 ARGSWYFDF
NRFVH5-2.3 IGHV5S30 IGHD4-1 IGHJ2 0 11 ATDNSGYYFDY
Sequences from IGHV5 gene family from MZ-Be cells
NMZVH5-2 IGHV5S30 no 
results
IGHJ2 0 4 ATNY
NMZVH5-10 IGHV5S30 IGHD4-1 IGHJ2 0 10 ATDSGYYFDY
NMZVH5-2 IGHV5-3 IGHD1-2 IGHJ4 0 10 ARHGYYVMDA
NMZVH5-3 IGHV5-2 IGHD1-8 IGHJ2 0 10 ARHDGYYFDY
NMZVH5-5 IGHV5S43 IGHD1-5 IGHJ2 0 10 TRDNNYYFDY
NMZVH5-6 IGHV5S65 no 
results
IGHJ2 1 8 AKAHYFDY
NMZVH5-11 IGHV5S10 IGHD1-4 IGHJ2 1 11 ATHYGYNYFDY
NMZVH5-12 IGHV5-6 IGHD1-7 IGHJ2 1 12 ARHYYDGSYYDY
NMZVH5-14 IGHV5S32 IGHD1-7 IGHJ2 1 14 ARHYDGSYYYYFDY
NMZVH5-15 IGHV5S16 IGHD4-1 IGHJ3 0 9 ARHNSGFAY
NMZVH5-16 IGHV5S16 IGHD1-4 IGHJ2 0 6 ATHNDY
NMZVH5-17 IGHV5S30 IGHD1-3 IGHJ4 0 10 ATYSSYVMDA
NMZVH5-18 IGHV5S43 IGHD1-5 IGHJ2 0 11 TRDHNNYYFDY
NMZVH5-20 IGHV5S11 IGHD1-6 IGHJ1 0 16 ARHNYGGYSDYWYFDF
NMZVH5-3.15 IGHV5S30 IGHD1-3 IGHJ2 0 8 ATEYWSDY
NMZVH5-3.16 IGHV5S30 IGHD5-1 IGHJ2 0 9 ATTGSYFDY
a  Cµ (IgM) transcripts from FO-B cells and MZ-B cells 
b  Mutations, nucleotide differences of one or more basis between IMGT germline gene and  rearranged 
 Cµ transcript
c  H-CDR3, heavy chain complementarity determining region 3
d  FO-B cells, recirculating follicular B cells
e  MZ-B cells, marginal zone B cells
f  Lenght of H-CDR3 in amino acids
g  The sequence NRFVH4-71 and NRFVH4-37 are from clonally related B cells and designated as clone 
 set C#1
In a previous study we showed that the proportion of mutated IgM+ MZ-B cells varies sig-
nificantly when different IGHV gene families were analysed. This proportion mutated MZ-B 
cell derived sequences ranged up to 28% for IGHV5 transcripts and up to 66% for IGHV4 
transcripts in adult rats (chapter 4). For this reason we chose to analyse IGHV-Cµ transcripts 








































encoding for IGHV5 and IGHV4 family genes. The IGHV5 gene family is the second largest 
IGHV gene family in the rat and consists of 27 potentially functional IGHV genes (Hendricks et 
al., 2010). In total we amplified 16 unique IGHV5-Cµ transcripts from neonatal MZ-B cells and 
22 IGHV5-Cµ transcripts from neonatal FO-B cells (Table 1). These transcripts were encoded 
by various germline genes: 10 different IGHV5 germline genes were used by MZ-B cells and 
12 by FO-B cells. The IGHV4 gene family is composed of only 2 potentially functional IGHV 
genes (Hendricks et al., 2010), of which only one (IGHV4S2) seems to be expressed (chapter 
4). We obtained 21 unique IGHV4-Cµ sequences derived neonatal MZ-B cells and 9 IGHV4-
Cµ sequences from neonatal FO-B cells (Table 1). All these transcripts were encoded by the 
IGHV4S2 gene, confirming our previous findings in adult rats, that only this family member is 
functionally expressed by rat B cells. Importantly, as is shown in Table 1, mutational analysis 
of the IGHV5-Cµ and IGHV4-Cµ transcripts revealed that none of the transcripts from either 
MZ-B cells or FO-B cells were mutated (i.e. expressed more than two nucleotide differences 
compared to their germline counterparts). This is in marked contrast to adult rat MZ-B cells 
and FO-B cells, of which a significant proportion of the transcripts encoding for IgM heavy 
chains are mutated (Dammers et al., 2000; chapter 4). SHM of (heavy and light) IGV genes 
are generally believed to take place during the generation of memory B cells within the GC 
and is associated with selection of B cells expressing high affinity surface Ig. GC’s are typically 
antigen- and T-cell dependent structures. GC’s are absent in neonatal rats during the first few 
weeks of life, and in fact, GC’s can even not be induced by deliberate antigenic stimulation 
after birth until spleen and lymph nodes have reached a certain stage of maturity (Kroese et 
al., 1987; van Rees et al., 1986). The appearance of follicular dendritic cell networks might be 
a critical factor in the maturation process, allowing GC formation (Kroese et al., 1985; Kroese 
et al., 1987). The absence of B cells with mutated IgM transcripts in neonatal rats thus cor-
responds with the absence of GC in these animals and favours the hypothesis that mutated 
MZ-B and FO-B cells in adult animals are both memory B cells which are generated in GC 
during antigen driven immune responses. A possible GC origin of mutated IgM+IgD+CD27+ B 
cells is supported by findings of Seifert and Küppers (Seifert and Kuppers, 2009). They sho-
wed that, similar to class switched memory B cells, mutated peripheral blood IgM+IgD+CD27+ 
B cells carry mutated Bcl6 genes, similar to class switched memory B cells. Bcl6 is expressed 
at high levels by GC B cells and is considered to be the master transcriptional regulator of 
these B cells (Basso and Dalla-Favera, 2010). When GC B cells acquire SHM of their IGHV 
genes also the Bcl6 gene can become mutated (Pasqualucci et al., 1998). Presence of mu-
tations in the Bcl6 gene is therefore considered to be a genetic feature of GC experience 
(Seifert and Kuppers, 2009). Importantly, Seifert and Küppers (Seifert and Kuppers, 2009) 
also identified mutated IgM+IgD+CD27+ B cells that were clonally related to class switched, 
classical IgG+ memory B cells, with both shared and unshared mutation, which is strongly 
indicative for a common, GC origin. Taken together, the absence of mutated Cµ transcripts 








































from both IgM+ MZ-B cells and FO-B cells in neonatal rats led us to postulate that both IgM+ 
memory B cell subsets in adult rats are likely derived from GC, as a consequence of stimula-
tion by exogenous antigens, similar to IgG+ memory B cells. At least in rats it is thus unlikely 
that MZ-B cells acquire SHM during their antigen-independent generation as proposed for 
humans (Scheeren et al., 2008; Weller et al., 2004; Weller et al., 2001).









































1. Basso K. and Dalla-Favera R., 2010. BCL6: master regulator of the germinal center reaction and 
key oncogene in B cell lymphomagenesis. Advances in immunology 105, 193-210.
2. Dammers P. M. and Kroese F. G., 2005. Recruitment and selection of marginal zone B cells is 
independent of exogenous antigens. Eur J Immunol 35, 2089-99.
3. Dammers P. M., Lodewijk M. E., Zandvoort A. and Kroese F. G., 2002. Marginal zone B cells in 
neonatal rats express intermediate levels of CD90 (Thy-1). Developmental immunology 9, 187-95.
4. Dammers P. M., Visser A., Popa E. R., Nieuwenhuis P. and Kroese F. G., 2000. Most marginal 
zone B cells in rat express germline encoded Ig VH genes and are ligand selected. Journal of im-
munology 165, 6156-69.
5. Dunn-Walters D. K., Isaacson P. G. and Spencer J., 1995. Analysis of mutations in immunoglobulin 
heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that 
the MGZ of human spleen is a reservoir of memory B cells. The Journal of experimental medicine 
182, 559-66.
6. Guinamard R., Okigaki M., Schlessinger J. and Ravetch J. V., 2000. Absence of marginal zone 
B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature immunology 1, 
31-6.
7. Hendricks J., Terpstra P., Dammers P. M., Somasundaram R., Visser A., Stoel M., Bos N. A. and 
Kroese F. G., 2010. Organization of the variable region of the immunoglobulin heavy-chain gene 
locus of the rat. Immunogenetics 62, 479-86.
8. Hendricks J., Visser A., Dammers P. M., Burgerhof J. G., Bos N. A. and Kroese F. G., 2011. Class-
switched marginal zone B cells in spleen have relatively low numbers of somatic mutations. Mole-
cular immunology 48, 874-82.
9. Klein U., Rajewsky K. and Kuppers R., 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood 
B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: 
CD27 as a general marker for somatically mutated (memory) B cells. The Journal of experimental 
medicine 188, 1679-89.
10. Kroese F. G., Leceta J., Dopp E. A., Herraez M. P., Nieuwenhuis P. and Zapata A., 1985. Dendritic 
immune complex trapping cells in the spleen of the snake, Python reticulatus. Developmental and 
comparative immunology 9, 641-52.
11. Kroese F. G., Wubbena A. S., Kuijpers K. C. and Nieuwenhuis P., 1987. The ontogeny of germinal 
centre forming capacity of neonatal rat spleen. Immunology 60, 597-602.
12. Kruetzmann S., Rosado M. M., Weber H., Germing U., Tournilhac O., Peter H. H., Berner R., Pe-
ters A., Boehm T., Plebani A., Quinti I. and Carsetti R., 2003. Human immunoglobulin M memory B 
cells controlling Streptococcus pneumoniae infections are generated in the spleen. The Journal of 
experimental medicine 197, 939-45.
13. Makowska A., Faizunnessa N. N., Anderson P., Midtvedt T. and Cardell S., 1999. CD1high B cells: 
a population of mixed origin. Eur J Immunol 29, 3285-94.
14. Martin F. and Kearney J. F., 2002. Marginal-zone B cells. Nature reviews. Immunology 2, 323-35.
15. Martin F., Oliver A. M. and Kearney J. F., 2001. Marginal zone and B1 B cells unite in the early 
response against T-independent blood-borne particulate antigens. Immunity 14, 617-29.
16. Mebius R. E. and Kraal G., 2005. Structure and function of the spleen. Nature reviews. Immuno-
logy 5, 606-16.
17. Oliver A. M., Martin F. and Kearney J. F., 1999. IgMhighCD21high lymphocytes enriched in the 
splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. Journal 
of immunology 162, 7198-207.
18. Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R. S., Klein U., 
Kuppers R., Rajewsky K. and Dalla-Favera R., 1998. BCL-6 mutations in normal germinal center 
B cells: evidence of somatic hypermutation acting outside Ig loci. Proceedings of the National Aca-
demy of Sciences of the United States of America 95, 11816-21.
19. Pillai S., Cariappa A. and Moran S. T., 2005. Marginal zone B cells. Annual review of immunology 
23, 161-96.








































20. Scheeren F. A., Nagasawa M., Weijer K., Cupedo T., Kirberg J., Legrand N. and Spits H., 2008. 
T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ 
CD27+ B cells. The Journal of experimental medicine 205, 2033-42.
21. Seifert M. and Kuppers R., 2009. Molecular footprints of a germinal center derivation of human 
IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. The Journal of experi-
mental medicine 206, 2659-69.
22. Stoel M., Jiang H. Q., van Diemen C. C., Bun J. C., Dammers P. M., Thurnheer M. C., Kroese F. 
G., Cebra J. J. and Bos N. A., 2005. Restricted IgA repertoire in both B-1 and B-2 cell-derived gut 
plasmablasts. Journal of immunology 174, 1046-54.
23. Tangye S. G. and Good K. L., 2007. Human IgM+CD27+ B cells: memory B cells or “memory” B 
cells? Journal of immunology 179, 13-9.
24. Tierens A., Delabie J., Michiels L., Vandenberghe P. and De Wolf-Peeters C., 1999. Marginal-zone 
B cells in the human lymph node and spleen show somatic hypermutations and display clonal 
expansion. Blood 93, 226-34.
25. van Rees E. P., Dijkstra C. D. and van Rooijen N., 1986. The early postnatal development of the 
primary immune response in TNP-KLH-stimulated popliteal lymph node in the rat. Cell and tissue 
research 246, 673-7.
26. Weller S., Braun M. C., Tan B. K., Rosenwald A., Cordier C., Conley M. E., Plebani A., Kumararatne 
D. S., Bonnet D., Tournilhac O., Tchernia G., Steiniger B., Staudt L. M., Casanova J. L., Reynaud C. 
A. and Weill J. C., 2004. Human blood IgM “memory” B cells are circulating splenic marginal zone 
B cells harboring a prediversified immunoglobulin repertoire. Blood 104, 3647-54.
27. Weller S., Faili A., Garcia C., Braun M. C., Le Deist F. F., de Saint Basile G. G., Hermine O., Fischer 
A., Reynaud C. A. and Weill J. C., 2001. CD40-CD40L independent Ig gene hypermutation sug-
gests a second B cell diversification pathway in humans. Proceedings of the National Academy of 
Sciences of the United States of America 98, 1166-70.
28. Weller S., Mamani-Matsuda M., Picard C., Cordier C., Lecoeuche D., Gauthier F., Weill J. C. and 
Reynaud C. A., 2008. Somatic diversification in the absence of antigen-driven responses is the 




Class switched marginal zone B cells in spleen have relatively low 








Molecular Immunology 48 (2011) 874–882









































The vast majority of rodent splenic marginal zone B (MZ-B) cells are naive IgM+ cells. A 
small fraction of these MZ-B cells carry mutated V-genes, and represent IgM+ memory 
MZ-B cells. Here we reveal further heterogeneity of B cells with a MZ-B cell phenotype, 
by providing evidence for the existence of class switched memory MZ-B cells in the rat. In 
essence, we observed IGHV5 encoded Cγ transcripts, among FACS-purified MZ-B cells, 
defined as HIS24lowHIS57bright cells. Furthermore, we found that most IgG encoding trans-
cripts are mutated. There is no significant difference in IGHV5 repertoire and subclass 
usage of these IgG encoding transcripts collected from B cells with a MZ-B cell pheno-
type and B cells with a follicular (FO-B) cell phenotype. However, the IGHV5 genes enco-
ding for IgG antibodies of MZ-B cells exhibited significantly fewer mutations, compared to 
those with a FO-B cell phenotype. In one rat we found a clonally related set of IgG enco-
ding sequences, of which one was derived from the MZ-B cell fraction and the other from 
the FO-B cell fraction. We speculate that these two subpopulations of class switched B 
cells are both descendants from naive FO-B cells and are generated in germinal centers. 
Class switched memory B cells with a MZ-B cell phenotype may provide the animal with 
a population of IgG memory B cells that can respond rapidly to blood-borne pathogens.
 









































The marginal zone (MZ) represents a distinct anatomical B cell compartment in the spleen 
located at the outer areas of the white pulp, at the border of the red pulp (for review see e.g. 
(Steiniger et al., 2006). The circulatory system of the spleen ensures an intimate contact of 
blood and cells of the MZ. Most of the cells in this compartment are B cells, but macropha-
ges and dendritic cells (and in humans also CD4+ T cells) are also present. MZ-B cells have 
unique characteristics (for reviews see e.g. (Martin and Kearney, 2002; Pillai et al., 2005; 
Weill et al., 2009). In rodents the vast majority of MZ-B cells expresses high levels of IgM 
and low levels of IgD (IgMhiIgDlo) in combination with high levels of CD21 and low levels of 
CD23 (CD21hiCD23lo) (Oliver et al., 1997). This unique phenotype distinguishes them from the 
majority population of mature, naive B cells, i.e. follicular B (FO-B) cells, which are IgMloIgD-
hiCD21loCD23hi. Rat FO-B cells can also be defined as mature (i.e. CD90− (Kroese et al., 1995) 
small-sized, HIS24highHIS57neg/low B cells whereas MZ-B cells are slightly larger cells and can 
be distinguished as CD90−HIS24lowHIS57high cells (Dammers et al., 1999; Kroese et al., 1990; 
Kroese et al., 1995). Importantly, MZ-B cells also have different functional characteristics, 
such as their pre-activated status and their proliferative and stimulatory requirements (Oliver 
et al., 1997; Oliver et al., 1999). Rodent MZ-B cells appear to be biased towards T cell-inde-
pendent (TI-2) immune responses against micro-organism-derived polysaccharide antigens 
(Guinamard et al., 2000; Martin et al., 2001; Vinuesa et al., 2003). These properties in combi-
nation with their topographical localization in spleen, allow them to respond rapidly to blood-
borne pathogens by the generation of massive numbers of antibody secreting cells during the 
first few days after infection (Martin et al., 2001). MZ-B cells are a heterogeneous population 
of cells, and comprise both naive and memory cells. In rats and mice, the majority (up to 80%) 
of MZ-B cells are naive cells which express germline encoded V region of the Ig genes (Dam-
mers et al., 2000; Makowska et al., 1999). Occurrence of memory B cells in the MZ was first 
demonstrated by (Liu et al., 1988), showing the appearance of hapten-binding, IgM+ memory 
cells with a MZ-B cell phenotype in the MZ of spleens from immunized rats. Hapten-binding 
MZ-B cells were also demonstrated by flow-cytometry and/or immunohistology in several 
subsequent studies in immunized normal and Ig-gene targeted mice (Gatto et al., 2007; Gatto 
et al., 2004; Obukhanych and Nussenzweig, 2006; Pape et al., 2003; Phan et al., 2005). In 
rodents, memory cells constitute a minority MZ-B cell population. Up to 20% of the rodent 
MZ-B cells might be IgM memory B cells as indicated by the presence of mutated IgH chain 
V gene (IGHV) trancripts encoding for IgM antibodies (IGHV-Cγ transcripts) among purified 
sIgM+ MZ-B cells (Dammers et al., 2000; Makowska et al., 1999). There are some data that 
suggest that, in addition to these unswitched IgM-expressing memory MZ-B cells, also some 
class switched memory B cells are found among the MZ-B cell population in rodent spleens 
after immunization (Gatto et al., 2004; Liu et al., 1988; Obukhanych and Nussenzweig, 2006; 








































Pape et al., 2003). For example, (Gatto et al., 2004) observed the presence of IgG+ phage 
(Qβ)-specific B cells with a MZ-B cell phenotype (i.e. CD21hiCD23low B cells), up to 21 days 
upon immunization of normal mice. Whether these class switched MZ-B cells were indeed 
“classical” memory B cells with their characteristic mutated high affinity BCR’s was, however, 
not investigated. The presence of mutated, antigen-specific memory MZ-B cells were sub-
sequently demonstrated in mice 12 days after immunization with viral particles (Gatto et al., 
2007). The isotype of these B cells was, however, not known, but the authors speculated that 
these mutated MZ-B cell sequences were derived from class switched memory B cells. In 
humans, a relative large proportion (30%) of the MZ-B cells (defined as CD21+CD23−CD27+ 
cells) appear to express IgG (Ettinger et al., 2007); the mutational status of these class swit-
ched IGHV genes is also not known. Thus, although both IgM+ and IgG+ memory cells ap-
pear to be present among the pool of MZ-B cells in rodents and humans, direct evidence for 
presence of MZ-B cells with mutated IgG encoding genes is currently lacking. Furthermore, 
the origin of the IgG+ memory MZ-B cells is enigmatic. This prompted us to analyse in detail 
the nucleotide sequences of IgG encoding (IGHV-Cγ) transcripts from purified rat MZ-B cells, 
defined in a sIg independent fashion. We show that indeed naturally occurring (i.e. without 
deliberate antigenic stimulation) MZ-B cells express mutated IGHV genes encoding for IgG 
antibodies. The repertoire of the MZ-B cell derived IgG encoding transcripts does not differ 
from that obtained from class switched B cells with a FO-B cell phenotype, albeit that MZ-B 
cell derived IgG encoding transcripts exhibit lower numbers of mutations.
2. Materials and methods
2.1. Animals
Male PVG rats were purchased from Harlan (Horst, The Netherlands) at the age of 6–8 
weeks. Animals were maintained until use under clean conventional conditions at the central 
animal facility of the University Medical Center Groningen. Experiments were approved by the 
Animal Ethics Committee of the University of Groningen.
2.2. Flow-cytometry
Spleens were taken from 4.5 to 8 months old animals. Single cell suspensions were prepared 
from spleen and labeled with mAb as described previously (Dammers et al., 1999). Briefly, 
spleen cell suspensions from 4 animals were stained for flow-cytometry with the following two 
sets of mouse monoclonal antibodies: FITC conjugated anti-rat IgM (HIS40; eBioscience, San 
Diego, CA, USA) and biotinylated anti-rat IgD (MaRD3; AbD Serotec, Oxford, UK) or FITC an-
ti-rat MZ-B cell marker (HIS57; BD Pharmingen, San Diego, CA, USA; (Dammers et al., 1999) 
and biotinylated anti-rat CD45R (HIS24; Ebioscience). Biotinylated mAb were revealed with 








































streptavidin conjugated to the tandem fluorochrome PE-Cy5.5 (Ebioscience). The two sets of 
antibodies were used in combination with a mixture of PE conjugated anti-rat TCRαβ (R73; 
eBioscience); TCRγδ (V65; eBioscience), CD90/Thy1.1 (HIS51; eBioscience) and CD161a/
NKR-P1a (10/78; BD Pharmingen). The PE channel was used as a “Dump” channel; only PE 
negative (Dump−) cells were sorted. Herewith, we were able to exclude immature B cells (i.e. 
CD90 positive B cells: (Kroese et al., 1995), T cells and NK cells from our sorts. Cell analysis 
and cell sortings were performed on a MoFlo flow cytometer (Cytomation, Ft Collins, CO). 
Dead cell, plasma cell, monocyte/macrophage, and erythrocyte contamination was excluded 
from sorting by using forward and side scatter profiles. Sorted cells were collected in sterile 
FACS tubes (Greiner Bio-One, Alphen a/d Rijn, The Netherlands) containing 500µl of new-
born calf serum (PAA laboratories GmbH, Pasching, Austria). At least one million cells per B 
cell subset were sorted. B cell subsets were obtained with >95% purity. FlowJo software (Tree 
Star, San Carlos, CA) was used for flow cytometry data analysis.
2.3. Molecular cloning of rearranged IGHV5-Cγ transcripts
Total RNA was extracted from sorted cells using the Absolutely RNA Miniprep kit Stratage-
ne, La Jolla, CA, USA) according to instructions of the manufacturer. Briefly, sorted cells 
were pelleted by 300×g centrifugation for 10 min at 4°C and then resuspended in a total 
volume of 350 ml lysis buffer containing β-mercaptoethanol (Stratagene). First strand cDNA 
was synthesized using an oligo-(dT) 12–18 primer (Invitrogen, Breda, The Netherlands) and 
SuperScriptTMII reverse transcriptase (200 U/ml; Invitrogen) as described in the manufactu-
rer’s protocol. Rearranged immunoglobulin IGHV5-Cγ transcripts were amplified in a 50ml 
reaction mixture, containing 2µl cDNA and 0.6 pmol/ml IGHV5 (PC7183) family specific pri-
mer (5ˈ-CTTAGTGCAGCCTGGAAGGT-3ˈ; (Dammers et al., 2000), 0.6 pmol/ml universal Cγ 
constant region primer (5ˈ-GACAGGGATCCAGAGTTCCA-3ˈ) and 2.5U Taq DNA Polyme-
rase (Invitrogen). The universal Cγ region primer was designed on the basis of a conserved 
sequence found in exon 1 of all rat IgG subclasses. To assess the amount and quality of the 
cDNA, PCR was also performed for β-actin, using β-actin specific primers as described by 
(Stoel et al., 2008). The PCR program for amplification of IGHV5-Cγ transcripts and β-actin 
consisted of 35 cycles of 30s at 94°C (2min in first cycle), 1min at 58°C and 1min at 72°C, 
respectively. This program was followed by an additional incubation period of 25 min at 72°C 
to allow extension of all IGHV5-Cγ products. The quality and size of the PCR products was 
evaluated by agarose gel electrophoresis. PCR products were subsequently cloned into the 
pCR4-TOPO vector using the TOPO TA cloning kit (Invitrogen). Plasmid DNA was isolated 
from randomly picked colonies with the Nucleospin Plasmid QuickPure kit (Clontech, Moun-
tain View, CA, USA). Plasmids containing an insert of approximately 600bp were sequenced 
in both directions at our local sequence facility (Department of Pathology and Laboratory 
Medicine, Division of Medical Biology, University Medical Center Groningen, Groningen, The 








































Netherlands). Sequence processing was performed using ClustalW from the European Mo-
lecular Biology Laboratory and Chromas software (Digital River GmbH, Cologne, Germany).
2.4. Analysis of IGHV5-Cγ transcripts
Analysis of IGHV5-Cγ transcripts (accession numbers pending), was carried out as described 
previously (Dammers et al., 2000). Briefly, IGHV region sequences were compiled according 
to the format of the International Immunogenetics (IMGT) database (http://imgt.cines.fr) (Le-
franc et al., 1999b). Rearranged IGHV5 genes were compared to the 28 previously establis-
hed PVG germline IGHV5 genes (Dammers and Kroese, 2001) and to two newly identified 
germline IGHV5 genes from PVG rat (PC-39 and PC-41). PC-39 and PC-41 were established 
on the basis the following GenBank database accession numbers: AJ286206, AJ286170, and 
AJ286224 (PC-39); AJ286269, AJ286226, and AJ286210 (PC-41). IGHV5 gene sequences 
were considered to be germline when two or more independently sampled, rearranged or 
genomic, IGHV5 gene sequence(s) share 100% identity upon alignment. Germline IGHD 
and IGHJ gene sequences were taken from the IMGT database. IgG subclasses were deter-
mined by aligning the Cγ nucleotide sequence from the IGHV5-Cγ transcripts to the NCBI rat 
genome database using the BLASTN program (http://www.ncbi.nlm.nih.gov). The accession 
numbers for the C region genes encoding for rat IgG subclasses are: IgG2a, BC088240; 
IgG2b, M28671; IgG1, BC095846; and IgG2c, X07189.
2.5. Statistical analysis
Statistical analysis of the data was performed using SPSS 16 software (SPSS Inc. Chicago, 
IL, USA). IGHV5 sequences displaying 100% identity were considered to be derived from a 
single B cell and counted only once for statistical analysis. We used Fisher’s exact test for 
comparison of IGHV, IGHD, IGHJ gene usage, the subclass distribution of the expressed Cγ 
regions and the number of mutations between the different groups. In all statistical tests we 
considered a P-value < 0.05 to be significant. The number of mutations was determined by 
counting the number of nucleotide mismatches in comparison with each IGHV5 gene sequen-
ce to its closest germline counterpart. Possible differences in H-CDR3 length between diffe-
rent groups were tested with the Mann–Whitney test. The R/S mutation ratio is the quotient of 
replacement (R) to silent (S) mutations. R/S mutation ratios are calculated separately for H-
CDR1 and 2 and the H-FR chain. The theoretical expected (inherent) R/S mutation ratio is the 
quotient of total possible R to total possible S mutations in the germline gene, as described 
by (Chang and Casali, 1994). The probability that an excess or scarcity of R mutations in the 
H-CDR or the H-FR results solely from chance is negated by the significantly low probability 
values (P < 0.05) calculated according to the Binomial distribution. 









































3.1. Mutated IGHV5-Cγ transcripts are found among B cells with a MZ-B cell phenotype
Classical memory B cells are class switched and carry somatically hypermutated IGHV genes 
(see e.g. (Tangye and Tarlinton, 2009). In order to see whether class switched memory B 
cells with a MZ-B cell phenotype exist, we first analysed the presence of IgG encoding (IGHV-
Cγ) transcripts among FACS-purified B cell subsets defined in a sIg-independent fashion. 
As shown in Figure. 1, FO-B cells are mature (i.e. CD90−; (Kroese et al., 1995) small-sized, 
HIS24highHIS57neg/low B cells whereas MZ-B cells are slightly larger cells and are defined as 
CD90−HIS24lowHIS57high cells (Dammers et al., 1999; Kroese et al., 1990). Plasma cells are 
not included in these two B cell fractions, since they lack expression of HIS24-determinant 
(CD45R) (Kroese et al., 1987). We first looked for the presence of IGHV-Cγ transcripts en-
coding for IGHV5 (PC7183) family genes using RT-PCR. For comparison, we also analysed 
IGHV5-Cγ transcripts from B cells with a FO-B cell phenotype (CD90−HIS24highHIS57neg/low) 
and from a fraction of cells that should include classical, class switched memory B cells, i.e. 
IgM−IgD− (non-T, non-NK) B cells. This IgM−IgD− fraction of B cells comprises class switched B 
cells with a FO-B cell and a MZ-B cell phenotype. In all four rats analysed, we found expres-
sion of IGHV5-Cγ transcripts in all three B cell fractions (i.e. MZ-B, FO-B, and IgM−IgD− cell 
phenotypes). These observations indicate that class switched B cells are present both among 
the sorted MZ-B cells and FO-B cells. Since presence of mutations is another hallmark of 
(most) classical memory B cells, IGHV5-Cγ transcripts from the three B cell subsets were 
subsequently cloned and sequenced. As shown in Table 1 (see below), nearly all sequences 
were uniquely and productively rearranged. Only very few 100% identical IGHV5-Cγ sequen-
ces were found (three sets in the FO-B cell fraction and one set in the IgM−IgD− cell fraction). 
These sequences were counted only once in our further analysis, since we could not rule out 
the possibility that they originate from the same cell. In total, we obtained 33 unique produc-
tive IGHV5-Cγ transcripts from the MZ-B cell fraction (HIS24lowHIS57high), 27 from the FO-B 
cell fraction (HIS24highHIS57neg/low) and 37 from the class switched B cell fraction (IgM−IgD−). 
Alignment of the constant region of these transcripts to known constant regions of rat revea-
led that all sequences were indeed encoded by Cγ genes (see below in Table 1), and that 
the V-regions of the transcripts were encoded by IGHV5 genes. Nearly all sequences reveal 
somatic hypermutations (SHM) upon comparison to the nearest germline sequence of PVG 
rats. Since Taq errors might be responsible for 1–2 mutations per sequence, we considered 
only sequences with more than 2 mutations as truly mutated (Dammers et al., 2000). Using 
this criterion, at least 80% of the IGHV5-Cγ sequences of all three fractions display SHM (see 
below in Table 1). Because of the presence of Cγ transcripts and mutated IGHV5 genes, we 
provide evidence for the existence of classical, class switched memory B cells in the pheno-
typically defined MZ-B cell and FO-B cell compartments.








































Figure 1. Phenotype of MZ-B cells and FO-B cells in rat spleen. Spleen cell suspensions of rat spleen 
were stained with mAb directed against CD90, TCRαβ, TCRγδ and CD161a to exclude immature B cells, 
T cells and NK cells from the analysis (Dump channel). These mAb’s were combined with HIS24 (anti-
CD45R) HIS57, a mAb directed to an unknown determinant on MZ-B cells (panel a) or combined with 
mAb directed against IgM and IgD (panel b). MZ-B cells are defined as Dump-HIS24loHis57hi cells, and 
FO-B cells as Dump-HIS24hiHIS57-/low cells. Classical, class switched memory B cells are found among 
the Dump-IgM-IgD- fraction. SSC = side scatter, FSC = forward scatter.
3.2. IGHV5-Cγ transcripts from B cells with a MZ-B cell phenotype exhibit fewer soma-
tic mutations compared to B cells with a FO-B cell phenotype 
The average number of mutations and the mutation frequency of the IGHV5-Cγ transcripts 
from B cells with a MZ-B cell phenotype appeared to be lower than that obtained from B 
cells with a FO-B cell phenotype: 7±4.9 (i.e. 2.9±2.07%) (mean±s.d.) vs 10±8.0 mutations 
(i.e. 4.3±3.36%) per IGHV gene, respectively (Table 1). Dividing the IGHV5-Cγ transcripts 
into four categories regarding the number of mutations, i.e. unmutated (0–2 mutations), low 
(3–5 mutations), intermediate (6–10 mutations) and high (>10 mutations), revealed that the 
number of mutations in IGHV5-Cγ transcripts from sorted MZ-B cells differ statistically signi-
ficantly from transcripts from sorted FO-B cells (Fisher’s exact test, P = 0.004). As we show 
in Figure 2, transcripts from B cells with a MZ-B cell phenotype are enriched in the category 
with an intermediate number of mutations whereas most sequences from B cells with a FO-B 



























































Figure 2. IGHV genes encoding for IgG antibodies from B cells with a MZ-B or FO-B cell phenotype differ 
in mutation frequencies. PCR products from IGHV5-Cγ transcripts from FACS-purified MZ-B cells, FO-B 
cells and IgM-IgD- cells were cloned and sequenced. Sequences were compared to known germline 
IGHV5 genes from PVG rats, and the numbers of mutations compared to these germline genes was 
calculated. Sequences were divided into four groups based upon the number of mutations. Sequences 
with 0-2 mutations were considered to be unmutated, because we could not exclude the possibility that 
1-2 mutations are the result of Taq errors. Class switched B cells with a FO-B and MZ-B cell phenotype 
have a statistically different mutation profile (Fisher’s exact test, P = 0.004).
3.3. Class switched memory type MZ-B cells have a similar IgG subclass distribution 
as their FO-B cell counterpart
There are four IgG subclasses in rat: IgG1, IgG2a, IgG2b and IgG2c. Based upon sequence 
identity, we were able to establish the IgG subclasses of the IGHV5-Cγ trancripts. The con-
stant region primer used to amplify IGHV5-Cγ trancripts was located in the first exon of the 
Cγ regions. Since this part of the Cγ region is identical for both the Cγ1 and Cγ2a regions 
(Bruggemann, 1988), it was not possible to discriminate between these two IgG subclasses. 
Figure 3 shows that the three B cell fractions express IGHV5-Cγ transcripts encoding for all 
IgG subclasses (IgG1/IgG2a, IgG2b and IgG2c). The usage of the various IgG subclasses ap-
pear, however, not to be statistically significant between the various B cell fractions (Fisher’s 


























































Figure 3. Subclasses distribution of IGHV5-Cγ transcripts derived from B cells with a MZ-B or FO-B cell 
phenotype are comparable. The subclasses of IGHV5-Cγ transcripts obtained from purified MZ-B cells, 
FO-B cells and IgM-IgD- B cells was determined by comparing the part of the PCR-amplified Cγ region 
to known rat Cγ genes encoding for the various rat IgG subclasses. The sequence of this part of Cγ1 
and Cγ2a regions are identical to each other and cannot be discriminated. The usage of the various IgG 
subclasses is similar in the three B cell subsets (Fisher’s exact test, P = 0.127)
3.4. The repertoire of class switched IGHV region genes obtained from B cells with a 
MZ-B cell or FO-B cell phenotype is highly similar
There are no substantial differences in the usage of individual IGHV5 family members among 
the IGHV5-Cγ transcripts derived from the three B cells fractions (see below Table 1). Some 
IGHV5 family members are, however, more frequently expressed in the different fractions. 
For example, B cells with a MZ-B cell phenotype appear to use most frequently PC-5 (20%), 
PC-29 (16%) and PC-4 (13%) to encode for their IgG antibodies, whereas B cells with a FO-B 
cell phenotype use most frequently PC-5 (15%), PC-1 (15%) and PC-34 (15%). These dif-
ferences are, however, not statistically significant (Fisher’s exact test, P = 0.60). Of the four 
IGHJ genes, the IGHJ2 gene was the most abundantly found among the IGHV-Cγ transcripts 
in all three B cell fractions, compared to the other IGHJ gene members. Approximately 50–
60% of these IgG encoding transcripts appear to utilize the IGHJ2 gene, followed by IGHJ3 
(20–30%) and the two other IGHJ genes. This biased usage of IGHJ2 genes is similar to the 
usage of IGHJ2 genes by mature, naive FO-B and MZ-B cells (Dammers et al., 2000). Also 
the utilization of IGHD genes by the IGHV5-Cγ transcripts is similar for all three B cell fractions 
(Fisher’s exact test, P = 0.794). Of the known functional IGHD genes (Hendricks et al., 2010) 
the IGHD genes 1–6 and 1–7 appear to be preferentially used to encode for IgG antibodies 
in all three fractions. We have previously shown that naive MZ-B cells and FO-B cells differ 
with respect to the length of H-CDR3 region (Dammers and Kroese, 2005; Dammers et al., 




























































On average, the length of the H-CDR3 region of naive MZ-B cells is 10.9±2.8 codons, which 
is 1.7 codons shorter than used by FO-B cells (Dammers et al., 2000). Here we show that the 
average length of the H-CDR3 regions of the sequenced IGHV5-Cγ transcripts derived from 
B cells with an MZ-B cell phenotype is 12.2±2.8 codons and does not differ from the H-CDR3 
codon length of encoding for IgG antibodies expressed by B cells with a FO-B cell phenotype 
(12.6±3.4 codons) (Mann–Whitney test, P = 0.61). In summary, we conclude that there are no 
major differences in the primary IGHVDJ repertoire between the IgG expressing B cells with 
a MZ-B cell phenotype and a FO-B cell phenotype.
3.5. IGHV-Cγ transcripts from B cells with an MZ-B cell phenotype show signs of anti-
gen selection 
High affinity antibodies which are generated during humoral immune responses generally 
result in amino acid replacements in the H-CDR regions. Selection of antibodies that can bind 
with high affinity to a particular antigen takes place within the germinal center (GC) during 
the formation of memory B cells. The replacement over silent mutation (R/S) ratio of antigen-
selected antibodies in the H-CDR regions is therefore higher than expected in case these 
mutations are randomly introduced. In contrast, selected antibodies favor relatively more si-
lent mutations in the framework (FR) regions, resulting in lower R/S values than expected. In 
accordance to the method developed by (Chang and Casali, 1994) we calculated the binomial 
change for the R/S ratio of H-CDR and H-FR regions of the IGHV5-Cγ transcripts with more 
than 4 mutations. As we show in Table 1 (see below), approximately 40% of the IGHV5-Cγ 
sequences in all B cell fractions show signs of antigen selection, i.e. reveal a significantly 
higher R/S ratio for the H-CDR regions and/or a significantly lower R/S ratio for the H-FR 
regions than expected. Thus, there is evidence that both IgG antibodies produced by B cells 
with a MZ-B cell phenotype and FO-B cell phenotype are likely the result of antigen-selection.






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.6. Clonally related B cells are found in both MZ-B cell fraction and FO-B cell fractions
IGHV sequences with identical H-CDR3 regions obtained incompletely separate PCR’s are 
considered to be derived from clonally related cells. We found two sets of two clonally related 
sequences in one rat (rat #3). In this animal one of the MZ-B cell derived sequences (MZ18) 
was clonally related to a FO-B cell derived sequence (FO26) (set #1), and another MZ-B 
cell derived sequence (MZ23) was clonally related to an IgM−IgD− B cell derived sequence 
(CM22), whereas the two members of set #2 express different IgG subclasses (IgG2b and 
IgG2c, respectively). There are no shared mutations between the sequences of both mem-
bers of set #1 and set #2, indicating that the two members of each clone may have developed 
independently from each other from one single naive B cell, upon antigenic stimulation.
4. Discussion
Most MZ-B cells present in rodent spleen show characteristic features of naive B cells, i.e. 
they express IgM molecules on their membrane of which the variable domains are encoded 
by unmutated V-region genes. A small fraction of IgM+ MZ-B cells, however, carry mutated 
V-genes and are qualified as IgM+ memory MZ-B cells. In this study we provide molecular 
evidence for the existence of a third type naturally occurring B cell population with a MZ-B cell 
phenotype in rat spleen, viz. class switched memory MZ-B cells. Previous studies described 
the appearance of antigen-specific, class switched MZ-B cells (and FO-B cells) after immuni-
zation of rats and mice with protein antigens (Gatto et al., 2004; Liu et al., 1988; Obukhanych 
and Nussenzweig, 2006), and that antigen (virus like particle)-specific MZ-B cells are enco-
ded by somatically mutated IGHV genes (Bergqvist et al., 2010; Gatto et al., 2007). The work 
presented here, combines these data by directly showing the presence of somatically muta-
ted IGHV5 transcripts encoding for IgG antibodies among the pool of purified rat MZ-B cells. 
These two characteristics, class switching recombination (CSR) and SHM, are hallmarks of 
classical, class switched memory B cells (Tangye and Tarlinton, 2009). The developmental 
origin of class switched memory MZ-B cells is not clear. Also the developmental relationship 
with their FO-B cell counterpart remains to be established. Memory B cells are generally be-
lieved to be generated in germinal centers (GC’s) (for reviews see e.g. (MacLennan, 1994; 
Manser, 2004). Proliferating GC B cells alter their BCR’s by SHM and CSR on their way to 
become memory B cells. (Toyama et al., 2002) have shown that Bcl6-deficient mice, which 
cannot develop GC’s, are still able to generate class switched memory B cells after immuni-
zation with a foreign protein antigen, albeit that the V-genes of these memory B cells are not 
mutated. Similarly, CD40−/− mice, which also cannot form GC, are still able to generate intes-
tinal IgA plasma cells whereas SHM in these cells are absent (Bergqvist et al., 2010). These 
findings illustrate that SHM, but not CSR, during the humoral immune response to exogenous 








































antigens are indispensable of the GC microenvironment. The somatic mutations are, in prin-
ciple, randomly introduced into the IGHV genes (Winter and Gearhart, 1998). Mutated B cells 
are subsequently subjected to positive selection for B cells expressing BCR’s that bind with 
high affinity to the inducing antigen. To this end, follicular dendritic cells uniquely located in the 
GC’s present immune complexes to the proliferating B cells. Many of the IGHV5-Cγ trans-
cripts from class switched memory B cells with a MZ-B or FO-B cell phenotype show signs of 
selection. An appreciable proportion of the IGHV5-Cγ genes exhibit significantly more R mu-
tations in H-CDR’s and/or significantly fewer R mutations in the H-FR’s, than expected from a 
random distribution of mutations. This indicates that after acquiring somatic mutations during 
proliferation the cells must have undergone some form of selection of their BCR’s. Thus, the 
observation that the mutation patterns of IgG transcripts obtained from both B cells with a 
MZ-B or FO-B cell phenotype show signs of antigen-selection therefore favors the notion that 
both types of memory cells are probably GC derived. It could be that class switched memory 
B cells with a MZ-B or FO-B cell phenotype are derived from antigen stimulated naive MZ-B 
cells and naive FO-B cells, respectively. Transfer experiments of purified B cell subsets into 
SCID mice have indeed revealed that both MZ-B cells and FO-B cells can generate GC’s 
upon stimulation with T cell-dependent (protein) antigen, albeit that MZ-B cells appear to be 
far less effective (Song and Cerny, 2003). Furthermore, both anti-hen egg lysozyme (HEL) 
transgenic MZ-B cells and FO-B cells, transferred into wild type recipients, are capable of 
generating a robust anti-HEL IgG1 response and forming GC’s after immunization with a pro-
tein antigen (Phan et al., 2005). The entry of MZ-B cells into GC’s in these experiments was, 
however, delayed. Although it thus seems possible that class switched MZ-B cells and FO-B 
cells are derived from their own naïve counterparts, we have some arguments to assume that 
naive B cells that give rise to class switched memory B cells with a MZ-B or FO-B cell pheno-
type belong to the same B cell pool. First, even within the relatively small number of sequen-
ces analysed in this study, we detected a set of sequences derived from clonally related cells 
(i.e. IGHV5 sequences with identical H-CDR3 regions, and same IGHV genes) with members 
in both the MZ-B and FO-B cell fraction (clone #1). Apparently, descendants of one and the 
same activated (naive) B cell can become either a class switched B cell with a FO-B cell phe-
notype or a class switched MZ-B cell. Second, there are no differences in the primary, unmu-
tated, H-chain repertoire between these two memory B cell subsets since usage of IGHV, 
IGHD and IGHJ gene segments is similar. Third, also the H-CDR3 lengths of the IGHV-Cγ 
transcripts between B cells with a FO-B or MZ-B cell phenotype are comparable: 12.2±2.8 
codons for class switched MZ-B cells and 12.6±3.4 codons for the class switched FO-B cells, 
respectively. This is in contrast to naive, IgM expressing, MZ-B cells which have significantly 
shorter H-CDR3 regions compared to naive, IgM expressing, FO-B cells (Dammers et al., 
2000; Makowska et al., 1999). Also (Gatto et al., 2007) observed that the length of H-CDR3 
regions expressed by virus-specific (possibly class switched) MZ-B cells and FO B cells are 








































comparable. Notably, the average H-CDR3 length of both class switched B cell subsets is 
identical to the reported H-CDR3 length of naive FO-B cells (Dammers et al., 2000). Together, 
these observations may suggest that class switched memory MZ-B cells are probably derived 
from naive FO-B cells and not from naive MZ-B cells, with their shorter H-CDR3 regions. In 
this context we like to mention that also naive FO-B cells can develop into naive MZ-B cells 
(Dammers et al., 1999; Guay et al., 2009; Srivastava et al., 2005; Vinuesa et al., 2003). Alt-
hough the repertoire of naturally occurring class switched memory MZ-B cells is very similar 
to the repertoire of naturally occurring class switched B cells with a FO-B cell phenotype, the 
numbers of mutations between the two subsets vary significantly. Class switched MZ-B cells 
are enriched in the category of 7–10 mutations per sequence, whereas class-switched B cells 
with a FO-B cell phenotype have most sequences in the category of >10 mutations per se-
quence (Fig. 2). A similar mutational difference has been observed by (Gatto et al., 2007) 
between antigen-specific B cells with a FO-B cell phenotype and a MZ-B cell phenotype after 
immunization with virus like particles. As shown by (Bende et al., 2007) recirculating class 
switched IgG memory cells in humans can participate in several successive GC reactions 
herewith acquiring possibly more mutations. In vivo intravital imaging in mice revealed that 
GC’s are open structures and that high affinity antigen-specific B cells can participate in pre-
existing GC’s (Schwickert et al., 2009). The difference in mutation frequency between class 
switched memory B cells with a MZ-B or FO-B cell phenotype might therefore be explained by 
the migratory properties of MZ-B cells. It could be that similar to naive MZ-B cells also class 
switched memory MZ-B cells are sessile cells. In contrast, FOB cells recirculate between the 
various lymphoid organs, herewith giving them the opportunity to participate in multiple GC 
reactions, and acquiring more mutations. An alternative explanation for the difference in mu-
tation frequencies between class switched B cells with a MZ and FO-B cell phenotype might 
be that there are intrinsic differences between the precursor cells for the two different types of 
memory cells, such as levels in activation induced deaminase. This enzyme plays a critical 
role in both CSR and SHM (Maul and Gearhart, 2010). As mentioned before, purified murine 
MZ-B cells and FO-B cells can give rise to IgG expressing memory B cells upon transfer into 
recipient animals followed by immunization (Phan et al., 2005; Song and Cerny, 2003). It 
could be that levels of activation induced deaminase in activated MZ-B cells are lower, com-
pared to activated FO-B cells, possibly as a result of differences in the signaling requirements 
of the two subsets. Lower levels of this enzyme may consequently result in lower mutation 
frequencies. Preliminary data suggest that there are no significant differences in levels of 
mRNA encoding for activation induced deaminase in flow cytometry purified rat B cells with a 
MZ-B or FO-B cell phenotype (data not shown). Since class switched B cells with a FO-B cell 
phenotype carry more mutations in their IgG encoding transcripts than MZ-B cells, it is very 
unlikely that class switched B cells with FO-B cell phenotype simply acquire a MZ-B cell phe-
notype, e.g. during differentiation towards plasma cells. This is supported by the observation 








































that class switched B cells with a MZ-B cell phenotype are absent from lymph nodes, whereas 
memory cells with a FO-B cell phenotype are present (Bergqvist et al., 2010; Gatto et al., 
2007). In summary, the present study shows that in addition to naïve MZ-B cells and mutated 
IgM+ memory MZ-B cells, also class switched somatically mutated cells with a MZ-B cell phe-
notype are present in rat spleen. It remains, however, to be formerly proven that these class 
switched B cells also reside in the anatomically defined splenic MZ. We speculate that these 
class switched memory MZ-B cells are derived from naïve FO-B cells and are generated in 
GC’s. The function of these classical, memory type MZ-B cells, is not known. Excitingly, (Et-
tinger et al., 2007) demonstrated that human IgG+ MZ (like) B cells can respond vigorously in 
an antigen- and T cell-independent fashion to the combination of IL-21 and B cell activating 
factor belonging to the TNF family (BAFF). Triggering by these cytokines results in the rapid 
differentiation of IgG+ MZ-B cells into IgG-secreting plasma cells. Whether class switched 
memory MZ-B cells in rodents respond similarly remains to be seen. These B cells in human 
splenic MZ’s are in close association with CD4+ TH-cells and dendritic cells that could poten-
tially secrete IL-21 and BAFF, respectively (Ettinger et al., 2007). In rodents, however, T cells 
are absent from the MZ. Class switched MZ-B cells may provide the immune system with a 
sessile pool of memory B cells that reflects the antigenic experience of the animal. These cells 
may respond rapidly to the presence of blood-borne antigens by producing IgG antibodies in 
addition to naive MZ-B cell-derived IgM antibodies, herewith contributing to humoral immunity 
in this extremely dangerous situation.
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Summary and general discussion
 
The marginal zone (MZ) is a well-defined anatomical compartment of the spleen that encloses 
the follicles and periarteriolar lymphocyte sheaths (PALS). Together, these three structures 
form the so-called “the white pulp”, which contain mostly lymphocytes. The MZ forms an 
interface with the red pulp, an area which is very rich in venous sinuses. Next to macropha-
ges and dendritic cells, the MZ is primarily populated with a unique population of B cells, the 
MZ-B cells, with unique phenotypical, developmental and functional properties. Because of 
their anatomical location at the border of the red pulp, and their rich supply of capillaries, that 
are widely open (Kusumi et al., 2015). MZ-B cells are thought to play an important role in 
rapid immune responses against blood-borne pathogens. In particular, they are believed to 
respond rapidly to polysaccharide antigens (TI-2 antigens) which are present on the surface 
of encapsulated bacteria, such as pneumococci and meningococci (Guinamard et al., 2000; 
Kruetzmann et al., 2003; Martin et al., 2001; Vinuesa et al., 2003). Herewith the MZ and MZ-B 
cells in particular, may play an important role in the prevention of sepsis.
Previous experimental data have provided evidence of the presence of both naive B cells and 
memory B cells in the MZ (Colombo et al., 2013; Dammers et al., 2000a; Dunn-Walters et 
al., 1995; Gatto et al., 2007; Gatto et al., 2004; Makowska et al., 1999; Tangye et al., 1998; 
Weller et al., 2004b; Zandvoort et al., 2001). Naïve B cells are cells that have not responded 
yet to antigen and are characterized by the expression of IgM molecules on their cell surf-
ace membrane, which are encoded by unmutated immunoglobulin (Ig) variable region (IGV) 
genes. Naïve MZ-B cells are likely derived from transitional B cells or follicular (FO) B cells. 
In contrast to naïve B cells, memory B-cells are antigen experienced cells, which frequently 
express also non-IgM isotypes on their membrane, which are encoded by mutated IGV ge-
nes. The presence of somatic hypermutations (SHM) in the IGV regions of Ig genes are the 
primary hallmark of memory B cells. Mutations are introduced both in the Ig heavy chain (IGH) 
and Ig light chain V regions genes during humoral immune responses when antigen-activated 
B cells expand in a T cell dependent (TD) fashion in the germinal centers (GC’s). Although, 
GC’s are generally believed to be the sole sites where this SHM of IGV genes takes place, the 
origin of mutated MZ-B cells is, however, still elusive. This thesis aims to analyse the memory 
compartment of splenic MZ-B cells in the rat, in particular to get some insights into the origin 
and function of these memory MZ-B cells. As experimental animal model for the study of the 
immune system, rats offer a selective advantage over mice, because in comparison to mice, 
rats have a much larger MZ which can be easily visualised. 
Rat immunoglobulin variable region genes
For establishing the presence of SHM in IGV genes it is of crucial importance to have informa-
tion about the genomic sequences of their germline V gene counterparts (unrearranged ge-








































nomic sequences) available. In view of this it was necessary to identify germline IGV genes of 
the rat. Furthermore, understanding the genomic organization of the organization of the IGH 
locus of the rat, including the localization of germline nucleotide sequences of all IGH chain 
variable genes, may help to unravel further possible differences in humoral immune respon-
ses and Ig repertoires between rats on the one hand and humans and mice on the other hand. 
These studies in rats became possible when the genome sequence of the Brown Norway 
(BN/SsNHsdMCW) rat (Rattus norvegicus) became available in 2004 and generated by the 
Rat Genomic Sequence Consortium (RGSC) (Gibbs et al., 2004; Havlak et al., 2004). This 
genome sequence includes the IGH locus located on chromosome 6q32–33. Of note, the 
BN rat strain that was used in this analysis differs from other inbred rats strains, also at the 
IGH locus. For example, Dammers et al. found by restriction fragment length polymorphism 
analysis that the BN rat differs significantly from other (e.g. PVG, AO, Lew) rat strains in terms 
of numbers of IGV genes at the IGH locus that belong to the IGHV5 family (Dammers, 2001). 
These data indicate that the BN rat strain contains probably a lower number of IGHV5 genes 
compared to other rat strains. The V part of the IGH chain is encoded by three different gene 
segments (genes): IGH variable (IGHV), IGH diversity (IGHD), and IGH joining (IGHJ) gene 
segments, whereas the immunoglobulin kappa variable (IGK) and immunoglobulin lambda 
(IGL) chain V domains are encoded by a combination of (IGKV–IGKJ) and immunoglobulin 
kappa variable (IGLV–IGLJ) genes, respectively (Roth, 1996). Although the genomic sequen-
ce of the rat was published, the exact number and location of IGHV genes including IGHD and 
IGHJ genes were not established. Therefore we first analysed several available sources for 
germline IGHV, IGHD, and IGHJ genes. These sources were: the genomic sequence RGSC 
genome assembly version 3.4, the unmapped sequences from contigs in the “unplaced sec-
tion” of the NCBI database and newly established bactigs of the BN rat genome (Baylor 
College of Medicine; http://www.hgsc.bcm. tmc.edu/projects/rat) not yet present in assembly 
RGSC V3.4. In chapter 2 we present an annotated map of the V region of the IGH locus of the 
BN rat, including not only functional and non-functional IGHV genes but also the IGHD and 
IGHJ genes. In chapter 3 we provide an update on the rat IGH chain locus in the rat in com-
parison to mouse and humans, and describe what is currently known about the organization 
of the Ig light chain locus in the rat. In total we were able to identify 353 IGHV genes, of which 
131 appear to be functional. This number of 131 functional IGHV genes in rats is the highest 
among mammalian species of which the whole genome sequences are available, in line with 
the prediction of Das (2009). This number might even increase since the whole genome map 
of the variable region of the IGH locus displays a number of small gaps (~300 kb) of which the 
nucleotide sequence still has to be determined. 
By analysing the rat genomic sequence of the IGVH locus we have identified 11 new IGHV 
genes in the BN rat. These novel IGHV genes were unidentified IGHV genes that were not 








































placed in the current assembly (RGSC V3.4) available at the NCBI database and also not 
listed in the International Immunogenetics (IMGT) database (http://imgt.cines.fr) (Lefranc et 
al., 1999). These genes were found among rat genomic sequences available from the Baylor 
College of Medicine Human Genome Sequencing Group that were not yet incorporated into 
the rat assembly of the BN rat at that time. Thus including the 11 newly identified IGHV genes, 
the BN rat genome comprises at least 353 individual IGHV genes. Similar to the mouse, rat 
IGHV genes can be subdivided into IGHV gene families, on the basis of nucleotide sequence 
identity. Individual IGHV genes belong to the same family when the IGHV genes share more 
than 80% of their nucleotides (Brodeur and Riblet, 1984). From the 11 newly discovered IGHV 
genes, 6 belong to the IGHV2 gene family and 5 belong to the IGHV5 gene family. Further-
more because the largest gap regions on the IGH locus of which the nucleotide sequence still 
needs to be determined is also located in the area of the IGHV2 and IGHV5 gene families it 
is plausible to assume that these 11 newly discovered IGHV genes are located in gap region 
found in the IGHV2-IGHV5 regions of assembly V3.4. In summary our studies have provided 
evidence that rats harbours the highest number of (functional) germline IGHV genes among 
all mammalian species studies so far. Given the notion that BN rats may have a lower number 
of IGHV5 genes compared to other rat strains (Dammers et al., 2001), and the fact that there 
are some gaps in the genomic sequence, in particular in the area of the IGHV2 and IGHV5 
gene families it is plausible to assume that the number of IGHV genes in the rat might even 
be higher.
Similar to the mouse and human, the vast majority of rat IGHV genes are orientated in the 
same direction as the IGHD and IGHJ genes and therefore deletional joining, instead of in-
versional joining, is most preferably used as recombination mechanism at the IGH locus. For 
both rats and mouse the overall density of IGHV genes (number of IGHV genes per Mb nu-
cleotide sequence) is the highest at the 3’end of the IGHV region in comparison to the 5’end. 
As expected, rats and mouse share a close evolutionary relationship as shown by the almost 
identical organization of IGHV gene families and the distribution of IGHV genes at the IGH 
locus. 
At present, little is known about the genomic organization of the rat Ig light chain loci including 
IGK and IGL chain genes. Similar to the IGHV chain genes, rats and mouse share almost the 
same number of IGKV genes with rats harbouring slightly more functional IGKV genes than 
the mouse. Overall, the comparison between the two species indicates that they have main-
tained the same basic structure of their IG loci including a similar order of IGHVDJ arrange-
ment. In these species diversity in the IG antigen-recognition site is established during early B 
cell development by rearrangement of V region genes (or gene segments) located at the IGH 
and IGL chain loci. Recombination at the IGH, IGK and IGL loci result in the generation of a 
highly diversified IG (antibody) primary repertoire with a wide range of antibody specificities. 








































IgM expressing marginal zone memory B cells 
Previous experiments provide evidence for the existence of mutated, IgM expressing, me-
mory MZ-B cells in rat (Dammers et al., 2000b). Dammers et al. demonstrated that less than 
20% of the MZ-B cells isolated from spleens of PVG rats carried mutated IGHV genes. These 
findings were in marked contrast with humans, where >95% of the splenic MZ-B cells are 
mutated (Colombo et al., 2013; Dunn-Walters et al., 1995; Tangye et al., 1998). One possible 
explanation for this difference could be that only one particular IGHV gene family (viz. the 
IGHV5 family, the homologue of PC7183 in the mouse) has been analysed in the (PVG) rat 
and that this IGHV gene family was not representative for other IGHV genes, or IGHV gene 
families. By establishing the genomic germline IGHV gene repertoire of the BN rat (chapter 
2), it became possible to accurately analyse other IGHV gene families as well. To avoid pos-
sible strain differences we used the BN rat strain, instead of the PVG rat strain that was used 
before (Dammers et al., 2000b). In chapter 4 we report on the frequency of mutated sequen-
ces in rearranged IGHV-Cµ transcripts derived from FACS sorted MZ-B cells (IgMhighIgDlow) 
in comparison with FO-B cells (IgMlowIgDhigh) from adult BN rat spleen. The analysis was con-
fined to three different IGHV gene families, which differ in size: IGHV3, IGHV4 and IGHV5. 
These three IGHV gene families have 4, 2 and 26 functional IGHV genes, respectively. The 
IGHV3 and IGHV4 genes families were chosen to determine whether there is a difference in 
mutation frequencies among members of IGHV gene families that are relatively small and to 
compare this frequency to the second largest IGHV gene family (IGHV5) in the rat, which had 
also been analysed before in the PVG rat (Dammers et al., 2000a). The BN rat strain contains 
26 functional IGHV5 (germline) genes compared to the 28 germline genes in the PVG rat. As 
was shown before, we found that splenic MZ-B cells express a significantly higher percentage 
of mutated sequences than FO-B cells and all three analysed IGHV gene families contributed 
to this difference. In BN rats a slightly higher proportion (27%) of the MZ-B cells expressed 
mutated IgM molecules encoded by IGHV5 family genes, compared to this proportion in the 
PVG rat (10-20%) (Dammers et al., 2000a). This difference in mutation frequency can be due 
to the strain differences that exist between the PVG and BN rat strain, such as for example 
the fact that BN rats have fewer IGHV genes, or might also be caused by different environ-
mental conditions (microbial environment; different microbiota) of the two rat strains. Analysis 
of the IGHV3 gene family showed a similar proportion (approximately 30%) of mutated IgM 
encoding sequences can be found among BN rat derived MZ-B cells. In marked contrast, to 
these two IGHV families, a very high proportion (66%) of the IGHV4 sequences from purified 
MZ-B cells was mutated. This family consists of only two potential functional IGHV genes, 
albeit that only one of these members appeared to be functionally expressed. Our findings 
thus show that the proportion of mutated sequences derived from MZ-B cells varies between 
the different IGHV gene families in the BN rat and that in total a higher proportion (27-66%) of 
IGHV genes were mutated compared to the (10-20%) of mutated sequences found previously 








































for the IGHV5 gene family in PVG rats (Dammers et al., 2000a; Makowska et al., 1999). Our 
observation that the highest percentage of mutated frequencies occurred in the single functi-
onal member IGVH4 gene family, suggests that there could be more antigen selection pres-
sure on this particular IGHV4 gene in expanding its available repertoire by SHM. Although in 
total a higher average number of mutated sequences among rat MZ-B cells was observed 
than previously, the frequency of mutated sequences among human MZ-B cells is still much 
higher. In humans, nearly all MZ-B cells are mutated (Colombo et al., 2013; Dunn-Walters et 
al., 1995; Tangye et al., 1998). Our observation that there is variation in frequency of muta-
ted IGHV genes between the different IGHV families, may also contribute to the difference 
in mutated MZ-B cells between humans and rats, since in humans the analysis of mutated 
IGHV genes was restricted to a restrictive set of IGHV genes. Dunn-Walters et al. analysed 
only two particular IGHV genes: the IGHV6 gene and IGHV4.21 gene. It is formally possible 
that these IGHV genes are more mutated than other genes. However the analysis of Tangye 
et al. (1998) has proven that Ig genes isolated from IgM+ memory B cells among IGHV5 and 
IGHV6 gene families were all mutated and shows that the high frequency of mutations is not 
only due to individual IGHV genes. Further, Colombo et al. (2013) investigated and compared 
the presence of mutations in human IGHV1, IGHV3 and IGHV4 gene families among splenic 
derived MZ-B cells (IgMhighCD27+), GC B cells and class switched B cells. Also they found that 
most of the MZ-B cells were mutated, albeit with a lower average number of mutations than 
both GC and class switched B cells. However, the average number of mutations in human 
MZ-B cells (11.8) (Colombo et al., 2013) is higher both for rat IgM+ MZ-B cells (8.8) and rat 
IgG+ MZ-B cells (7) (Hendricks et al., 2011). This might be due to the fact that humans have 
fewer functional IGHV genes than rats. We postulate that the higher number of germline 
IGHV genes in rodents have as a consequence that rats require fewer mutations to diversify 
their antibody repertoire after immunization than humans, because rats can encode for a 
larger pool of different antibodies for their primary repertoire. In addition, it is possible that 
differences in life span and environmental conditions also contribute to differences in average 
mutation frequency per IGHV gene. During their (long) lives humans may encounter much 
more different antigens than laboratory rats that live in well-controlled laboratorial conditions. 
Memory cells are generally believed to be generated in GC’s. It is still controversial, however, 
whether mutated (memory) IgM+ MZ-B cells are derived from GC’s or whether they represent 
a GC-independent B cell population. In humans, Colombo et al. (Colombo et al., 2013) ob-
served a small number of clonally related sequences that were shared between MZ-B cells 
and GC B cells, indicative that mutated IgM+ MZ-B cells can be derived from GC’s. In con-
trast, Weill et al. (Weill et al., 2009; Weller et al., 2004a; Weller et al., 2008) suggested that 
the (mutated) IgM+ MZ-B cells are not GC-derived memory B cells. Instead, these authors 
postulated that the mutations in human MZ-B cells are acquired during their development in 
order to diversity their primary repertoire, in a GC (and T-cell) independent fashion. To test this 








































hypothesis in rats we investigated in chapter 5 the possible presence of mutated IgM+ MZ-B 
cells in neonatal rats. Neonatal rats do not develop GC in the first weeks of their life (Kroese 
et al., 1987; van Rees et al., 1986). Thus, when MZ-B cells are unmutated in neonatal rats 
this would strongly argue against the hypothesis of Weill et al. (Weill et al., 2009; Weller et al., 
2004a; Weller et al., 2008), that SHM is part of the developmental program of MZ-B cells. To 
this end, we analysed IGHV-Cµ transcripts using IGHV4 and IGHV5 gene families from both 
MZ-B cells and FO-B cells (chapter 4). However, no mutations at all were found in any of the 
neonatal sequences, even not in IGHV4 gene family genes with the highest number of mu-
tated sequences (66%) in the adult rat. These results support the notion that at least in rats, 
mutated IgM+ MZ-B cells seen in adult animals are bona fide memory cells, which are most 
probably generated under the influence of external antigenic stimuli in GC. 
IgG expressing marginal zone memory B cells 
In addition to unswitched (IgM+) MZ-B cells, also class switched B cells can be found within 
the human (Ettinger et al., 2007b) and rodent MZ (Gatto et al., 2004). The phenotype of these 
cells is not clear, nor whether their IGHV genes exhibit SHM, as hallmark of memory B cells. 
This issue was analysed in chapter 6, where we analysed class switched (IgG+) MZ-B cells. 
To analyse IgG+ expressing B cells with a MZ-B cell phenotype we obviously could not use 
IgM and IgD to define MZ-B cells. Therefore, we made use of the fact that rat MZ-B cells 
express low levels of CD45R, defined by monoclonal antibody HIS24, and high levels of a 
surface molecule defined by the monoclonal antibody HIS57. Mature (CD90-) MZ-B cells can 
thus defined as CD90−HIS24lowHIS57high cells, and FO-B cells CD90−HIS24highHIS57neg/low cells. 
From purified (FACS-sorted) MZ-B cells (CD90−HIS24lowHIS57high) and FO-B cells (CD90−HIS-
24highHIS57neg/lo) we amplified rearranged IGHV-Cγ transcripts, specific for the IGHV5 gene 
family. For comparison, we also amplified IGHV-Cγ transcripts from a fraction of cells that 
should include classical class switched memory B cells, i.e. IgM−IgD− B cells. We were able to 
detect the presence of IGHV5-Cγ transcripts in all B cell subsets analysed, implying that IgG 
expressing cells can apparently exhibit at least two different phenotypes: cells with a MZ-B 
cell phenotype and cells with a FO-B cell phenotype. Analysis of the individual IGHV5 genes 
used by these IgG transcripts revealed that almost all IGHV5 genes were mutated, as is typi-
cal for memory B cells. We did observe that IgG expressing MZ-B cells had a lower number 
of mutations compared to IgG expressing FO-B cells. There were no differences in the usage 
of IGHV, IGHD and IGHJ genes between the IgG+ MZ-B cells and IgG+ FO-B cell subsets 
and the H-CDR3 lengths were also comparable between these two subsets. An important 
observation was that we found sets of clonally related IgG-encoding sequences (sequences 
with identical H-CDR3 regions, and usage of the same IGHV genes) derived from cells with 
members both in MZ-B cell (CD90−HIS24lowHIS57high) and FO-B cell (CD90−HIS24highHIS57neg/
low) fractions. Such sets of clonally related sequences were also found among the mutated 








































IgM+ MZ-B cells and IgM+ FO-B cells (chapter 4). These observations strongly indicate that 
(mutated) memory B cells with a MZ-B cells phenotype and a FO-B cell phenotype have a 
common origin. The origin of these cells is not clear. Classical memory B cells (i.e. mutated 
class switched B cells) are usually generated in the GC. At these sites the mutated B cells 
undergo some form of selection for the antigen that drives the GC reaction. This antigen se-
lection is crucial to increase the affinity of the Ig molecules that recognize the antigen, and is 
reflected in the fact that the IGHV genes that encode for the Ig molecules exhibit not random 
mutations. Some of the mutation patterns of IgG encoded sequences from both the MZ-B cell 
fraction and FO-B cell fraction show indeed signs of antigen selection (Chapter 6), and thus 
favours the hypothesis that they are both generated in the GC’s. The finding that mutated IgM+ 
memory B cells are absent in neonatal animals, in which GC’s cannot be formed yet, supports 
the hypothesis that also IgM+ memory MZ-B cells are generated in the GC. The common ori-
gin of IgM+ and IgG+ memory MZ-B cells and FO-B cells, illustrated by the presence of clonally 
related mutated sequences between MZ-B and FO-B cells, suggest that at least some GC-
derived memory cells can either acquire a FO-B cell phenotype or a MZ-B cell phenotype. The 
factors that drive this differentiation towards these two phenotypes are not known. 
Concluding remarks
B cells in the MZ are a heterogeneous population of cells and both naïve MZ-B cells, class 
switched and unswitched memory MZ-B cells are present at this unique site in the spleen. Na-
ive MZ-B cells carry unmutated Ig genes, produce low affinity IgM molecules and constitute a 
first line of defense against invading pathogens. The antibody repertoire expressed by these 
B cells has been suggested to be selected to bind to carbohydrate, carried by micro-organis-
ms (e.g. Galson et al., 2015). These antigens do not require T cell help for their responses. 
Furthermore, the heavy chains of the IgM molecules expressed by naïve MZ-B cells contain 
shorter H-CDR3 regions compared to FO-B cells in rats (Dammers et al., 2000a) and mice 
(Carey et al., 2008). Shorter H-CDR3 is associated with polyreactive antibody responses i.e. 
the binding of an antibody to several different structural antigenic elements (Schroeder et al., 
1995). Memory MZ-B cells express high affinity Ig molecules, directed to (microbial) antigens 
that have been encountered during life. Thus the presence of naïve MZ-B cells and memory 
MZ-B cells allows the MZ to make rapid innate-like and adaptive antibody responses to mi-
crobial antigens, to both TI and TD antigens. A novel role for neutrophils in the response of 
MZ-B cells has been proposed by Puga et al. (Puga et al., 2012). Neutrophils present in the 
spleen induce IgM+ production by activating MZ-B cells via BAFF, APRIL and IL-21 to make 
antibody responses to TI-2 antigens such as LPS, after induction of BLIMP-1 in the activated 
MZ-B cells (Puga et al., 2012). BAFF and IL-21 can also stimulate IgG+ MZ-B cells in a T cell 
independent fashion, to become antibody secreting plasma cells (Ettinger et al., 2007a). 








































MZ-B cells, are in some form of pre-activated state, and they express high levels of com-
plement receptor (CR) CD21 (Timens et al., 1989) and toll like receptors (TLR’s) (Gunn and 
Brewer, 2006) which underlie the fact that MZ-B cells are equipped for rapid and easy acti-
vation in (primary) immune responses. Further Garraud et al. (Garraud et al., 2012) suggest 
that shuttling of MZ-B cells between the MZ and follicles and transport of antigens (immune 
complexes) to follicular dendritic cells (FDC’s) decipher the role of MZ-B cells as antigen pre-
senting cells to participate in immune responses that generate high affinity antibodies. They 
observed that type 1 interferon produced in response to blood-borne pathogens, inactivates 
the sphingosin-1-phosphate receptor 1 (S1P1) and S1P3, allowing MZ-B cells to migrate 
from the MZ in response to CXCL13, which is highly expressed in follicles. Down regulation of 
CXCR5 allows MZ-B cells to exit from the follicles and return to the MZ. Herewith MZ-B cells 
transport immune complexes towards the follicles where the immune complexes are subse-
quently be captured by FDC’s in a complement dependent manner. The immune complexes 
trapped by the FDC’s are involved in the selection of mutated B cells that express Ig with 
higher affinities with the help of follicular helper T (Tfh) cells. First FDC’s will present antigen 
to the B cells that undergo SHM, and class switch recombination (CSR). Then these B cells 
will go on to present antigens to Tfh cells which will deliver survival signals to this high affinity 
GC B–cells, leading to selection. The selected GC B cells will then either differentiate into 
memory B cells or plasma cells.
MZ-B cells express the inhibitory IgG binding Fc-like receptor FcRL5, (Wilson et al., 2012). Af-
ter binding IgG, this receptor can inhibit the BCR. As is known for FcRL4, that binds IgA, and 
also inhibits the BCR, it is possible that occupation of FcRL5 by IgG similarly acts as an adap-
tive innate molecular switch dampening the BCR signaling and enhancing the TLR signaling 
(Sohn et al., 2011). Herewith MZ-B cells become more innate-like B cells that do not rely 
so much anymore on their BCR for their activation, but more on TLRs. Herewith these cells 
can respond rapidly to microbiological antigens present in the blood, in a BCR independent 
fashion. Since MZ-B cells have a broad repertoire, contain memory B cells (IgM and IgG) and 
are in a kind of pre-activated state these cells are ideally suited to respond rapidly to a broad 
range of blood borne antigens to prevent sepsis to occur. Targeting these B cells by vaccina-
tion in the future will be crucial for efficient protection against life-threatening infections. 
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Nederlandse samenvatting en discussie
De marginale zone (MZ) is een anatomisch omschreven compartiment van de milt dat de 
follikels en de peri-arteriolaire lymfocytenschede (PALS) omsluit. Samen vormen deze drie 
structuren de zogenaamde “witte pulpa” In de witte pulpa liggen vooral lymfocyten naast 
kleinere aantallen niet-lymfoïde cellen. De MZ vormt de grens met de “rode pulpa” en bevat 
veel veneuze sinussen. In de MZ is een unieke populatie van B cellen aanwezig, de zoge-
heten MZ-B cellen, naast macrofagen en dendritische cellen. Deze MZ-B cellen hebben 
unieke fenotypische-, ontwikkelings- en functionele eigenschappen. Vanwege hun anatomi-
sche positie op de grens met de rode pulpa en de vele bloedvaten, wordt verondersteld dat 
MZ-B cellen een belangrijke rol spelen bij de immuunrespons tegen infecties in het bloed. 
Ze worden met name gedacht snel te kunnen reageren tegen de polysaccharide antigenen 
(TI-2 antigenen) van kapseldragende bacteriën, zoals pneumococcen en meningococcen. 
Hierdoor speelt de MZ en met name de MZ-B cellen een belangrijke rol bij de preventie van 
sepsis. 
Voorgaande experimenten hebben laten zien dat er in de MZ zowel naïeve B cellen als ge-
heugen B cellen aanwezig zijn. Naïeve B cellen zijn cellen die nog niet met een antigeen 
gereageerd hebben. Deze worden gekarakteriseerd door de expressie van IgM moleculen 
op hun oppervlak die gecodeerd worden door ongemuteerde immuunglobuline (Ig) variabele 
regio (IGV) genen. Naïeve MZ B cellen zijn waarschijnlijk ontstaan uit onrijpe B cellen die 
net gevormd zijn in het beenmerg (transitionele B cellen) of uit rijpe B cellen die recirculeren 
en in de lymfoïde organen vooral in de follikels liggen. In tegenstelling tot naïeve B cellen 
zijn geheugen B cellen die al antigeen-gestimuleerd zijn en meegedaan hebben aan een 
immuunrespons. Zij brengen vaak andere isotypen dan IgM tot expressie op hun celopper-
vlak, en deze immuunglobulinen worden over hel algemeen gecodeerd door gemuteerde 
IGV genen. De aanwezigheid van somatische hypermutaties (SHM) in de IGV genen is dan 
ook het primaire kenmerk van geheugen B cellen. Mutaties treden op in zowel de Ig zware 
keten (IGH) en de Ig lichte keten V regio genen gedurende humorale immuun responsen. Dit 
gebeurt tijdens de proliferatie van geactiveerde B cellen in de zogenaamde kiemcentra (ger-
minal centers, GC’s). Deze GC’s worden gevormd in de follikels van de lymfoïde organen. In 
de MZ zijn ook B cellen aanwezig waarvan de immuunglobulinen gemuteerd zijn, en dus zeer 
waarschijnlijk geheugen cellen zijn. Over het algemeen wordt gedacht dat het GC de enige 
locatie is waar SHM van IGV genen plaats vindt. Desondanks is de origine van de MZ aan-
wezige gemuteerde B cellen nog onbekend. Dit proefschrift heeft tot doel om het geheugen-
compartiment van de MZ-B cellen in de milt van de rat te bestuderen, met name om meer 
inzicht te verkrijgen in de oorsprong en functie van deze geheugen MZ-B cellen. De rat heeft 
als experimenteel proefdier model van het immuunsysteem voordelen ten opzichte van de 








































muis als het gaat om de MZ, omdat in ratten een veel grotere MZ aanwezig is, die anatomisch 
gezien veel duidelijker te onderscheiden is van de overige compartimenten van de milt.
Rat immuunoglobuline variabele regio genen
Om vast te kunnen stellen of er mutaties aanwezig zijn in de IGV genen is het essentieel 
om de nucleotide volgorde van de kiemlijn V regio genen (de niet-geherschikte genomische 
sequenties) beschikbaar te hebben. Daarom was het noodzakelijk om eerst de kiemlijn IGV 
genen in het genoom van ratten te identificeren. Inzicht in de genomische organisatie van de 
IGH locus van de rat kan daarnaast helpen om mogelijke verschillen tussen de humorale im-
muun respons van ratten ten opzichte van die bij mens en muis beter te begrijpen.
De identificatie van de genomische organisatie van de IGH locus van de rat werd mogelijk 
toen in 2004 de nucleotide sequenties van het genoom van de Brown Norway (BN/SsNHsdM-
CW) rat (Rattus norvegicus) beschikbaar werd gemaakt door het Rat Genomic Sequence 
Consortium (RGSC). De beschikbare sequenties omvatte ook de IGH locus op chromosoom 
6q32-33. Wat wel van belang is, is dat voor deze analyse de BN rat gebruikt was. Deze ratten-
stam vertoont in het IGH locus ten opzichte van andere ingeteelde rattenstammen grote ver-
schillen. Dammers et al. hebben bijvoorbeeld gevonden met behulp van “restriction fragment 
length polymorphismes” dat de BN rat minder IGV genen heeft dan andere ratten stammen 
(bijvoorbeeld PVG. AO, Lewis ratten). 
Het V gedeelte van de IGH keten wordt gecodeerd door drie verschillende gen segmenten: 
IGH variabele (IGHV), IGH diversity (IGHD) en IGH joining (IGHJ) gen segmenten. Door her-
schikking van deze drie gen segmenten (VDJ recombinatie) worden er één V gen segment 
gekoppeld aan één D gen segment en één J gen segment  (VDJ recombinatie). Slechts na 
herschikking kunnen deze coderen voor het V gedeelte van de IGH keten. Ook al was het 
totale genoom van de rat gepubliceerd, het exacte aantal en de lokalisatie van de IGHV ge-
nen alsmede van de IGHD en IGHJ genen, was nog niet bekend. Daarom hebben we eerst, 
gebruik makend van verschillende beschikbare bronnen, de kiemlijn sequenties van de IGHV, 
IGHD en IGHJ genen geanalyseerd. De bronnen die gebruikt werden waren: de genoom 
volgorde van het RGSC “genome assembly version 3.4”, de niet-gelokaliseerde sequenties 
(contigs) in de “unplaced section” van de NCBI database en in de nieuw gevonden zoge-
naamde bactigs van het BN ratten genoom (Baylor College of Medicine; http://www.hgsc.
bcm. tmc.edu/projects/rat). 
In hoofdstuk 2 hebben we de organisatie van de V regio van de BN rat gedetailleerd in kaart 
gebracht. Dit is uitgevoerd voor zowel de functionele en niet-functionele IGHV genen als ook 
voor de IGHD en IGHJ genen.  In hoofdstuk 3 presenteren we een update van de IGH locus 
van de rat in vergelijking met die van de muis en van de mens. Tevens beschrijven we wat 
er op dit moment bekend is over de organisatie van de lichte keten locus bij de rat. In totaal 








































waren wij in staat om 353 IGHV genen te identificeren waarvan er 131 functioneel lijken te 
zijn. Dit aantal van 131 functionele IGHV genen bij de rat is het grootste aantal wat gevonden 
is bij zoogdieren waarvan het gehele genoom beschikbaar is. Door de analyse van de geno-
mische sequenties van het IGVH locus hebben we 11 nieuwe IGHV genen geïdentificeerd in 
de BN rat. Deze nieuwe IGHV genen waren nog niet geïdentificeerd in de huidige samen-
stelling (RGSC V3.4) van de NCBI database en ook nog niet genoemd in de  International 
Immunogenetics (IMGT) database (http://imgt.cines.fr). Deze genen werden gevonden in de 
rat genoom sequenties die beschikbaar waren gemaakt door de Baylor College of Medicine 
Human Genome Sequencing Group die nog niet waren opgenomen in de samengestelde 
map van de BN rat op dat moment. 
Net als bij de muis kunnen bij ratten IGHV genen onderverdeeld worden in zogeheten IGHV 
gen families op basis overeenkomsten in nucleotide volgorden. Individuele IGHV genen be-
horen tot dezelfde familie als hun IGHV genen voor meer van 80% van hun nucleotiden volg-
orde met elkaar overeenkomen.  Van de 11 nieuw gevonden IGHV genen behoren er 6 tot 
de IGHV2 gen familie en 5 tot de IGHV5 gen familie. De onbekende regio van het IGH locus 
waarvan de nucleotide volgorde nog bepaald moet worden is precies gelegen in het gebied 
van de IGHV2 en IGHV5 gen families. Daarom is het redelijk om te veronderstellen dat deze 
11 nieuw gevonden IGHV genen waarschijnlijk gelegen zijn in de IGHV2-IGHV5 regio van 
assembly V3.4.
Net als bij de muis en bij de mens is het overgrote merendeel van de ratten IGHV genen in 
dezelfde richting georiënteerd als de IGHD en IGHJ genen en daarom zal  VDJ recombinatie 
meestal gebruik maken van deletie en van inversie tijdens. Voor zowel rat als muis is de totale 
dichtheid van IGHV genen (dat is het aantal IGHV genen per Mb nucleotiden volgorde) het 
hoogst aan de 3’ kant van de IGHV regio in vergelijking met de 5’ kant. Zoals verwacht tonen 
de rat en de muis een sterke evolutionaire overeenkomst zoals aangetoond met de bijna 
identieke organisatie van de IGHV gen families en de verspreiding van de verschillende IGHV 
genen op het IGH locus.
Samenvattend laten onze studies (Hoofdstuk 2) zien dat ratten het hoogste aantal (functio-
nele) kiemlijn IGHV genen hebben van alle bestudeerde zoogdieren soorten. Gezien het feit 
dat de BN rat misschien wel een lager aantal IGHV5 genen heeft ten opzichte van andere rat-
ten stammen en het feit dat er nog wat gaten zitten in de genoom volgorde in het gebied van 
de IGHV2 en IGHV5 gen families is het niet onwaarschijnlijk dat het aantal van IGHV genen 
in de rat mogelijk zelfs nog hoger is.
Op dit moment is er nog weinig bekend over de genomische organisatie van het ratten Ig 
lichte keten locus die gevormd wordt door genen die coderen voor de kappa lichte keten (IGK) 
en de lambda lichte keten (IGL) genen. De variabele delen van de IGK en IGL worden geco-
deerd door respectievelijk een combinatie van (IGKV-IGKJ) of (IGLV-IGLJ) gen segmenten. 








































Net als bij de IGHV genen, hebben ratten en muizen ongeveer hetzelfde aantal IGKV genen 
waarbij de ratten een paar meer functionele IGKV genen hebben dan de muis.  
IgM positieve marginale zone geheugen B cellen 
Eerdere experimenten lieten zien dat er in gemuteerde IgM-positieve geheugen MZ-B cellen 
aanwezig zijn in de rat. Dammers et al. hebben aangetoond dat ongeveer 20% van de MZ-B 
cellen afkomstig van de milt van PVG ratten gemuteerde IGHV genen hebben. Deze bevin-
dingen stonden in scherp contrast met de situatie bij mensen waarbij meer dan 95% van de 
MZ-B cellen uit de milt gemuteerd zijn. Een mogelijke verklaring voor dit verschil zou kunnen 
zijn dat er in de (PVG) rat alleen maar een bepaalde IGHV gen familie (met name de IGHV5 
familie, de homoloog van de PC7183 in de muis) was geanalyseerd. Mogelijk was deze IGHV 
gen familie niet representatief voor andere IGHV gen families. Door het in kaart brengen van 
de op het genoom aanwezige kiemlijn IGHV genen van de BN rat (hoofdstuk 2), werd het 
mogelijk om nauwkeurig ook andere IGHV gen families te analyseren. Om bovendien mo-
gelijke verschillen tussen rattenstammen te voorkomen,  gebruikten we de BN ratten stam 
in plaats van de PVG ratten stam die eerder was onderzocht. In hoofdstuk 4 laten we de 
frequentie zien van het aantal gemuteerde sequenties in herschikte IgM transcripten (IGHV-
Cµ transcripte) afkomstig van MZ-B cellen (IgMhighIgDlow) in vergelijking met die van de FO-B 
cellen (IgMlowIgDhigh) afkomstig uit de milt van volwassen BN ratten. Deze B cel subpopula-
ties werden verkregen door gebruik te maken van sortering met behulp van flow-cytometrie 
(FACS). De analyse van de transcripten was gericht op drie IGHV gen families die verschil-
lend zijn in het aantal leden dat deel uit maakt van deze families: IGHV3, IGHV4 en IGHV5. 
Deze drie IGHV gen families hebben in de BN rat respectievelijk 4, 2 en 26 functionele IGHV 
genen. De IGHV3 en IGHV4 gen zijn dus relatief klein vergeleken met de IGHV5 gen familie, 
welke de op-één-na grootste familie is. De IGHV5 familie was ook eerder al eerder geanaly-
seerd in de PVG rat..
Zoals eerder was aangetoond, vonden we dat in de milt een significant hoger percentage van 
de IgM sequenties van de MZ-B cellen gemuteerd is dan de FO-B cellen. Bovendien bleek 
dat alle drie de geanalyseerde IGHV gen families bijdragen aan dit verschil. In BN ratten 
waren 27% van de MZ-B cellen die gebruik maken IgM moleculen gecodeerd door de IGHV5 
familie gemuteerd, wat iets hoger is dan in de PVG rat (10-20%). Dit verschil in frequentie van 
gemuteerde IgM sequenties kan veroorzaakt zijn door stam verschillen tussen de PVG en de 
BN rattenstam, zoals bijvoorbeeld het feit dat BN ratten minder IGHV genen hebben, of kan 
veroorzaakt worden door verschillen in omgevingsfactoren (andere microbiota) bij de twee 
ratten stammen. Analyse van de IGHV3 gen familie liet zien dat een vergelijkbaar percentage 
(30%) van MZ-B cellen gemuteerde IgM sequenties heeft. In tegenstelling tot deze twee 
IGHV families is een groot gedeelte (66%) van de IGHV4 sequenties afkomstig van MZ-B 
cellen gemuteerd. Deze familie bestaat uit maar twee potentieel functionele IGHV genen, 








































waarvan er waarschijnlijk slechts één van deze leden functioneel tot expressie komt. 
Onze bevindingen laten dus zien dat het aandeel van gemuteerde sequenties afkomstig van 
MZ-B cellen varieert tussen de verschillende IGHV gen families en dat een groter deel  (27-
66%) van de IGHV genen in de BN rat gemuteerd is, dan eerder was gevonden voor alleen de 
IGHV5 gen familie in de PVG rat (10-20%). Onze observatie dat het hoogste percentage van 
gemuteerde sequenties te vinden was in de IGHV4 gen familie met één enkel functioneel lid, 
suggereert dat er mogelijk meer antigene selectiedruk is op dit bepaalde IGHV4 gen om het 
beschikbare repertoire te expanderen door middel van somatische hypermutatie. Ondanks 
dat er een hoger gemiddeld aantal gemuteerde sequenties werd gevonden in MZ-B cellen 
van de rat dan eerder werd gevonden, is bij de MZ-B cellen van de mens nog steeds een 
veel groter percentage gemuteerd. Bij de mens zijn nagenoeg alle MZ-B cellen van de milt 
gemuteerd. Onze waarneming dat er een variatie bestaat in de percentage gemuteerde IGHV 
genen tussen verschillende IGHV families kan voor een deel het verschil verklaren tussen het 
aantal gemuteerde MZ-B cellen van mens en rat. Immers de analyse van humane MZ-B cel-
len is sterk beperkt tot een smalle set van IGHV genen. Zo analyseerden Dunn-Walters et al. 
alleen twee individuele IGHV genen: het IGHV6 gen en het IGHV4.21 gen. Colombo et al on-
derzochten de aanwezigheid van mutaties in humane IGHV1, IGHV3 en IGHV4 gen families 
in onder andere MZ-B cellen. Ook zij vonden dat de meeste MZ-B cellen gemuteerd waren.
Het gemiddeld aantal mutaties per sequentie is in MZ-B cellen bij de mens (gemiddeld 11.8 
mutaties per sequentie) is echter hoger dan bij ratten IgM+ geheugen MZ-B cellen (gemiddeld 
8.8 mutaties per sequentie). Mogelijk dat dit veroorzaakt wordt door het feit dat bij de mens er 
minder functionele IGHV genen zijn dan in de rat. We speculeren dat misschien het hogere 
aantal kiemlijn IGHV genen in ratten en muizen tot gevolg heeft dat ratten minder mutaties no-
dig hebben om hun antistof repertoire te vergroten na immunisatie dan mensen, omdat ratten 
een grotere diversiteit van verschillende antistoffen kunnen maken met hun primaire (kiemlijn) 
repertoire.  Bovendien is het mogelijk dat een verschil in levensverwachting tussen mens en 
rat alsmede omgevingsfactoren ook bijdragen aan het verschil van de  gemiddelde mutatie 
frequentie per IGHV gen. Gedurende hun (lange) leven kunnen mensen meer verschillende 
antigenen tegenkomen dan laboratorium ratten die leven onder streng gecontroleerde labo-
ratorium omstandigheden. 
Geheugen B cellen worden over het algemeen gedacht gevormd te worden in de GC’s, tij-
dens de T cel afhankelijke immuunrespons van antigeen-specifieke B cellen. In deze GC’s 
worden, zoals eerder gezegd de V genen (van zowel de lichte als de zware ketens) gemu-
teerd door middel van somatische hypermutatie (SHM).  Het is echter nog niet goed bekend 
of ook gemuteerde (geheugen) IgM+ MZ-B cellen afkomstig zijn van de GC’s of dat ze een 
GC-onafhankelijke B cel populatie zijn. Bij de mens vond Colombo et al. een klein aantal van 
klonaal-gerelateerde IGH sequenties, afkomstig van B-cellen afkomstig van MZ-B cellen en 








































GC-B cellen. Deze bevinding suggereert dat gemuteerde IgM+ MZ-B cellen inderdaad moge-
lijk afkomstig zouden zijn van GC’s. Daartegenover stelt Weil et al. dat bij de mens de (ge-
muteerde) IgM+ MZ-B cellen juist niet gevoprmd worden in het GC, maar ontstaan gedurende 
de  ontwikkeling van het immuunsysteem. Dit zou niet het gevolg zijn van een immuunres-
pons maar een eigenschap van MZ-B cellen om het primaire repertoire te verbreden op een 
GC- (en T-cel) onafhankelijke manier. De hypothese van Weill et al. is vooral gebaseerd op 
de waarneming dat bij patiënten met een bepaalde immuundeficiëntie waarbij GC’s afwezig 
zouden zijn, er toch gemuteerde MZ-B cellen gevonden worden. 
Om de oorsprong van gemuteerde IgM+ MZ-B cellen te onderzoeken bij de rat hebben we 
in hoofdstuk 5 de mogelijke aanwezigheid van deze cellen onderzocht in neonatale ratten. 
Neonatale ratten kunnen in de eerste paar weken van hun leven nog geen GC’s vormen in 
de lymfoïde organen. Dus wanneer de MZ-B cellen in de milt van deze neonatale ratten ge-
muteerd zijn, zou dit een sterk argument zijn voor de hypothese van Weill et al. dat SHM een 
onderdeel is van de natuurlijke ontwikkeling van MZ-B cellen.
Daarom hebben we in dit hoofdstuk de IGHV-Cµ transcripten van de  IGHV4 en IGHV5 gen 
families van zowel de MZ-B cellen als de FO-B cellen geanalyseerd. In geen van de neo-
natale sequenties werd een mutatie gevonden, zelfs niet in de IGHV4 gen familie met het 
hoogste aantal gemuteerde sequenties in MZ-B cellen afkomstig van volwassen ratten. Deze 
resultaten ondersteunen het feit dat ten minste in de rat, de gemuteerde IgM+ MZ-B cellen 
zoals te vinden in de volwassen rat het meest waarschijnlijk echte geheugen cellen zijn, die 
ontstaan onder de invloed van externe antigene stimulatie in GC’s.
IgG positieve marginale zone geheugen B cellen 
Naast IgM+ MZ-B cellen, kunnen er ook in de MZ ook B cellen gevonden worden waarvan de 
immuunglobulinene genen isotype switching (klasse switch recombinatie) hebben Dergelijke 
IgG+ B cellen zijn gevonden in de MZ van de milt van zowel mens als rat. B cellen met een 
geswitcht isotype worden over het algemeen beschouwd als geheugen B cellen, en deze cel-
len hebben dan ook meestal gemuteerde IGHV genen. Of geschwitchte B cellen in de MZ ook 
mutaties hebben en of deze B cellen met betrekking tot hun fenotype lijken op niet-geswitchte 
(IgM+) was niet bekend. Dit werd geanalyseerd in hoofdstuk 6 waar we IgG+ MZ-B cellen 
van de milt van de rat hebben geanalyseerd. Om de te onderzoeken of er IgG+ B cellen met 
een MZ-B cel fenotype voorkomen en vervolgens te analyseren hebben we gebruik gemaakt 
van het feit dat ratten MZ-B cellen een laag niveau van CD45R tot expressie brengen, zoals 
dat gedefinieerd wordt door de monoclonale antistof HIS24, en hoge niveaus van het op-
pervlakte molecuul dat gedefinieerd wordt door de monoclonale antistof HIS57. Uitgerijpte 
B cellen, inclusief MZ-B cellen, brengen daarentegen het eiwit CD90 niet meer op hun op-
pervlak tot expressie.  Op deze manier kunnen MZ-B celle van de rat gedefinieerd worden 
als CD90−HIS24lowHIS57high cellen en FO-B cellen als CD90−HIS24highHIS57neg/low.  We hebben 








































eerst onderzocht of er van gezuiverde (FACS-gesorteerde) MZ-B cellen en FO-B cellen ge-
herrangschikte IGHV-Cγ transcripten geamplificeerd konden worden, die specifiek zijn voor 
de IGHV5 gen familie. Ter vergelijking hebben we ook IGHV-Cγ transcripten geamplificeerd 
van klassieke “geswichte””  geheugen (IgM-IgD-) B cellen.
We waren in staat om de aanwezigheid van IGHV5-Cγ transcripten aan te tonen in  alle B cel 
subsets die we geanalyseerd hebben. Dit betekent dat IgG+ B cellen tenminste twee fenoty-
pes kunnen hebben: cellen met een MZ-B cel fenotype en cellen met een FO-B cel fenotype. 
Analyse van de individuele IGHV5 genen onder deze IgG transcripten liet zien dat bijna alle 
IGHV5 genen gemuteerd waren, zoals karakteristiek is voor geheugen B cellen. We zagen 
wel dat de IgG+ MZ-B cellen een lager aantal mutaties had in vergelijking tot de IgG+ FO-B 
cellen. Er was geen verschil in het gebruik van IGHV, IGHD en IGHJ genen tussen de IgG+ 
MZ-B cellen en de IgG+ FO-B cellen en de H-CDR3 lengte was ook hetzelfde tussen beide 
subpopulaties. Een belangrijke observatie was dat we sets van klonaal- gerelateerde IgG-co-
derende sequenties (sequenties met identieke H-CDR3 regio en gebruik van dezelfde IGHV 
genen) vonden afkomstig van cellen met leden in zowel de MZ-B cel (CD90−HIS24lowHIS-
57high)  fractie als in de FO-B cel (CD90−HIS24highHIS57neg/low)  fractie.
Degelijke sets van klonaal-gerelateerde sequenties werden ook gevonden bij de gemuteerde 
IgM+ MZ-B cellen en IgM+ FO-B cellen (hoofdstuk 4). Deze waarnemingen suggereren zeer 
sterk dat (gemuteerde) geheugen B cellen met een MZ-B cel fenotype en met een FO-B cel 
fenotype een gezamenlijke oorsprong hebben. De oorsprong van die cellen is niet  helemaal 
duidelijk. Zoals eerder gezegd, worden klassieke geheugen B cellen (dat wil zeggen gemu-
teerde die ook een geswitcht isotype hebben B cellen) meestal geproduceerd in de GC’s. 
Op die lokaties ondergaan de gemuteerde B cellen een vorm van selectie voor het antigeen 
dat de GC reactie aanzet. Deze antigene selectie is een cruciale stap in het proces van de 
affiniteitsrijping van geheugen B cellen. Hierbij worden B cellen die door de somatische hy-
permutatie een hogere affiniteit voor het antigeen gekregen hebben geselecteerd, ten koste 
van B cellen met een lagere affiniteit voor het antigeen. Dit is terug te zien in het feit dat de 
IGHV genen die coderen voor de Ig moleculen in geheugen B cellen geen willekeurige mu-
taties hebben. Aan de hand van de mutatie patronen van de IgG–coderende sequenties van 
zowel de MZ-B cel fractie als van de F0-B fractie konden we vaststellen (hoofdstuk 6) dat er 
in sprake was van antigene selectie. Dit past bij de  hypothese dat deze ook IgG+ MZ-B cellen 
gegenereerd zijn in de GC’s. De bevinding dat gemuteerde IgM+ geheugen B cellen afwezig 
zijn in neonatale dieren (hoofdstuk 5) waar nog geen GC’s aanweizg zijn, ondersteunt de 
hypothese dat ook de IgM+ geheugen MZ-B cellen afkomstig zijn van de GC’s. De gezamen-
lijke oorsprong van IgM+ en IgG+ geheugen MZ-B cellen en FO-B cellen, zoals geïllustreerd 
door de aanwezigheid van klonaal-gerelateerde sequenties tussen MZ-B en FO-B cellen, 
suggereert dat tenminste een aantal van de GC-afkomstige geheugen cellen zowel een FO-B 
cel fenotype als een MZ-B cel fenotype kunnen verkrijgen. De factoren die deze differentiatie 








































tussen deze twee fenotypes aan sturen zijn onbekend.
Concluderende opmerkingen
B cellen in de MZ vormen een heterogene populatie van cellen en zowel naïeve MZ-B cel-
len, als geswitchte en niet-geswitchte geheugen MZ-B cellen zijn aanwezig op deze unieke 
locatie in de milt. Naïeve MZ-B cellen hebben ongemuteerde Ig genen, produceren IgM mo-
leculen met een lage affiniteit en vormen een eerste lijn van afweer tegen binnendringende 
pathogenen. Het antistof repertoire van deze B cellen wordt verondersteld geselecteerd te 
zijn te binden aan suiker-antigenen zoals aanwezig op sommige micro-organismen. Voor 
de immuunrespons tegen deze antigenen is er geen T cel hulp nodig.  Daarnaast hebben 
in rat en muis de IgM moleculen zoals te vinden in naïeve MZ-B cellen kortere H-CDR3 re-
gio’s in vergelijking met die van FO-B cellen. Kortere H-CDR3 regio’s zijn geassocieerd met 
poly-reactiviteit, dat wil zeggen dat de antistoffen kunnen binden aan meerdere antigenen. 
Geheugen (MZ-)B cellen hebben daarentegen Ig moleculen met een hoge affiniteit, die ge-
richt zijn tegen de microbiële antigenen waarmee in aanraking is gekomen tijdens het leven. 
De aanwezigheid van naïeve MZ-B cellen en geheugen MZ-B cellen zorgen ervoor dat in de 
MZ zowel aangeboren (laag affiene, polyreactieve) als verworven (hoog affiene) antistof res-
ponsen tegen T cel onafhankelijke (koolhydraten) als T cel afhankelijke (eiwitten) microbiële 
antigenen kunnen plaatsvinden. 
MZ-B cellen zijn in een soort van pre-geactiveerde staat. Hierdoor lijken ze uitermate geschikt 
om snel te kunnen reageren op antigeen, wat zeker in het geval van een dreigende sepsis 
van groot belang is.  Ze brengen hoge niveaus van de complement receptor CD21 tot expres-
sie alsmede Toll-like receptoren (TLR’s) wat verder bewijs is van het feit dat MZ-B cellen goed 
zijn uitgerust om snel en gemakkelijk geactiveerd te worden in (primaire) immuunresponsen. 
Een nieuwe rol van neutrofiele granulocyten in de immuunrespons van MZ-B cellen is voorge-
steld door Puga et al. Deze neutrofielen in de milt induceren IgM productie door de MZ-B cel-
len te activeren via de cytokinen BAFF, APRIL en IL-21 om zo een antistof respons te maken 
tegen TI-2 antigenen zoals LPS.  Deze cytokinen kunnen de transcriptie factor de inductie van 
BLIMP-1 induceren in de geactiveerde MZ-B cellen. BAFF en IL-21 kunnen samen ook IgG+ 
MZ-B cellen stimuleren op een T-cel onafhankelijke manier om te differentiëren tot antistof-
producerende plasma cellen.
Behalve (snelle) antistof productie spelen MZ-B cellen ook mogelijke een andere rol. Gar-
raud et al. hebben gevonden dat MZ-B cellen op en neer gaan tussen de MZ en de follikels 
en daarmee het transport van antigenen (in de vorm van immuuncomplexen) naar folliculair 
dendritische cellen (FDC’s) verzorgen. Hierbij is er dus ook een rol weggelegd voor MZ-B 
cellen als antigeen-presenterende cellen en zo een aandeel hebben aan immuunresponsen 
waarbij hoog-affiene antistoffen geproduceerd worden. Deze onderzoekers vonden dat  type 








































1 interferon dat wordt gemaakt in reactie op pathogenen dit transport stuurt.  Onder invloed 
van het interferon wordt de sphingosine-1-phosphate receptor 1 (S1P1) en S1P3 geïnacti-
veerd waardoor de MZ-B cellen de gelegenheid gegeven wordt om de MZ te verlaten en te 
migreren naar de follikels toe onder invloed van het chemokine CXCL13. Het verlagen van 
de expressie van CXCR5, de receptor voor CXCL13, staat de MZ-B cellen dan weer toe om 
de follikels weer te verlaten en terug te keren naar de MZ. Op die manier transporteren MZ-B 
cellen immuuncomplexen naar de follikels toe waarna deze immuuncomplexen vervolgens 
vast gehouden worden voor een lange tijd door de FDC’s op een complement-afhankelijke 
manier. De immuuncomplexen die worden vastgehouden door de FDC’s zijn betrokken bij de 
selectie van gemuteerde B cellen in het GC die een hogere affiniteit hebben voor het anti-
geen dat de reactie induceerde. Dit gebeurt samen met de hulp van folliculaire helper T (Tfh) 
cellen. Eerst presenteren de FDC’s het antigeen aan GC-B cellen die het proces van SHM 
en isotype switching ondergaan. Dan presenteren deze B cellen het antigeen aan Tfh cellen 
die op hun beurt overlevingssignalen voor deze hoog-affiene GC-B cellen afgeven waardoor 
deze geselecteerd worden. De geselecteerde GC-B cellen zullen dan daarna differentiëren in 
geheugen B cellen of in plasma cellen.
Recent is gevonden dat MZ-B cellen ook de Fc-like receptor FcRL5 tot expressie brengen. 
Dit is een receptor, die na binding van IgG de signalering via de B cel receptor (BCR) kan 
remmen. Zoals dat al bekend is voor FcRL4 dat bind aan IgA en dat ook de BCR signalering 
inhibeert, maar niet de signalering via TLR’s. TLR’s kunnen slechts een beperkt aantal mole-
culaire patronen van vooral micro-organismen herkennen, en zijn dus niet zo specifiek. Deze 
receptoren zijn vooral betrokken bij responsen van het aangeboren immuunsysteem. Het is 
mogelijk dat bezetting van de FcRL5 door IgG op een vergelijkbare manier als FcRL4 werkt. 
Hierdoor zou het BCR signaal van de MZ-B cel geremd kunnen worden en het signaal van 
de TLR’s versterkt. Op deze manier krijgen de MZ-B cellen als het ware meer eigenschappen 
van het aangeboren immuunsysteem en worden de MZ-B cellen meer B cellen die reageren 
op microbiële antigenen. Op deze manier kunnen deze cellen heel snel reageren op microbi-
ele antigenen in het bloed op een BCR-onafhankelijke manier.
Omdat de MZ-B cellen zo’n breed repertoire hebben en ook geheugen B cellen (zowel IgM 
als IgG) omvatten en zij zich bevinden in een soort van pre-geactiveerd stadium zijn deze 
cellen uitermate geschikt  om snel te kunnen reageren op een breed spectrum van antigenen 
in het bloed om op die manier bloedvergiftiging (sepsis) te voorkomen. Het aanspreken van 
deze B cellen door middel van vaccinatie zal in de toekomst cruciaal zijn voor een effectieve 
















































































Opsomming en algemene bespreking in het Afrikaans
Die marginale zone (MZ) is ‘n goed-gedefinieerde, anatomiese kompartement van die milt 
wat die follikels en peri-arteriolêre limfosiet skedes (PALS) omsluit. Saam vorm hierdie drie 
strukture die sogenaamde “wit pulp”, wat meestal limfosiete bevat. Die MZ vorm ‘n koppel-
vlak met die rooi pulp, ‘n gebied wat baie ryk is in veneuse sinusse. Benewens makrofage 
en dendritiese selle, bestaan die MZ hoofsaaklik uit ‘n unieke bevolking van B-selle, die 
MZ-B selle, wat unieke fenotipiese, ontwikkelings- en funksionele eienskappe besit. As 
gevolg van hul anatomiese posisie op die grens van die rooi pulp, asook die ryk toevoer 
van kapillêre, wat wyd oop presenteer ( Kusumi et al, 2015), speel die MZ-B selle vermoe-
delik ‘n belangrike rol in die vinnige immuunreaksies teen bloed-oordraagbare patogene. 
Daar word besonders geglo dat hulle vinnig reageer tenopsigte van polisakkaried antigene 
(TI-2 antigene) op die oppervlak van geinkapsuleerde bakterieë, soos pneumokokke en 
meningokokke  (Guinamard et al, 2000; Kruetzmann et al, 2003; Martin et al, 2001; Vinuesa 
et al, 2003). Dus kan die MZ en MZ-B selle in die besonder, ‘n belangrike rol vervul in die 
voorkoming van sepse. 
Vorige eksperimentele data lewer bewyse van die teenswoordigheid van beide naïef B selle 
en geheue B selle binne in die MZ (Colombo et al, 2013; Dammers et al, 2000a; Dunn-Walters 
et al, 1995; Gatto et al, 2007; Gatto et al, 2004; Makowska et al., 1999; Tangye et al, 1998; 
Weller et al, 2004b; Zandvoort et al, 2001). Naïewe B selle is selle wat nog nie teenoor anti-
gene gereageer het nie, en word gekenmerk deur die vorming van immunoglobulien M (IgM) 
molekules op hul seloppervlakmembraan, wat gekodeer word deur die ongemuteerde gene 
van die immunoglobulien veranderlike gebied (IGV). Naïewe MZ-B selle word waarskynlik 
gevorm vanaf oorgangs B selle, óf follikulêre (FO) B selle. Inteenstelling met naïewe B selle, 
is geheue B selle antigeen ervare selle, wat dikwels ook nie-IgM isotypes uitdruk op hul mem-
brane, wat gekodeer word deur gemuteerde IGV gene. Die teenswoordigheid van somatiese 
hypermutasies (SHM) binnein die IGV streke van Ig gene is die primêre kenmerk van geheue 
B selle. Mutasies vorm in beide die Ig swaarketting (IGH) en Ig ligteketting V streekgene ty-
dens die humorale immuunrespons, wanneer antigeengeaktiveerde B selle uitbrei in ‘n T-sel 
afhanklike (TD) wyse binne in die kiemsentrums (GC). Alhoewel, daar geglo word dat GC’s 
oor die algemeen die plekke is waar hierdie SHM van IGV gene uitsluitlik plaasvind, is die 
oorsprong van gemuteerde MZ-B selle egter nog steeds ontseker. Die doel van hierdie tesis 
is om milt MZ-B selle te analiseer in die geheue kompartement van die rot, omsodoende tot 
insigte te bekom oor die oorsprong en funksie van hierdie geheue MZ-B-selle. As proefdier-
model vir die bestudering van die immuunstelsel, bied rotte ‘n selektiewe voordeel bo muise, 
omdat rotte ‘n veel groter MZ het wat maklik gevisualiseer kan word. 








































Rot immunoglobulien veranderlike streek gene 
Om die teenswoordigheid van SHM in die IGV gene te bepaal, is dit van kardinale belang 
om inligting beskikbaar te hê oor die genomiese volgorde van hul kiemlyn V geen eweknieë 
(ongeherrangskikte genomiese volgordes). Dit was dus belangrik om die kiemlyn IGV gene 
in die rot te identifiseer. Daarbenewens sal die kennis van die genomiese rangskiking van die 
organisasie van die IGH lokus van die rot, insluitend die lokalisering van kiemlyn nukleotied 
volgordes van alle IGH veranderlike ketting gene, help om moontlike verdere verskille in hu-
morale immuunreaksies, asook die Ig repertoires tussen rotte aan die een kant en mense en 
muise aan die ander, te ontrafel.
Hierdie studies in rotte het moontlik geword toe die genoom van die Brown Norway (BN/
SsNHsdMCW) rot (Rattus norvegicus) beskikbaar gestel word deur die Rat Genomic Se-
quence Consortium (RGSC) in 2004 (Gibbs et al, 2004; Havlak et al, 2004). Die genomiesein-
ligting bevat ook die IGH lokus geleë te chromosoom 6q32-33. Dit is tog belangrik om te weet 
dat die BN rot wat gebruik is vir hierdie analise wel verskil van ander ingeteelde rotstamme, 
en ook by die IGH lokus. Byvoorbeeld, Dammers et al. het deur beperkings fragment lengte 
polimorfisme analise gevind dat die BN rot aansienlik verskil van ander rotstamme (soos bv 
PVG, AO, Lew) in terme van die getal IGV gene in die IGH lokus wat aan die IGHV5 familie 
behoort (Dammers, 2001). Hierdie data dui daarop dat die BN rot waarskynlik ‘n laer aantal 
IGHV5 gene bevat in vergelyking met ander rotstamme. Die V gedeelte van die IGH ketting 
word gekodeer deur drie verskillende geensegmente (gene): IGH veranderlike (IGHV), IGH 
diversiteit (IGHD), en IGH aansluitend (IGHJ) geensegmente, terwyl die immunoglobulien 
kappa veranderlike (IGK) en immunoglobulien lambda (IGL) ketting V domeine geïnkripteer 
word deur ‘n kombinasie van hierdie (IGKV-IGKJ) en immunoglobulien kappa veranderlike 
(IGLV-IGLJ) gene, onderskeidelik (Roth, 1996). Hoewel die genomiese volgorde van die rat 
gepubliseerd is, is die presiese aantal en ligging van IGHV gene insluitend IGHD en IGHJ 
gene nie vasgestel nie. Daarom het ons eers verskeie beskikbare bronne ontleed vir kiemlyn 
IGHV, IGHD en IGHJ gene. Hierdie bronne was: die genomiese volgorde RGSC genoom-
samestelling weergawe 3.4, die ongekarteerde volgordes van “contigs” in die “ongeplaasde 
afdeling” van die NCBI databasis en nuut gestigte “bactigs” van die BN rotgenoom, nog nie 
in die RGSC V3.4 samevatting nie. In hoofstuk 2 bied ons aan ‘n geannoteerde kaart van die 
V-streek van die IGH lokus van die BN rot, wat nie net funksionele en nie-funksionele IGHV 
gene insluit nie, maar ook die IGHD en IGHJ gene. In hoofstuk 3 bied ons ‘n update van die 
rot IGH kettinglokus en vergelyk dit met die muis en die mens, asook ‘n beskrywing van wat 
tans bekend is oor die organisasie van die Ig ligtekettinglokus in die rot. In geheel was ons 
instaat om 353 IGHV gene te identifiseer, waarvan 131 vermoedelik funksioneel is. Hierdie 
getal van 131 funksionele IGHV gene in rotte is die grootste onder soogdiere waarvan die 
hele genoomvolgorde beskikbaar is, in lyn met die voorspelling van Das (2009). Hierdie getal 
kan selfs verhoog word omdat die hele genoomkaart van die veranderlike streek van die IGH 








































lokus nog ‘n aantal klein gapings vertoon (~ 300 KB) waarvan die nukleotiedvolgorde nog 
bepaal moet word. 
Deur die rot genomiese volgorde van die IGVH lokus te ontleed het ons 11 nuwe IGHV gene 
in die BN rot geïdentifiseer. Dié NOVEL IGHV gene was ongeïdentifiseerde IGHV gene wat 
nie geplaas is in die huidige beskikbare NCBI databasis samestelling (RGSC v3.4); en is 
ook nie gelys in die Internasionale Immunogenetiese (IMGT) databasis (http://imgt.cines.fr) 
nie (Lefranc et al, 1999). Hierdie gene is gevind tussen rot genomiese volgordes beskikbaar 
vanaf die Mensgenoom Volgordebepalingsgroep van die Baylor College of Medicine, en is 
nog nie opgeneem nie in die rot samestelling van die BN rot op die hedige tydstip nie. Dus 
saam met die 11 nuut geïdentifiseer IGHV gene, bestaan die BN rotgenoom uit ten minste 
353 individuele IGHV gene. Soortgelyk aan die muis, kan rot IGHV gene onder verdeel word 
in IGHV gene families, op die basis van nukleotiedvolgorde identiteit. Individuele IGHV gene 
behoort aan dieselfde familie indien die IGHV gene meer as 80% van hul nukleotiedes deel 
(Brodeur en Riblet, 1984). Uit die 11 nuut ontdekte IGHV gene, behoort 6 aan die IGHV2 gene 
familie en 5 behoort aan die IGHV5 gene familie. Verder, omdat die grootste gapingsgebiede 
op die IGH lokus waarvan die nukleotiedvolgorde nog bepaal moet word, geleë is in die ge-
bied van die IGHV2 en IGHV5 geen families is dit geloofwaardig om te aanvaar dat hierdie 
11 nuut ontdekte IGHV gene geleë is in ‘n gapingstreek van die IGHV2-IGHV5 streke van 
samestelling v3.4. Ter opsomming het ons studies bewys gelewer dat rotte die hoogste aantal 
(funksionele) kiemlyn IGHV gene bevat onder alle soogdierspesies wat tot dusver bestudeer 
is. Gegewe die idee dat BN rotte ‘n laer aantal IGHV5 gene het in vergelyking met ander 
rotstamme (Dammers et al., 2001), en die feit dat daar ‘n paar gapings is in die genomiese-
volgorde, veral in die gebied van die IGHV2 en IGHV5 gene families, is dit geloofwaardig om 
te aanvaar dat die getal IGHV gene in die rot selfs hoër kan wees. 
Soortgelyk aan die muis en die mens is die oorgrote meerderheid van die rot IGHV gene ge-
oriënteerde in dieselfde rigting as die IGHD en IGHJ gene en dus word wegdoen aansluiting, 
in plaas van inversionale aansluiting, verkieslik die meeste gebruik as rekombinasie meganis-
me by die IGH locus. In beide rotte en muise is die algehele digtheidsverspreiding van IGHV 
gene (aantal IGHV gene per Mb nukleotiedvolgorde) die hoogste by die 3’-kant van die IGHV 
streek in vergelyking met die 5’-kant. Soos verwag, deel rotte en muise ‘n noue evolusionêre 
verwantskap soos vertoon deur die byna identies organisasie van IGHV geenfamilies en die 
verspreiding van IGHV gene by die IGH locus. 
Op hede, is min bekend oor die genomiese organisasie van die rot Ig ligteketting loci, wat 
IGK en IGL ketting gene insluit. Soortgelyk aan die IGHV kettinggene, deel rotte en muise 
byna dieselfde aantal IGKV gene, met rotte wat effens meer funksionele IGKV gene as die 
muis bevat. Oor die algemeen, toon die vergelyking tussen die twee spesies daarop dat hulle 
dieselfde basiese struktuur van hul IG loci behou, insluitend ‘n soortgelyke rangskiking van 
die IGHVDJ orde. In hierdie spesie is diversiteit in die IG antigeen-erkennings setel gestig 








































gedurende die vroeë B sel ontwikkeling deur herrangskikking van V streekgene (of gene 
segmente) geleë op die IGH en IGL ketting loci. Rekombinasie by die IGH, IGK en IGL loci 
veroorsaak die ontwikkeling van ‘n hoogs gediversifiseerde IG (teenliggaam) primêre reper-
toire met ‘n wye verskeidenheid van teenliggaam spesifieke eienskappe. 
IgM uitdrukkende marginale zone geheue B-selle 
Vorige eksperimente het bewys gelewer vir die bestaan van gemuteerde, IgM uitdrukkende, 
geheue MZ-B-selle in die rot (Dammers et al, 2000b ). Dammers et al. het bewys dat minder 
as 20% van die MZ-B selle wat vanaf die milt van PVG rotte geïsoleer was gemuteerde IGHV 
gene bevat. Hierdie bevindinge is in sterk kontras met die mens, waar >95% van die milt-
siekte MZ-B selle gemuteerde is (Colombo et al, 2013; Dunn-Walters et al, 1995;Tangye et al, 
1998). Een moontlike verklaring vir hierdie verskil kan wees dat slegs een spesifieke IGHV 
geenfamilie (nl. die IGHV5 familie, die homoloog van PC7183 in die muis) in die (PVG) rot 
ontleed is, en dat hierdie IGHV geenfamilie nie verteenwoordigend was vir ander IGHV gene, 
of IGHV geenfamilies nie. Met die vorming van die genomiese kiemlyn IGHV geen repertoire 
van die BN rot (hoofstuk 2), het dit moontlik geword om ander IGHV geenfamilies ook akku-
raat te analiseer. Om moontlike stam verskille te vermy het ons die BN rotstam gebruik, in 
plaas van die PVG rotstam, wat voorheen gebruik is (Dammers et al, 2000b). In hoofstuk 4 
lewer ons verslag oor die frekwensie van gemuteerde volgordes in herrangskikte IGHV-Cμ 
transkripte wat vanaf FACS gesorteer MZ-B selle afgelei is (IgM hoog IgD laag)), in vergelyking 
met FO-B selle (IgM laag IgD hoog)) vanaf die volwasse BN rot milt. Die analise is beperk tot drie 
verskillende IGHV geenfamilies, wat in grootte verskil: IGHV3, IGHV4 en IGHV5. Hierdie drie 
IGHV geenfamilies het 4, 2 en 26 funksionele IGHV gene, onderskeidelik. Die IGHV3 en 
IGHV4 geenfamilies is gekies om te bepaal of daar ‘n verskil in mutasie frekwensies onder 
lede van die IGHV geenfamilies is, wat relatief klein is, en om hierdie frekwensie te vergelyk 
met die tweede grootste IGHV geenfamilie (IGHV5) in die rot, wat voorheen ook ontleed is in 
die PVG rot (Dammers et al, 2000a). Die BN rotstam bevat 26 funksionele IGHV5 (kiemlyn) 
gene in vergelyking met die 28 kiemlyn gene in die PVG rot. Soos reeds aangetoon, het ons 
gevind dat milt MZ-B selle ‘n aansienlik hoër persentasie gemuteerde volgordes uitdruk as 
wat daar FO-B selle is, en al drie van die IGHV geenfamilies wat ontleed is het bygedra tot 
hierdie verskil. BN rotte het ‘n effens hoër proporsie (27%) van MZ-B selle gemuteerde IgM 
molekules uitgedruk wat deur IGHV5 familie gene gekodeer is, in vergelyking met hierdie 
proporsie in die PVG rot (10-20%) (Dammers et al, 2000a). Dié verskil in mutasie frekwensie 
kan wees as gevolg van die stam verskille wat tussen die PVG en BN rot stamme bestaan, 
soos byvoorbeeld, die feit dat BN rotte minder IGHV gene het, of mag dalk ook veroorsaak 
word deur verskillende omgewingstoestande (mikrobiese omgewing mikrobiota) van die twee 
rotstamme. Ontleding van die IGHV3 geenfamilie het getoon dat ‘n soortgelyke proporsie 
(ongeveer 30%) van gemuteerde IgM gekodeerde volgordes gevind kan word in MZ-B selle 








































wat van die BN rot afkomstig is. In sterk kontras met  hierdie twee IGHV families, is ‘n baie 
hoë persentasie (66%) van die IGHV4 volgordes van gesuiwerde MZ-B selle gemuteer. Hier-
die familie bestaan uit slegs twee moontlike funksionele IGHV gene, hoewel slegs een van 
hierdie lede waarskynlik funksioneel uitgedruk word. Ons bevindinge toon dus dat die verhou-
ding van gemuteerde volgordes afkomstig van MZ-B selle wissellend is tussen verskillende 
IGHV geenfamilies in die BN rot, en dat in total, ‘n hoër proporsie (27-66%) IGHV gene gemu-
teer is in vergelyking met dié (10-20%) van gemuteerde volgordes wat voorheen vir die IGHV5 
geenfamilie in PVG rotte gevind is (Dammers et al, 2000a; Makowska et al, 1999). Ons waar-
neming dat die hoogste persentasie van gemuteerde frekwensies plaasgevind het in die en-
kele funksionele lid IGVH4 geenfamilie, dui daarop dat daar meer antigeen drukseleksie kan 
wees op hierdie spesifieke IGHV4 geen in die uitbreiding van sy beskikbare repertoire deur 
SHM. Alhoewel daar in totaal ‘n hoër gemiddelde aantal gemuteerde volgordes onder rot 
MZ-B selle is as wat voorheen waargeneem is, is die frekwensie van gemuteerde volgordes 
onder menslike MZ-B selle nog baie hoër. In die mens, is byna al die MZ-B selle gemuteerde 
(Colombo et al, 2013; Dunn-Walters et al, 1995; Tangye et al, 1998). Ons waarneming dat 
daar variasie in frekwensie is vir gemuteerde IGHV gene tussen die verskillende IGHV fami-
lies, kan ook bydra tot die verskil in gemuteerde MZ-B selle tussen mense en rotte, juis omdat 
in die mens die ontleding van gemuteerde IGHV gene beperk is tot ‘n beperkende stel van 
IGHV gene. Dunn-Walters et al. het slegs twee spesifieke IGHV gene ontleed: die IGHV6 
gene en IGHV4.21 gene. Dit is formeel moontlik dat hierdie IGHV gene meer gemuteerde is 
as ander gene. Maar die ontleding van Tangye et al (1998) het bewys dat Ig gene geïsoleerd 
van IgM + geheue B-selle onder IGHV5 en IGHV6 geenfamilies is almal gemuteer en bewys 
dat die hoë frekwensie van mutasies nie net as gevolg van individuele IGHV gene is nie. 
Verder, het Colombo et al. (2013) die teenwoordigheid van mutasies in die menslike IGHV1, 
IGHV3 en IGHV4 geenfamilies ondersoek en vergelyk met onder milt afgelei MZ-B selle (Ig-
Mhoë CD27+), GC B selle en klas verwisselde B selle. Ook het hulle gevind dat die meeste van 
die MZ-B selle gemuteer is, alhoewel teen ‘n laer gemiddelde aantal mutasies as beide GC 
en klas verwisselde B selle. Tog is die gemiddelde aantal mutasies in die menslike MZ-B 
selle (11,8) ( Colombo et al, 2013) hoër vir beide rot IgM+ MZ-B selle (8,8) en rot IgG+ MZ-B 
selle (7) ( Hendricks et al, 2011). Dit kan wees as gevolg van die feit dat die mens minder 
funksionele IGHV gene het as rotte. Ons postuleer dat die groter aantal kiemlyn IGHV gene 
in knaagdiere is as gevolg dat rotte minder mutasies benodig om hul teenliggaam repertoire 
na immunisering te diversifiseer as mense, want rotte kan kodeer vir ‘n groter poel van verskil-
lende teenliggaampies vir hul primêre repertoire. Daarbenewens is dit moontlik dat die vers-
kille in lewensduur en omgewingstoestande ook bydra tot verskille in die gemiddelde mutasie 
frekwensie per IGHV gene. Tydens hul (lang) lewens mag mense baie meer verskillende an-
tigene teëkom as laboratorium rotte wat in goed beheerde laboratoriumteostande leef. Ge-
heueselle soos oor die algemeen geglo word gegenereer in GCs. Dit is egter nog steeds 








































omstrede of gemuteerde (geheue) IgM+ MZ-B selle afkomstig is van GCs en of hulle ‘n GC-
onafhanklike B sel bevolking verteenwoordig. In die mens, het Colombo et al. (Colombo et al, 
2013) ‘n klein aantal klonaal verwante volgordes waargeneem wat gedeel word tussen MZ-B 
selle en GC B selle, wat ‘n aanduiding gee dat die gemuteerde IgM+ MZ-B selle van GCs af-
gelei kan word. In teenstelling hiermee het Weill et al (Weill et al, 2009; Weller et al, 2004a; 
Weller et al, 2008) voorgestel dat die (gemuteerde) IgM+ MZ-B selle nie GC-afgelei geheue 
B-selle is nie. Instede hiermee het hierdie skrywers gepostuleer dat die mutasies in die men-
slike MZ-B selle tydens hul ontwikkeling verkry word om hul primêre repertoire te diversifiseer, 
in ‘n GC (en T-sel) onafhanklike manier. Om hierdie hipotese in rotte te toets het ons in hoof-
stuk 5 ondersoek onderneem van die moontlike teenwoordigheid van gemuteerde IgM+ MZ-
B-selle in neonatale rotte. Neonatale rotte ontwikkel nie GC in die eerste weke van hul lewens 
nie (Kroese et al, 1987; van Rees et al, 1986). Dus, wanneer MZ-B selle  ongemuteerd in 
neonatale rotte voorkom, sou dit sterk argumenteer teen die hipotese van Weill et al. (Weill et 
al, 2009; Weller et al, 2004a; Weller et al, 2008), dat SHM deel is van die ontwikkelingspro-
gram van MZ-B selle. Vir hierdie doel, het ons IGHV-Cμ transkripte ontleed met behulp van 
IGHV4 en IGHV5 geenfamilies van beide MZ-B selle en FO-B selle (hoofstuk 4). Daar was 
egter geen mutasies gevind in enige van die neonatale volgordes, selfs nie in IGHV4 geenfa-
milie gene met die hoogste aantal gemuteerde volgordes (66%) in die volwasse rot. Hierdie 
resultate ondersteun die idee dat ten minste in rotte, gemuteerde IgM+ MZ-B selle wat in vol-
wasse diere voorkom bona fide geheue selle is, wat waarskynlik ontwikkel onder die invloed 
van eksterne antigeniese stimuli in GC. 
IgG uitdrukkende marginale zone geheue B-selle 
Bykomend tot onverwisselde (IgM+) MZ-B selle, kan klas verwisselde B selle ook gevind word 
binne die menslike (Ettinger et al, 2007b) en knaagdier MZ (Gatto et al, 2004). Die fenotipe 
van hierdie selle is nie duidelik nie, nog of hulle IGHV gene SHM uitstal, as kenmerk van ge-
heue B-selle. Hierdie kwessie is in hoofstuk 6 ontleed, waar ons die klas verwisselde (IgG+) 
MZ-B selle ontleed. Om IgG+ uitdrukkende B selle met ‘n MZ-B sel fenotipe te ontleed kon 
ons natuurlik nie IgM en IgD gebruik nie om MZ-B selle te definieer. Daarom het ons gebruik 
gemaak van die feit dat rot MZ-B selle lae vlakke van CD45R uitdruk, gedefinieer deur mo-
noklonale antiliggaam HIS24, en hoë vlakke van ‘n oppervlak molekuul gedefinieer deur die 
monoklonale antiliggaam HIS57. Volwasse (CD90-) MZ-B selle kan dus gedefinieer word as 
CD90- HIS24lae HIS57hoë selle, en FO-B selle CD90- HIS24hoë HIS57neg/lae selle. Van gesuiwer-
de (FACS-gesorteer) MZ-B selle (CD90- HIS24lae HIS57hoog) en FO-B selle (CD90- HIS24hoë 
HIS57neg/lo) het ons herrangskikte IGHV-Cγ transkripte geamplifiseer, spesifiek vir die IGHV5 
geenfamilie. Ter vergelyking, het ons ook IGHV-Cγ transkripte geamplifiseer van ‘n fraksie 
van selle wat klassieke klas verwisselde geheue B-selle moet insluit, naamlik IgM- IgD- B sel-
le. Ons was in staat om die teenwoordigheid van IGHV5-Cγ transkripte in alle B sel  subklasse 








































te ontleed, wat impliseer dat IgG uitdrukkende selle blykbaar ten minste twee verskillende fe-
notipes kan uitstal: selle met ‘n MZ-B sel fenotipe en selle met ‘n FO-B sel fenotipe. Ontleding 
van die individuele IGHV5 gene wat deur hierdie IgG transkripte gebring word het aan die lig 
gebring dat byna alle IGHV5 gene gemuteerde is, soos tipies is vir geheue B-selle. Ons het 
wel gesien dat die IgG uitdrukkende MZ-B selle het ‘n laer aantal mutasies in vergelyking met 
IgG uitdrukkende FO-B selle. Daar was geen verskille in die gebruik van IGHV, IGHD en IGHJ 
gene tussen die IgG+ MZ-B selle en IgG+ FO-B sel subversamelings en die H-CDR3 lengtes 
was ook vergelykbaar tussen hierdie twee subversamelings. ‘n Belangrike waarneming was 
dat ons stelle klonaal verwante IgG-koderende volgordes gevind het (volgordes met identiese 
H-CDR3 streke, en gebruik van dieselfde IGHV gene) wat verkry is uit die selle met lede in 
beide MZ-B sel (CD90- HIS24lae HIS57hoë) en FO-B sel (CD90- HIS24hoë HIS57neg/laag) fraksies. 
Sulke stelle klonaal verwante reekse is ook gevind onder die gemuteerde IgM+ MZ-B selle 
en IgM+ FO-B selle (hoofstuk 4). Hierdie waarnemings dui sterk daarop dat (gemuteerde) ge-
heue B-selle met ‘n MZ-B sel fenotipe en ‘n FO-B sel fenotipe ‘n gemeenskaplike oorsprong 
het. Die oorsprong van hierdie selle is nie duidelik nie. Klassieke geheue B-selle (dit wil sê 
gemuteerde klas verwisselde B-selle) word gewoonlik gegenereer in die GC. By hierdie setels 
ondergaan die gemuteerde B selle ‘n vorm van keuring vir die antigeen wat die GC reaksie 
dryf. Dié antigeen seleksie is van kardinale belang om die affiniteit van die Ig molekules wat 
die antigeen kan herken te verhoog, en word weerspieël in die feit dat die IGHV gene wat 
kodeer vir die Ig molekules nie toevallige mutasies uitstal. Sommige van die mutasie patrone 
van IgG ingebou volgordes van beide die MZ-B selfraksie en FO-B selfraksie wys inderdaad 
tekens van antigeen seleksie (Hoofstuk 6), en bevoordeel dus die hipotese dat hulle albei 
gegenereer word in die GCs. Die bevinding dat gemuteerde IgM+ geheue B-selle afwesig is in 
neonatale diere, waarin GCs nog nie gevorm kan word nie, ondersteun die hipotese dat ook 
IgM+ geheue MZ-B selle in die GC gegenereer word. Die gemeenskaplike oorsprong van IgM+ 
en IgG+ geheue MZ-B selle en FO-B selle, geïllustreer deur die teenswoordigheid van klo-
naalverwante gemuteerde volgordes tussen MZ-B en FO-B selle, dui daarop dat ten minste 
sommige GC-afgeleide geheue selle kan óf ‘n FO-B sel fenotipe of ‘n MZ-B sel fenotipe kry. 
Die faktore wat hierdie differensiasie teenoor hierdie twee fenotipes aandryf is nie bekend nie. 
Slotopmerkings 
B-selle in die MZ is ‘n heterogene selbevolking en beide naïef MZ-B selle, klas verwisselend 
en onverwisselende geheue MZ-B selle is teenwoordig by hierdie unieke plek in die milt. 
Naïef MZ-B selle besit ongemuteerde Ig gene, produseer lae affiniteit IgM molekules en vorm 
‘n eerste linie van verdediging teen indringer patogene. Die teenliggaam repertoire wat deur 
hierdie B selle uitgedruk word is veronderstel om selekteer te word om koolhidrate te bind, 
wat op mikro-organismes voorkom (Galson et al, 2015). Hierdie antigene benodig nie die 
hulp van T selle om hul respons uit te voer nie. Verder bevat die swaar kettings van die IgM 








































molekules wat deur naïef MZ-B selle uitgedruk word korter H-CDR3 streke in vergelyking 
met FO-B-selle in rotte (Dammers et al, 2000a) en muise (Carey et al, 2008). Korter H-CDR3 
word geassosieer met polireaktiewe teenliggaam response, dit wil sê die binding van ‘n teen-
liggaam met verskillende strukturele antigeniese elemente (Schroeder et al, 1995). Geheue 
MZ-B selle druk hoë affiniteit Ig molekules uit, wat gerig word op (mikrobiese) antigene wat 
hul tydens hul leeftyd teekom. Dus laat die teenswoordigheid van naïef MZ-B selle en geheue 
MZ-B selle toe dat die MZ ‘n vinnige ingebore en verworwe teenliggaam response kan uitvoer 
teen mikrobiese antigene, teen beide TI en TD antigene. ‘n Nuwe rol vir neutrofiele is deur 
Puga et al. voorgestel in die reaksie van MZ-B selle (Puga et al, 2012). Neutrofiele teenswoor-
dig in die milt veroorsaak die produksie van IgM+ deur die aktivering van MZ-B selle via BAFF, 
April en IL-21 om teenliggaam response te maak teen TI-2 antigene soos LPS, na induksie 
van Blimp-1 binnein die geaktiveerde MZ-B selle (Puga et al, 2012). BAFF en IL-21 kan ook 
IgG+ MZ-B selle stimuleer, in ‘n T-sel onafhanklike wyse, om teenliggaam afskeidende plasma 
selle te word (Ettinger et al., 2007a). 
MZ-B selle, kom voor in ‘n pre-geaktiveerde vorm, en hulle druk hoë vlakke van komplemen-
treseptor (CR) CD21 (Timens et al, 1989) en toll-like reseptore (TLRs) uit (Gunn en Brewer, 
2006) wat onderliggend is van die feit dat MZ-B selle toegerus is vir ‘n vinnige en maklike 
aktivering in (primêre) immuun response. Verdere stel Garraud et al. (Garraud et al, 2012) 
voor dat die heen en weer oorskakeling van MZ-B selle tussen die MZ en follikels, en die ver-
voer van antigene (immuun komplekse) na follikulêre dendritiese selle (FDC) ontsluit die rol 
van MZ-B selle as antigeen-presenterende selle wat deel neem in immuunreaksies om hoë 
affiniteit teenliggaampies te genereer. Hulle het opgemerk dat die tipe 1 interferon wat gepro-
duseer word in reaksie op bloed-oordraagbare patogene, die sphingosin-1-fosfaat reseptor 
1 (S1P1) en S1P3 inaktiveer sodat MZ-B selle uit die MZ kan migreer in reaksie op CXCL13, 
wat ten hoogste in follikels uitgedruk word. Die afwaartse regulering van CXCR5 kan toelaat 
dat MZ-B selle uit die follikels migreer en terug keer na die MZ. Hiermee vervoer MZ-B selle 
immuunkomplekse na die follikels waar die immuunkomplekse derhalwe opgevang word deur 
FDC in ‘n komplement afhanklike wyse. Die immuunstelsel komplekse vasgevang deur die 
FDCs is betrokke by die seleksie van gemuteerde B selle wat hoër affiniteit Ig uitdruk met 
behulp van follikulêre hulper T (TFH) selle. Eers sal FDCs antigeen presenteer aan die B 
selle wat SHM, en klas wisselendsrekombinasie (CSR) ondergaan. Daarna sal hierdie B selle 
antigene aan TFH selle presenteer wat oorlewingseine sal oordra aan hierdie hoë affiniteit 
GC B-selle, wat tot seleksie lei. Die geselekteerde GC B selle sal dan óf in geheue B-selle of 
plasma selle differensieer.
MZ-B selle druk die inhiberende IgG bindende Fc tipe receptor FcRL5 uit (Wilson et al, 2012). 
Na IgG binding, kan dié reseptor die BCR inhibeer. Soos bekend is vir FcRL4, wat IgA bind, 
en ook die BCR inhibeer, dit is moontlik dat die besetting van FcRL5 deur IgG ‘n soortgelyke 








































rol vervul as ‘n aangepaste ingebore molekulêre skakelaar wat die BCR sein demper en die 
sein van die TLR verhoog (Sohn et al, 2011). Hiermee word  MZ-B selle meer soos ingebore 
B selle wat nie meer so veel staatmaak op hul BCR vir hul aktivering nie, maar meer op die 
TLRs. Sodoende kan hierdie selle vinnig reageer op mikrobiologiese antigene wat in die 
bloed teenswoordig is, in ‘n onafhanklike BCR wyse. Aangesien MZ-B selle ‘n breë repertoire 
het, geheue B-selle bevat (IgM en IgG) en in ‘n soort van pre-geaktiveer staat is, is hierdie 
selle ideaal geskik om vinnig te reageer op ‘n wye verskeidenheid van die bloedsgedraagte 
antigene om sepse te verhoed. Toespitsing op hierdie B selle deur inenting in die toekoms 
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